Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
40766183	s-dgpaba	— (—)	3500	3726	100.00%	Distribution not available
40766183	s-dgpaba	eliau/ml (u/ml)	2403	2480	0.00%
40766183	s-dgpaba	u/ml (u/ml)	774	823	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Coeliac disease

395

691

6.09

217.15

1.4

1.1

15.16

2.67

u/ml

8.38

158

318

Irritable bowel syndrome

536

1678

3.28

135.94

1.1

2.71

3.26

u/ml

0.42

188

926

Diseases of the digestive system

632

2175

2.94

134.06

1.3

1.0

11.36

2.73

u/ml

8.14

233

960

Other diseases of intestines

1409

4619

1.75

75.06

1.1

3.03

2.94

u/ml

0.09

555

2460

Examination and observation for other reasons

799

2297

2.03

67.46

1.1

3.89

2.82

u/ml

0.91

274

1315

Autoimmune diseases

1375

4225

1.67

60.27

1.1

4.96

2.41

u/ml

4.50

563

2223

Diarrhoea and gastroenteritis of presumed infectious origin

1239

4893

1.68

59.41

1.1

3.45

2.89

u/ml

0.65

568

2399

Used for control exclusion in common control thyroid runs

1293

3965

1.66

55.67

1.1

4.33

2.41

u/ml

3.19

546

2099

Intestinal infectious diseases

1357

4819

1.62

54.69

1.1

3.07

2.91

u/ml

0.17

618

2354

Diseases of oesophagus, stomach and duodenum

1231

4548

1.63

51.44

1.1

3.64

2.85

u/ml

0.84

447

2389

Other and unspecified iron deficiency

385

1703

2.29

49.41

1.1

5.23

3.33

u/ml

0.70

111

795

Autoimmune diseases excluding thyroid diseases

1234

4185

1.62

49.38

1.1

5.50

2.42

u/ml

5.02

461

2200

Autoimmune diseases excluding thyroid diseases, strict definition

1205

4093

1.62

48.67

1.1

5.52

2.42

u/ml

4.94

453

2148

Dermatitis and eczema

1299

5119

1.58

48.63

1.1

2.79

3.01

u/ml

0.25

556

2546

Sleep disorders

1097

4917

1.62

46.95

1.1

2.71

2.84

u/ml

0.15

551

2434

Abdominal and pelvic pain

1150

3559

1.63

46.77

1.1

3.45

3.02

u/ml

0.41

507

1867

Behavioural syndromes associated with physiological disturbances and physical factors

1133

5035

1.61

46.33

1.1

2.90

2.91

u/ml

0.02

569

2463

Symptoms and signs involving the digestive system and abdomen

1145

3560

1.62

45.26

1.1

3.18

3.02

u/ml

0.14

510

1868

Other gastritis (incl. Duodenitis)

230

836

2.79

44.97

1.2

1.1

6.47

3.31

u/ml

0.86

383

Insomnia

1083

4949

1.61

44.40

1.1

2.67

2.87

u/ml

0.23

542

2467

Iron deficiency anaemia

444

2135

2.07

44.34

1.1

4.90

3.21

u/ml

0.74

131

973

Nutritional anaemias

496

2427

1.99

44.17

1.1

4.51

3.17

u/ml

0.62

146

1103

Gastro-oesophageal reflux disease

722

3551

1.77

43.78

1.1

2.61

2.90

u/ml

0.20

258

1842

Noninfective enteritis and colitis

578

3125

1.87

42.76

1.1

2.08

3.24

u/ml

2.48

198

1551

Headache

851

4101

1.67

41.49

1.1

2.70

3.05

u/ml

0.45

382

2162

Pain in joint

677

2465

1.76

38.63

1.1

3.32

2.87

u/ml

0.26

258

1319

Other noninfective gastroenteritis and colitis

312

1406

2.25

38.50

1.1

2.21

4.06

u/ml

1.74

653

Gastrointestinal diseases

778

2284

1.72

38.37

1.1

1.0

3.91

2.29

u/ml

1.58

348

1346

Triptan medication for migraine, min. 3 purchases

835

3906

1.65

38.17

1.1

2.16

2.83

u/ml

1.24

428

2054

Other functional intestinal disorders

466

2256

1.93

38.15

1.1

3.25

3.50

u/ml

0.10

139

1097

Functional dyspepsia

315

1442

2.21

37.47

1.1

4.78

3.19

u/ml

0.67

108

755

Triptan medication for migraine, single purchase ok

996

4330

1.57

36.70

1.1

2.22

3.07

u/ml

2.02

509

2204

Migraine, single triptan purchase ok & required. ICD-code if available is included

996

4330

1.57

36.70

1.1

2.22

3.07

u/ml

2.02

509

2204

Hypothyroidism, strict autoimmune

826

3346

1.63

35.91

1.1

1.0

3.16

2.38

u/ml

0.78

384

1738

Anaemias

401

1297

2.05

35.72

1.1

3.84

3.54

u/ml

0.11

134

799

Inflammatory bowel disease treatment related agents

1298

4955

1.47

34.46

1.1

2.48

3.04

u/ml

1.02

537

2525

ILD medications

1297

4806

1.47

33.97

1.1

3.00

3.01

u/ml

0.01

528

2478

First line medication for Crohn's disease

1277

4706

1.47

33.83

1.1

2.76

3.04

u/ml

0.33

535

2431

Chronic gastritis

224

933

2.42

33.22

1.1

5.36

3.42

u/ml

0.41

390

Migraine

716

3570

1.64

32.75

1.1

2.40

2.96

u/ml

0.56

328

1868

GASTRO-related operations

1005

3281

1.55

32.71

1.1

2.59

2.76

u/ml

0.20

423

1870

Any gastric operation

1005

3281

1.55

32.71

1.1

2.59

2.76

u/ml

0.20

423

1870

Diverticular disease of intestine

602

2236

1.73

32.26

1.1

3.41

3.34

u/ml

0.03

199

1140

Disorders of conjunctiva

978

5236

1.51

31.19

1.1

3.41

2.85

u/ml

0.51

451

2580

ILD medications: prednisolone, methylprednisolone, prednisone

1212

4658

1.46

31.16

1.1

2.83

2.98

u/ml

0.15

502

2417

Conjunctivitis

923

5088

1.53

31.14

1.1

3.40

2.79

u/ml

0.54

429

2526

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

707

4321

1.60

30.36

1.1

3.10

2.69

u/ml

0.30

353

2200

Diaphragmatic hernia

315

1565

2.03

30.26

1.1

3.86

3.36

u/ml

0.11

660

Benign neoplasm of colon, rectum, anus and anal canal

495

2466

1.75

29.59

1.1

4.04

3.58

u/ml

0.17

157

1060

Hypothyroidism, other/unspecified

977

4305

1.50

29.48

1.1

3.09

3.00

u/ml

0.07

457

2105

Coxibs

286

689

2.20

29.40

1.0

1.1

1.69

2.81

u/ml

1.47

133

301

Hypothyreosis and Thyroxine purchase for inclusion criteria

1011

4481

1.49

29.26

1.1

3.06

2.98

u/ml

0.06

470

2169

Autoimmune diseases related-to ILD

925

5301

1.50

29.16

1.1

2.53

2.90

u/ml

0.52

331

2700

Disorders of the thyroid gland

1022

4519

1.48

28.81

1.1

3.13

3.01

u/ml

0.09

471

2209

Benign neoplasm: Colon

408

2146

1.83

28.46

1.1

3.35

3.71

u/ml

0.18

133

870

Atopic dermatitis

781

4160

1.55

28.33

1.1

2.54

3.01

u/ml

0.66

389

2209

Allergic conjunctivitis

725

4546

1.57

28.22

1.1

3.06

2.75

u/ml

0.23

362

2280

Constipation

865

3977

1.51

27.47

1.1

2.91

3.20

u/ml

0.24

334

1894

Special screening examination for infectious and parasitic diseases

400

1632

1.83

26.40

1.1

2.48

2.53

u/ml

0.03

206

1032

Acetic acid derivatives and related substances

274

668

2.15

26.40

1.1

2.84

2.82

u/ml

0.01

124

297

Medical observation and evaluation for suspected diseases and conditions

711

2310

1.58

25.98

1.1

3.25

2.81

u/ml

0.35

276

1325

Collagenous colitis

120

427

2.87

24.82

1.1

1.0

1.84

3.30

u/ml

1.28

191

Oral corticosteroids

1109

4663

1.42

24.57

1.1

2.69

3.05

u/ml

0.40

470

2391

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

998

4814

1.44

24.45

1.1

4.14

2.90

u/ml

1.08

307

2468

Chronic diseases of tonsils and adenoids

912

3961

1.46

24.22

1.1

2.92

3.04

u/ml

0.09

469

1954

Pruritus

146

583

2.55

24.05

1.1

1.0

6.14

3.40

u/ml

0.41

288

Cystitis

918

3752

1.46

24.03

1.1

2.28

3.27

u/ml

2.13

446

1788

Pain (limb, back, neck, head abdominally)

763

2512

1.53

23.96

1.1

3.25

2.95

u/ml

0.22

345

1335

Sleep disorders (combined)

1191

4489

1.40

23.88

1.1

3.00

2.83

u/ml

0.16

570

2187

Budesonide

184

820

2.28

23.68

1.1

1.32

3.95

u/ml

4.26

432

Recurrent or chronic depression

490

2084

1.67

23.48

1.1

2.49

3.03

u/ml

0.69

229

1127

Noninfectious colitis NAS

170

746

2.31

22.71

1.1

1.73

2.96

u/ml

1.61

354

Symptoms and signs concerning food and fluid intake

118

436

2.74

22.62

1.1

3.95

4.27

u/ml

0.08

186

General symptoms and signs

1190

4323

1.39

22.38

1.1

2.61

3.06

u/ml

0.71

524

2284

Symptoms and signs involving the circulatory and respiratory systems

1164

4231

1.38

21.84

1.1

2.62

2.95

u/ml

0.46

546

2223

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1179

4671

1.38

21.83

1.1

4.25

2.62

u/ml

1.66

444

2441

Other diseases of upper respiratory tract

1115

4208

1.39

21.33

1.1

2.61

3.12

u/ml

0.77

538

1995

Depression or dysthymia

667

2425

1.53

21.26

1.1

2.37

3.17

u/ml

1.31

286

1203

Intestinal infectious diseases

994

5423

1.40

21.24

1.1

3.22

2.95

u/ml

0.25

424

2671

Other soft tissue disorders, not elsewhere classified

1016

4266

1.40

21.23

1.1

2.23

2.95

u/ml

1.79

402

2183

Hypothyroidism, strict autoimmune, 3 medication purchases required

884

4214

1.42

20.66

1.1

3.14

2.92

u/ml

0.17

406

2046

Fenamates

153

441

2.38

20.20

1.1

1.35

2.82

u/ml

1.58

205

Other headache syndromes

477

3034

1.58

19.76

1.1

2.39

3.13

u/ml

0.80

211

1557

Abnormal weight loss

104

390

2.71

19.55

1.1

4.45

2.37

u/ml

0.88

152

Iron deficiency

217

3.42

19.41

1.1

1.81

2.19

u/ml

0.30

122

Postmenopausal atrophic vaginitis

244

690

1.97

19.22

1.1

2.67

3.38

u/ml

0.36

131

309

Weight loss

112

444

2.56

18.83

1.1

4.09

2.39

u/ml

0.79

173

Other and unspecified anaemias

293

1591

1.76

18.48

1.1

6.74

3.80

u/ml

0.62

646

Inflammatory bowel disease

357

2156

1.67

18.44

1.1

1.83

3.18

u/ml

3.90

135

1126

Other anaemias

294

1606

1.75

18.01

1.1

6.74

3.83

u/ml

0.61

655

Other specific joint derangements/joint disorders

861

4005

1.40

17.96

1.1

3.14

2.70

u/ml

0.34

347

2083

Exposure to unspecified factor

1032

5518

1.35

17.92

1.1

3.43

2.90

u/ml

0.46

420

2739

Soft tissue disorders

1124

4321

1.34

17.81

1.1

2.97

2.94

u/ml

0.03

519

2209

Other antidepressants

1035

3910

1.36

17.76

1.1

2.66

3.09

u/ml

0.53

464

1987

Female infertility, cervical, vaginal, other or unspecified origin

354

1376

1.69

17.71

1.1

2.28

2.86

u/ml

0.55

179

748

ILD medications: immunosuppressive drugs

654

4228

1.44

17.47

1.1

3.68

3.13

u/ml

0.27

212

2191

Hypothyroidism and >3 levothyroxin purchases

403

1406

1.63

17.32

1.1

3.18

3.36

u/ml

0.10

213

866

Hypothyroidism, levothyroxine purchases

403

1406

1.63

17.32

1.1

3.18

3.36

u/ml

0.10

213

866

Chronic sinusitis

435

2803

1.56

17.10

1.1

2.17

3.10

u/ml

1.57

208

1404

Other symptoms and signs involving the digestive system and abdomen

169

830

2.06

17.09

1.1

1.52

3.83

u/ml

3.24

415

Pain and other conditions associated with female genital organs and menstrual cycle

278

1470

1.76

17.04

1.1

2.32

2.69

u/ml

0.18

114

786

Asthma, including avohilmo

1221

5230

1.32

17.01

1.1

2.78

3.01

u/ml

0.26

572

2545

Hypothyroidism (congenital or acquired)

404

1417

1.62

16.95

1.1

3.15

3.42

u/ml

0.15

213

872

Diseases of the skin and subcutaneous tissue

1044

3898

1.35

16.83

1.1

3.00

2.89

u/ml

0.08

449

2045

Migraine with aura

340

2084

1.65

16.67

1.1

2.38

3.00

u/ml

0.28

146

1126

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

445

1421

1.58

16.34

1.0

1.1

2.54

3.39

u/ml

0.78

214

830

Disturbances of skin sensation

322

1957

1.66

16.32

1.1

1.46

3.07

u/ml

6.14

121

1065

Aplastic and other anaemias

314

1760

1.67

16.30

1.1

7.26

4.02

u/ml

0.76

721

Diarrhoea and gastroenteritis of presumed infectious origin

737

4783

1.39

16.13

1.1

3.43

2.96

u/ml

0.43

310

2373

Systemic connective tissue disorders

310

1879

1.66

15.85

1.1

4.64

3.36

u/ml

0.44

877

Follow-up examination after treatment for conditions other than malignant neoplasms

450

1943

1.54

15.76

1.1

4.86

2.91

u/ml

0.87

177

1113

Dermatitis

567

3920

1.45

15.61

1.1

3.33

3.13

u/ml

0.11

204

1929

Pain in limb

830

4075

1.37

15.54

1.1

2.41

2.95

u/ml

0.67

317

2081

Other systemic involvement of connective tissue

247

1421

1.75

15.35

1.1

4.56

3.37

u/ml

0.39

660

Other dorsopathies, not elsewhere classified

1082

4305

1.32

15.30

1.1

3.04

2.88

u/ml

0.13

478

2224

Menorrhagia

374

1297

1.61

15.27

1.1

2.95

2.96

u/ml

0.00

150

671

Malaise and fatigue

449

2391

1.52

15.24

1.1

2.93

3.49

u/ml

0.35

139

1156

Other diseases of anus and rectum

224

1252

1.80

15.22

1.1

3.42

3.93

u/ml

0.21

605

Osteoporosis

181

883

1.93

15.22

1.1

3.86

3.45

u/ml

0.13

304

Dentofacial anomalies [including malocclusion]

802

4743

1.36

15.17

1.1

2.02

3.04

u/ml

4.15

419

2407

Hernia of abdominal wall, postoperative

155

773

2.02

15.06

1.1

3.15

3.76

u/ml

0.25

422

Other bacterial intestinal infections

209

1154

1.83

14.95

1.1

2.61

3.32

u/ml

0.43

538

Chronic rhinitis, nasopharyngitis and pharyngitis

333

2089

1.61

14.87

1.1

2.75

3.45

u/ml

0.58

156

1036

Certain infectious and parasitic diseases

765

2771

1.39

14.87

1.1

2.81

2.88

u/ml

0.05

373

1420

Urticaria and erythema

406

2669

1.53

14.75

1.1

3.63

2.99

u/ml

0.32

155

1335

Other special examinations and investigations of persons without complaint or reported diagnosis

648

2310

1.43

14.72

1.1

3.17

2.81

u/ml

0.24

283

1325

Other systemic involvement of connective tissue (FG)

241

1379

1.74

14.58

1.1

3.87

3.34

u/ml

0.17

669

IBD patients in KELA-register

265

1579

1.69

14.57

1.1

1.99

3.25

u/ml

2.46

105

860

Asthma (mode)

794

3112

1.37

14.56

1.1

2.48

2.90

u/ml

0.49

358

1613

Urticaria

350

2244

1.57

14.29

1.1

3.78

3.00

u/ml

0.36

136

1147

Migraine with aura and triptan purchases

225

1291

1.77

14.26

1.1

1.51

2.89

u/ml

2.87

701

Opioids

1056

4206

1.31

14.07

1.1

2.49

2.88

u/ml

0.55

459

2245

Other and unspecified dermatitis

472

3232

1.47

14.03

1.1

3.50

3.21

u/ml

0.13

161

1604

Female infertility

365

1418

1.58

13.84

1.1

2.04

2.85

u/ml

1.10

181

767

Pain in throat and chest

878

3966

1.33

13.80

1.1

3.02

u/ml

0.00

366

2095

Disorders of thyroid, IBD co-morbidities

230

925

1.76

13.79

1.1

2.91

3.10

u/ml

0.11

115

563

Codeine

989

4105

1.31

13.69

1.1

2.66

2.90

u/ml

0.23

421

2202

Episodal and paroxysmal disorders

1152

4564

1.29

13.65

1.1

2.78

3.04

u/ml

0.26

519

2268

Inflammatory bowel disease, strict (require KELA)

265

1613

1.66

13.47

1.1

1.99

3.23

u/ml

2.40

105

860

Other diseases of urinary system

977

4201

1.31

13.47

1.1

2.65

3.19

u/ml

0.69

456

2020

Nausea and vomiting

235

1357

1.71

13.40

1.1

2.63

3.69

u/ml

0.88

649

Haemorrhoids and perianal venous thrombosis

223

1295

1.73

13.33

1.1

2.64

4.07

u/ml

1.13

623

Abnormalities of heart beat

329

2071

1.57

13.30

1.1

2.87

3.35

u/ml

0.23

131

1012

Endometriosis

375

1427

1.55

13.28

1.1

2.37

2.87

u/ml

0.32

160

747

Heartburn

112

520

2.18

13.26

1.1

1.0

1.96

3.81

u/ml

1.49

273

Oxicams

176

524

1.92

13.25

1.1

5.83

3.18

u/ml

0.77

220

Codeine or tramadol medication

1128

4822

1.28

13.20

1.1

2.64

2.95

u/ml

0.36

473

2490

Noninflammatory disorders of female genital tract

488

1671

1.47

13.19

1.1

2.93

2.91

u/ml

0.01

229

838

Excessive, frequent and irregular menstruation

441

1622

1.50

13.17

1.1

3.67

2.78

u/ml

0.46

189

822

Dorsopathies

1100

4351

1.29

13.10

1.1

3.01

2.92

u/ml

0.07

494

2235

Dysphagia

179

984

1.83

13.05

1.1

1.53

4.13

u/ml

3.86

464

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

476

3215

1.45

13.04

1.1

1.76

3.10

u/ml

5.69

230

1582

Any death

159

2082

0.54

13.04

1.0

1.1

6.12

3.86

u/ml

0.85

812

Propionic acid derivatives

266

794

1.69

12.97

1.0

1.1

2.24

3.30

u/ml

1.01

125

322

Symptoms and signs involving the skin and subcutaneous tissue

661

4762

1.36

12.94

1.1

2.44

3.10

u/ml

0.75

246

2356

Diseases of the eye and adnexa

958

3673

1.31

12.92

1.1

3.33

2.76

u/ml

0.57

461

1962

Asthma (only as main-diagnosis)

726

3101

1.36

12.91

1.1

2.66

2.90

u/ml

0.22

316

1609

Asthma

793

3101

1.35

12.90

1.1

2.54

2.90

u/ml

0.41

358

1609

Dorsalgia

1031

4281

1.29

12.80

1.1

3.30

2.88

u/ml

0.35

426

2219

Caries of enamel

924

5132

1.30

12.73

1.1

2.97

2.88

u/ml

0.07

424

2600

Other menopausal disorders

268

912

1.67

12.66

1.1

1.87

3.04

u/ml

1.09

131

451

Shoulder lesions

668

2962

1.37

12.62

1.1

2.45

2.97

u/ml

0.69

276

1546

Asthma (only as main-diagnosis), excluding more controls

719

3043

1.36

12.53

1.1

2.65

2.92

u/ml

0.24

314

1599

Abnormalities of breathing

941

4209

1.30

12.51

1.1

3.23

2.96

u/ml

0.21

413

2208

Persons encountering health services in other circumstances, wide

1151

4676

1.27

12.33

1.1

4.14

2.62

u/ml

1.75

440

2442

Paracetamol or NSAID medication

191

527

1.84

12.27

1.0

1.1

1.98

3.91

u/ml

1.57

216

Pollen allergy

265

1635

1.62

12.18

1.1

3.56

3.15

u/ml

0.17

122

819

Myalgia

250

1541

1.64

12.13

1.0

1.1

1.87

3.10

u/ml

1.46

829

Persons encountering health services for examination and investigation

634

2310

1.38

12.10

1.0

1.1

2.89

2.81

u/ml

0.06

283

1325

Tonsillectomy and adenotomy

750

3933

1.33

12.10

1.1

3.05

2.85

u/ml

0.17

399

2072

Glomerular disorders in diseases classified elsewhere

105

494

2.15

12.07

1.1

11.88

2.69

u/ml

0.99

225

Mycoses

835

5577

1.31

12.06

1.1

2.06

3.06

u/ml

3.16

413

2707

5-aminosalicylic acid

234

1424

1.66

11.97

1.1

1.97

3.45

u/ml

2.78

100

789

Benign neoplasms

1021

4401

1.28

11.95

1.1

3.44

2.78

u/ml

0.70

485

2254

Vasomotor and allergic rhinitis

431

2942

1.45

11.90

1.1

3.12

3.16

u/ml

0.02

205

1482

Infections, IBD-co-morbidities

167

650

1.85

11.86

1.1

2.95

2.90

u/ml

0.02

380

Anti-inflammatory and antirheumatic products, non-steroids

261

795

1.66

11.86

1.0

1.1

2.45

3.30

u/ml

0.68

119

322

Cough

371

2378

1.48

11.67

1.1

2.61

3.43

u/ml

0.57

135

1119

Fissure and fistula of anal and rectal regions

203

1198

1.71

11.65

1.1

2.20

3.87

u/ml

2.27

649

Acute upper respiratory infections

1001

4846

1.28

11.50

1.1

3.25

2.93

u/ml

0.28

446

2368

Prurigo nodularis

3.84

11.38

1.0

8.88

1.64

u/ml

—

Kela-code for severe mental illness

149

2646

0.56

11.37

1.0

1.1

2.73

3.08

u/ml

0.18

1397

Neurotic, stress-related and somatoform disorders

936

5126

1.28

11.36

1.1

2.84

2.86

u/ml

0.02

367

2659

Asthma, excluding more controls

770

3043

1.32

11.32

1.1

2.52

2.92

u/ml

0.44

351

1599

Bullous disorders

216

2.73

11.24

1.3

1.0

6.93

1.87

u/ml

1.19

Sicca syndrome [Sjögren]

431

2.19

11.18

1.1

1.0

3.61

3.34

u/ml

0.06

198

Anxiety disorders

939

5135

1.28

11.17

1.1

2.83

2.87

u/ml

0.04

368

2662

Other bacterial intestinal infections

150

823

1.84

11.11

1.1

3.13

2.95

u/ml

0.07

358

Depression

973

5199

1.27

11.08

1.1

2.31

2.88

u/ml

1.46

341

2712

Chronic laryngitis and laryngotracheitis

121

620

1.97

11.06

1.1

1.0

3.11

3.55

u/ml

0.11

284

Other pulmonary diagnosis

818

3139

1.31

11.06

1.1

2.98

2.89

u/ml

0.06

381

1631

Certain infectious and parasitic diseases

1023

4040

1.27

11.04

1.1

2.88

2.85

u/ml

0.02

456

2092

Neurological diseases, wide definition

408

1400

1.47

11.04

1.0

1.1

2.83

2.98

u/ml

0.09

201

809

Pain, not elsewhere classified

273

1762

1.56

10.94

1.1

2.32

3.57

u/ml

1.23

921

Neurological diseases

955

3765

1.28

10.77

1.1

2.71

3.10

u/ml

0.38

439

1951

Lichen simplex chronicus and prurigo

268

2.50

10.76

1.1

5.14

3.00

u/ml

0.76

127

Osteopathies and chondropathies

468

3132

1.40

10.70

1.1

4.27

3.28

u/ml

0.31

141

1479

Low back pain

746

4113

1.31

10.58

1.1

3.63

2.88

u/ml

0.49

284

2130

Cervicalgia

184

1088

1.70

10.55

1.1

4.37

3.06

u/ml

0.44

549

Other diseases of liver

164

940

1.76

10.54

1.1

3.72

3.29

u/ml

0.10

441

Deviated nasal septum

260

1676

1.56

10.44

1.1

1.99

3.81

u/ml

3.76

124

818

Genitourinary diseases

578

2130

1.37

10.39

1.1

2.40

3.41

u/ml

1.77

291

1103

Other specified/unspecified systemic involvement of connective tissue

293

2.40

10.25

1.1

3.71

2.12

u/ml

0.66

139

Faecal incontinence

330

2.30

10.22

1.1

2.55

4.29

u/ml

0.73

136

Endometriosis of pelvic peritoneum

186

1060

1.69

10.21

1.1

1.60

3.19

u/ml

2.59

582

Candidiasis

281

1856

1.52

10.19

1.1

1.74

3.04

u/ml

2.89

129

895

Second line medication for Crohn's disease

542

4036

1.35

10.02

1.1

4.00

3.08

u/ml

0.43

183

2021

Bacterial intestinal infections, IBD co-morbidities

148

840

1.78

9.86

1.1

3.10

2.98

u/ml

0.04

364

Excluding asthma or asthma-COPD overlap

806

3139

1.29

9.82

1.1

3.01

2.89

u/ml

0.08

374

1631

COPD differential diagnosis

800

3114

1.29

9.79

1.1

3.00

2.90

u/ml

0.07

371

1614

Cholecystectomy

590

3842

1.33

9.76

1.1

2.21

3.16

u/ml

1.71

235

1840

ILD differential diagnosis

799

3112

1.29

9.73

1.1

3.00

2.90

u/ml

0.07

370

1613

Selective serotonin reuptake inhibitors

953

3959

1.26

9.69

1.1

2.40

3.12

u/ml

1.41

439

1996

Enthesopathies of lower limb, excluding foot

215

1355

1.60

9.64

1.1

4.75

3.27

u/ml

0.37

718

Diseases of liver

269

1783

1.52

9.60

1.1

3.24

3.51

u/ml

0.09

841

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

191

1172

1.64

9.58

1.1

2.08

3.60

u/ml

2.30

620

Ulcerative colitis

241

1566

1.55

9.47

1.1

2.01

3.41

u/ml

2.59

833

Other disorders of urethra and urinary system

634

3494

1.31

9.46

1.1

2.97

3.16

u/ml

0.13

257

1658

Schizophrenia

1044

0.37

9.45

1.1

3.98

3.12

u/ml

—

553

Other joint disorders

970

4095

1.25

9.42

1.1

3.39

2.78

u/ml

0.68

448

2121

Other/unspecified enthesopathies of lower limb, excluding foot

395

2.13

9.40

1.1

6.30

3.49

u/ml

0.33

209

Adenomyosis (Endometriosis of uterus)

125

686

1.84

9.35

1.1

1.0

3.05

2.90

u/ml

0.03

336

Voice disturbances

229

1476

1.56

9.33

1.1

2.15

3.45

u/ml

1.88

697

Thyrotoxicosis, other and/or unspecified

186

1143

1.64

9.28

1.1

3.30

3.14

u/ml

0.08

553

Schizophrenia, schizotypal and delusional disorders

132

2284

0.57

9.27

1.0

1.1

3.63

3.17

u/ml

0.13

1206

Chronic kidney disease

170

1000

1.67

9.24

1.1

8.82

3.91

u/ml

0.67

369

Schizophrenia or delusion

131

2269

0.57

9.24

1.0

1.1

3.63

3.17

u/ml

0.13

1198

Crohn disease

142

815

1.76

9.17

1.1

1.97

3.74

u/ml

2.16

423

Benign neoplasm: Colon, unspecified

154

903

1.72

9.16

1.1

4.47

3.91

u/ml

0.12

338

Exposure to other specified factors

739

5343

1.27

8.99

1.1

2.71

3.00

u/ml

0.29

313

2660

Polyp of the female genital tract

284

1091

1.50

8.92

1.1

2.22

3.02

u/ml

0.83

138

553

Intestinal malabsorption

225

2.49

8.92

1.1

1.0

9.99

1.84

u/ml

0.66

105

Other diseases of stomach and duodenum

213

2.52

8.89

1.2

1.0

5.49

2.84

u/ml

—

Other diseases of the digestive system

192

1201

1.61

8.89

1.1

1.0

3.70

2.64

u/ml

0.35

497

Other and unspecified polyneuropathies, also in other diseases

127

712

1.80

8.86

1.1

4.43

3.53

u/ml

0.31

279

All anxiety disorders

713

4420

1.28

8.83

1.1

2.67

2.83

u/ml

0.15

282

2413

Substance abuse

273

3734

0.68

8.80

1.1

4.18

3.13

u/ml

0.48

1907

Asthma and allergy

176

1068

1.64

8.80

1.1

3.42

3.11

u/ml

0.10

582

Rheumatism, unspecified

121

671

1.82

8.78

1.1

2.82

3.27

u/ml

0.17

326

Other extrapyramidal and movement disorders in other diseases

179

1105

1.63

8.78

1.1

2.69

3.57

u/ml

0.38

479

Acute upper respiratory infections of multiple and unspecified sites

759

4446

1.27

8.74

1.1

3.39

2.89

u/ml

0.36

336

2257

Endocrine, nutritional and metabolic diseases

908

3684

1.25

8.73

1.1

3.09

2.88

u/ml

0.20

418

1991

Crohn's disease of small intestine

416

2.05

8.61

1.0

2.20

2.33

u/ml

0.08

204

Mental and behavioural disorders due to alcohol

216

3146

0.66

8.59

1.1

4.00

3.27

u/ml

0.29

1600

Barrett oesophagus

142

2.86

8.56

1.1

1.0

3.19

2.10

u/ml

0.44

Rotator cuff syndrome

470

2505

1.35

8.52

1.1

2.45

3.09

u/ml

0.63

193

1267

Asthma and allergy, excluding more controls

176

1079

1.62

8.46

1.1

3.42

3.21

u/ml

0.06

584

Temporomandibular joint disorders, including avohilmo

505

3770

1.33

8.45

1.1

1.96

2.89

u/ml

2.99

255

1932

Mental and behavioural disorders due to psychoactive substance use

289

3828

0.70

8.44

1.1

4.16

3.09

u/ml

0.54

1947

Other diseases of intestine

501

1.93

8.42

1.1

2.48

3.64

u/ml

0.70

234

Other bullous disorders

117

3.06

8.37

1.5

1.0

9.16

1.54

u/ml

1.36

Viral infections characterized by skin and mucous membrane lesions

814

5589

1.25

8.33

1.1

2.53

2.98

u/ml

0.54

347

2733

L04AX Other immunosuppressants

511

3885

1.32

8.30

1.1

4.20

3.07

u/ml

0.51

169

1941

Other enthesopathies

262

1784

1.48

8.28

1.1

3.58

3.25

u/ml

0.10

104

944

Other disorders of lacrimal gland

294

2047

1.44

8.27

1.1

2.71

3.23

u/ml

0.40

108

964

Schizophrenia or delusion, excluding more controls

131

2179

0.59

8.27

1.0

1.1

3.63

3.09

u/ml

0.15

1223

Symptoms and signs involving speech and voice

262

1785

1.48

8.26

1.1

2.28

3.42

u/ml

1.70

111

837

Diseases of the respiratory system

640

2479

1.30

8.25

1.1

3.59

2.68

u/ml

0.69

299

1245

Disorders of other endocrine glands

405

2929

1.37

8.25

1.1

4.22

3.12

u/ml

0.53

135

1400

Substance abuse, excluding more controls

273

3342

0.69

8.15

1.1

4.18

3.05

u/ml

0.53

1789

Impingement syndrome of shoulder

178

1119

1.60

8.14

1.1

2.12

3.47

u/ml

1.82

546

Migraine without aura and triptan purchases

212

1391

1.54

8.09

1.1

1.98

2.92

u/ml

1.18

752

Restless leg syndrome

119

675

1.78

8.06

1.1

2.66

2.75

u/ml

0.02

299

Unspecified mental disorder

201

3044

0.66

8.06

1.0

1.1

2.80

2.98

u/ml

0.10

1611

Neoplasms

885

3788

1.24

8.04

1.0

1.1

3.34

2.75

u/ml

0.54

438

1977

Ulcerative colitis (strict definition, all Crohn cases excluded)

150

908

1.67

8.03

1.1

2.12

3.65

u/ml

2.03

487

Ulcerative colitis (strict definition, require KELA)

172

1079

1.61

7.98

1.1

2.18

3.67

u/ml

1.96

568

Continuous positive airway pressure

157

805

1.65

7.98

1.1

5.96

4.01

u/ml

0.45

424

Mental and behavioural disorders due to alcohol, excluding acute intoxication

166

2601

0.63

7.97

1.1

4.30

3.31

u/ml

0.32

1310

Inflammatory diseases of female pelvic organs

656

3792

1.28

7.96

1.1

2.59

2.72

u/ml

0.10

294

1900

Polyneuropathies and other disorders of the peripheral nervous system

142

849

1.68

7.94

1.1

4.19

3.29

u/ml

0.34

333

Mood [affective] disorders

988

5259

1.22

7.90

1.1

2.43

2.88

u/ml

0.98

349

2721

Sleep apnoea, including avohilmo

875

4394

1.24

7.87

1.1

3.22

2.88

u/ml

0.26

400

2186

Allergic asthma (mode)

276

1878

1.45

7.85

1.1

3.64

2.99

u/ml

0.29

128

1020

Allergic asthma (mode), excluding more controls

276

1878

1.45

7.85

1.1

3.64

3.02

u/ml

0.28

128

1025

Fever of other and unknown origin

487

3295

1.32

7.84

1.1

2.38

3.44

u/ml

1.22

168

1661

Depression medications

408

1498

1.38

7.83

1.0

1.1

2.83

3.07

u/ml

0.16

217

926

Abnormal findings on examination of blood, without diagnosis

305

1981

1.42

7.77

1.1

3.85

3.86

u/ml

0.00

870

Migraine without aura

262

1810

1.46

7.77

1.1

2.31

2.73

u/ml

0.47

119

982

Chronic lower respiratory diseases

1180

5244

1.20

7.74

1.1

2.84

2.94

u/ml

0.10

545

2578

Mood disorders

988

5263

1.22

7.73

1.1

2.43

2.88

u/ml

0.97

349

2722

Atopic dermatitis, strict definition with reimbursement

368

2603

1.37

7.72

1.1

3.70

3.09

u/ml

0.36

166

1381

KRA_PSY_EATING, excluding more controls

135

801

1.70

7.72

1.1

3.58

2.48

u/ml

0.52

448

Alcohol use disorder, ICD-based

154

2445

0.63

7.69

1.1

4.61

3.34

u/ml

0.38

1236

Irregular menses

573

3521

1.29

7.67

1.1

3.01

2.57

u/ml

0.30

258

1847

Anxiety disorders, excluding more controls

832

4386

1.24

7.62

1.1

2.80

2.88

u/ml

0.08

334

2346

Eating disorder

135

809

1.69

7.54

1.1

3.58

2.76

u/ml

0.35

405

Allergic rhinitis

369

2687

1.37

7.53

1.1

3.10

2.87

u/ml

0.12

172

1391

Other and unspecified urticaria

205

1357

1.52

7.53

1.1

2.78

3.10

u/ml

0.18

676

Polyuria

144

877

1.65

7.52

1.1

2.94

3.44

u/ml

0.29

376

Disorders of lacrimal system

346

2516

1.38

7.50

1.1

2.59

3.21

u/ml

0.61

136

1163

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

166

1049

1.60

7.50

1.1

2.21

3.49

u/ml

1.69

551

Anxiety (asthma-related co-morbidities)

687

4237

1.26

7.50

1.1

2.71

2.86

u/ml

0.14

273

2347

Nonorganic sleeping disorders

217

1455

1.50

7.49

1.1

2.72

3.36

u/ml

0.40

758

Parasetamol

808

3300

1.24

7.45

1.1

2.73

2.96

u/ml

0.19

379

1786

Speech therapy

201

1329

1.52

7.40

1.1

5.37

3.36

u/ml

0.53

593

Lower back pain or/and sciatica

984

5315

1.21

7.38

1.1

3.19

2.83

u/ml

0.28

387

2680

Herpesviral [herpes simplex] infections

259

1804

1.45

7.36

1.0

1.1

1.83

3.06

u/ml

2.49

115

934

Nonorganic sleeping disorders, excluding more controls

217

1462

1.50

7.33

1.1

2.72

3.11

u/ml

0.22

815

Thyroiditis, ILD-related definition

124

735

1.70

7.25

1.1

3.06

3.31

u/ml

0.12

372

Other spirochaetal diseases

240

1653

1.46

7.23

1.1

2.29

3.59

u/ml

1.50

777

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

493

3758

1.30

7.20

1.1

2.58

3.08

u/ml

0.62

189

1806

Mixed connective tissue disease

334

2.06

7.20

1.1

1.0

3.47

2.63

u/ml

0.32

151

Alcohol dependence

1395

0.53

7.14

1.0

1.1

2.28

3.38

u/ml

0.85

691

Other/unspecified dorsalgia

327

2362

1.38

7.14

1.1

2.25

2.99

u/ml

0.66

114

1214

Eating disorders

146

907

1.63

7.10

1.1

3.43

2.63

u/ml

0.40

451

Other spirochaetal diseases

243

1685

1.45

7.08

1.1

2.48

3.60

u/ml

1.13

792

Fibromyalgia

106

606

1.77

7.07

1.1

3.53

3.40

u/ml

0.04

326

Arthropathies

978

4106

1.21

6.94

1.1

3.34

2.79

u/ml

0.57

452

2123

Gastroduodenal ulcer

127

764

1.66

6.91

1.1

4.90

3.87

u/ml

0.16

316

Factors influencing health status and contact with health services

269

938

1.44

6.88

1.1

2.54

2.61

u/ml

0.05

111

578

Diseases of male genital organs

367

1359

1.37

6.87

1.1

3.42

3.18

u/ml

0.12

180

691

Thyrotoxicosis

217

1482

1.47

6.86

1.1

3.11

3.24

u/ml

0.08

101

709

Postmenopausal bleeding

182

624

1.56

6.86

1.1

2.46

3.38

u/ml

0.49

260

Renal failure

245

1509

1.44

6.82

1.1

9.03

3.80

u/ml

0.88

582

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

456

3510

1.30

6.81

1.1

2.52

3.12

u/ml

0.73

167

1666

Spirochaetal infections, other/unspecified

237

1649

1.44

6.80

1.1

2.19

3.56

u/ml

1.91

772

Adverse effects, not elsewhere classified

204

1380

1.49

6.80

1.1

4.31

2.98

u/ml

0.52

686

Benign neoplasm: Transverse colon

341

2.01

6.79

1.1

1.0

1.75

2.51

u/ml

0.52

128

Lyme disease

234

1625

1.45

6.78

1.1

1.99

3.58

u/ml

2.74

762

Benign neoplasm: Ascending colon

467

1.85

6.78

1.1

2.71

3.14

u/ml

0.16

166

GI-bleeding

181

1193

1.52

6.78

1.0

3.96

2.66

u/ml

0.43

492

Bronchitis

1008

5307

1.20

6.76

1.1

3.48

2.85

u/ml

0.56

430

2630

Disorders of synovium and tendon

476

3228

1.30

6.76

1.1

3.86

2.88

u/ml

0.64

215

1693

Other eating disorders

441

1.89

6.73

1.1

4.14

2.93

u/ml

0.37

221

Crohn disease (strict definition, all UC cases excluded)

310

2.06

6.68

1.0

1.1

1.75

2.25

u/ml

0.36

151

Undetermined asthma, excluding more controls

113

668

1.70

6.67

1.1

2.28

3.97

u/ml

0.90

343

Asthma, hospital admissions , main diagnosis only

765

5527

1.22

6.67

1.1

2.81

3.00

u/ml

0.17

323

2701

Medical treatment for female infertility

293

2114

1.39

6.65

1.1

2.02

2.81

u/ml

1.42

158

1213

Spirochaetal infections, other/unspecified

386

1.94

6.63

1.1

1.0

2.32

2.70

u/ml

0.13

160

Other general symptoms and signs

301

2.07

6.62

1.0

1.1

2.71

4.03

u/ml

0.42

147

Dizziness and giddiness

620

3934

1.25

6.60

1.1

2.60

3.20

u/ml

0.75

234

1907

Other viral diseases

414

3142

1.31

6.59

1.1

3.52

2.95

u/ml

0.36

210

1595

Atopic dermatitis, strict definition

361

2655

1.34

6.55

1.1

3.69

2.97

u/ml

0.44

163

1371

Dyshidrosis [pompholyx]

3.01

6.50

1.1

1.0

2.31

1.62

u/ml

0.39

294

3525

0.73

6.49

1.1

4.20

3.18

u/ml

0.46

107

1785

Generalized anxiety disorder

202

1378

1.48

6.49

1.1

2.49

2.86

u/ml

0.25

752

Diseases of the musculoskeletal system and connective tissue

610

2432

1.26

6.43

1.1

3.49

2.96

u/ml

0.34

294

1318

Undetermined asthma

113

676

1.68

6.40

1.1

2.28

4.00

u/ml

0.92

338

Extrapyramidal and movement disorders

241

1702

1.42

6.39

1.1

2.97

3.57

u/ml

0.29

722

Procreative management

359

2248

1.34

6.38

1.1

2.62

3.13

u/ml

0.50

175

1193

Complications of medical and surgical care

608

4496

1.25

6.35

1.1

2.69

3.02

u/ml

0.37

220

2216

1060

4614

1.19

6.34

1.1

3.42

2.83

u/ml

0.55

452

2290

Injuries to the ankle and foot

723

5265

1.22

6.33

1.1

2.64

3.00

u/ml

0.32

309

2699

Mood disorders, excluding more controls

898

4461

1.20

6.32

1.1

2.50

2.89

u/ml

0.70

325

2360

Oter anti-inflammatory and antirheumatic agents, non-steroids

120

393

1.69

6.27

1.1

3.13

3.82

u/ml

0.26

153

Lactose intolerance

168

2.43

6.25

1.2

1.0

4.50

1.58

u/ml

1.29

272

3360

0.73

6.21

1.1

3.72

3.25

u/ml

0.21

1693

Asthma (diagnoses ohter than nonallergic)

799

5497

1.21

6.13

1.1

2.71

3.02

u/ml

0.33

340

2668

Diabetic nephropathy

498

1.77

6.12

1.1

15.67

3.49

u/ml

0.98

173

Other external causes of accidental injury

829

3431

1.21

6.12

1.1

3.37

2.88

u/ml

0.39

375

1810

Disorders of skin appendages

472

3707

1.28

6.10

1.1

4.05

2.86

u/ml

0.79

202

1869

Other disorders of kidney and ureter

521

1.76

6.08

1.1

8.53

3.24

u/ml

0.58

214

Acute sinusitis

526

3876

1.26

6.07

1.1

2.83

2.80

u/ml

0.02

229

2025

Biguanides

565

4288

0.80

6.07

1.1

2.46

2.90

u/ml

0.48

227

2143

Unspecified/other endometriosis

117

721

1.64

5.99

1.1

2.45

2.81

u/ml

0.14

409

Dermatitis herpetiformis

3.11

5.97

1.6

1.0

11.18

1.45

u/ml

1.42

Ovarian cyst

347

1498

1.34

5.97

1.1

4.81

2.85

u/ml

0.82

151

773

Other diseases of oesophagus

316

1.98

5.96

1.2

1.1

6.20

2.36

u/ml

0.40

133

Other disorders of eye and adnexa

137

879

1.57

5.91

1.1

2.70

3.70

u/ml

0.70

425

Certain disorders involving the immune mechanism

153

1006

1.53

5.90

1.1

3.23

3.11

u/ml

0.04

474

Other intervertebral disc disorders

731

3620

1.22

5.85

1.1

2.36

2.97

u/ml

1.10

324

1900

Plantar fascial fibromatosis

513

1.75

5.84

1.0

1.1

5.54

2.92

u/ml

0.25

252

Any operation in hilmo

134

2.15

5.83

1.0

2.50

2.68

u/ml

0.05

Persons encountering health services in circumstances related to reproduction

579

3139

1.25

5.83

1.1

3.11

3.15

u/ml

0.02

274

1622

Other enthesopathy of foot (+metatarsalgia)

529

1.73

5.80

1.1

2.07

3.05

u/ml

0.32

262

Soft tissue disorders related to use, overuse and pressure

196

1360

1.45

5.78

1.1

1.97

3.52

u/ml

2.84

682

Ethmoidectomy

118

736

1.62

5.75

1.1

1.59

3.05

u/ml

2.48

355

Type 2 diabetes, strict (exclude DM1)

585

4232

0.81

5.70

1.1

2.51

2.88

u/ml

0.37

239

2160

Thyrotoxicosis with diffuse goitre

134

864

1.56

5.68

1.1

1.0

2.83

3.23

u/ml

0.18

432

Type 2 diabetes, definitions combined

585

4227

0.81

5.65

1.1

2.51

2.87

u/ml

0.36

239

2159

Cholelithiasis

678

3839

1.22

5.64

1.1

2.31

3.06

u/ml

1.24

260

1896

Other (not insulin) diabetes medications

598

4355

0.81

5.64

1.1

2.51

2.89

u/ml

0.41

239

2202

Lumbar disc prolapse

544

3355

1.25

5.64

1.1

2.28

2.99

u/ml

1.13

252

1760

Type 1 diabetes, wide definition, subgroup 1

216

1534

1.41

5.61

1.1

6.55

3.43

u/ml

0.98

814

Hyperhidrosis

159

2.36

5.53

1.0

1.1

0.93

2.60

u/ml

1.99

Dermatographic urticaria

441

1.79

5.52

1.1

4.71

2.37

u/ml

0.44

228

Infections with a predominantly sexual mode of transmission

473

3509

1.26

5.51

1.1

2.61

2.75

u/ml

0.12

222

1906

General examination and investigation of persons without complaint and reported diagnosis

552

2310

1.25

5.51

1.1

3.27

2.81

u/ml

0.30

242

1325

Type 1 diabetes, strict (exclude DM2)

126

807

1.57

5.47

1.1

8.09

3.46

u/ml

0.87

444

Acute gastritis

265

2.02

5.42

1.1

1.38

2.18

u/ml

0.74

119

Habitual aborter

161

2.35

5.42

1.1

1.79

3.71

u/ml

0.89

Type 1 diabetes, definitions combined

126

809

1.57

5.41

1.1

8.09

3.63

u/ml

0.83

447

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

290

2175

1.34

5.40

1.1

3.18

3.35

u/ml

0.11

137

1055

Glomerular diseases

133

866

1.54

5.40

1.1

9.58

3.02

u/ml

0.92

396

Cervical disc disorders

259

1910

1.36

5.38

1.1

2.95

3.32

u/ml

0.17

110

943

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

260

2.02

5.32

1.1

1.0

4.06

2.11

u/ml

—

Other disorders of skin and subcutaneous tissue

517

3707

1.24

5.31

1.1

3.82

3.04

u/ml

0.44

181

1734

Nonalcoholic fatty liver disease

521

1.70

5.29

1.1

3.36

3.38

u/ml

0.00

260

Abnormal serum enzyme levels

157

1035

1.48

5.29

1.0

1.1

2.11

4.12

u/ml

2.54

415

Other noninflammatory disorders of vulva and perineum

552

1.68

5.27

1.1

2.20

3.29

u/ml

0.79

292

Disorders of gallbladder, biliary tract and pancreas

821

4357

1.19

5.24

1.1

2.92

3.01

u/ml

0.08

316

2184

Colonic or urogenital fistula

207

1480

1.41

5.22

1.1

2.18

3.70

u/ml

2.18

722

Complications of procedures, not elsewhere classified

691

4758

1.20

5.21

1.1

2.81

3.05

u/ml

0.25

283

2371

Vitamin B12 deficiency anaemia

332

1.88

5.20

1.1

3.54

2.32

u/ml

0.31

121

Striking against or struck by other objects

307

2334

1.32

5.19

1.1

1.81

3.25

u/ml

4.39

138

1178

FESS (DNB20)

113

718

1.59

5.15

1.1

1.60

3.06

u/ml

2.38

350

Other arthritis (FG)

254

1883

1.35

5.13

1.0

1.1

3.99

3.27

u/ml

0.25

967

Alcohol use disorder, Swedish definition

253

3106

0.74

5.13

1.0

1.1

4.37

3.35

u/ml

0.39

1565

Paralytic ileus and intestinal obstruction

139

927

1.50

5.05

1.1

1.53

4.12

u/ml

3.93

426

Fibroblastic disorders

139

928

1.50

5.04

1.0

1.1

6.65

3.42

u/ml

0.51

432

Cholelithiasis, broad definition with cholecystitis

696

3905

1.20

5.01

1.1

2.33

3.03

u/ml

1.17

264

1934

Benign neoplasm: Sigmoid colon

111

707

1.58

4.99

1.1

3.19

3.30

u/ml

0.04

267

Transport accidents

447

3078

1.25

4.97

1.1

2.57

2.82

u/ml

0.28

200

1654

Type 2 diabetes, definitions combined, including avohilmo

605

4261

0.82

4.96

1.1

2.67

2.85

u/ml

0.16

253

2175

Type 1 diabetes, wide definition

219

1595

1.38

4.95

1.1

6.46

3.40

u/ml

1.00

847

Subjective visual disturbances

202

1453

1.40

4.95

1.1

4.83

3.38

u/ml

0.35

711

Hernia

791

4476

1.19

4.95

1.1

3.21

2.90

u/ml

0.22

321

2247

Preparatory care for dialysis

161

2.26

4.93

1.2

1.0

17.38

2.39

u/ml

—

Recurrent aphthous stomatitis , including avohilmo

125

821

1.53

4.93

1.1

3.34

3.29

u/ml

0.01

367

Enlarged lymph nodes

125

821

1.53

4.92

1.1

1.85

4.14

u/ml

2.80

414

Dislocation, sprain and strain of joints and ligaments of knee

586

4457

1.21

4.91

1.1

2.71

2.93

u/ml

0.19

287

2317

Asthma, unspecified (mode), excluding more controls

454

2722

1.25

4.91

1.1

2.15

2.96

u/ml

1.53

191

1395

408

3220

1.26

4.88

1.1

2.33

3.17

u/ml

1.36

155

1579

Appendectomy

620

4925

1.21

4.88

1.1

3.80

2.77

u/ml

0.99

297

2528

Type 1 diabetes

243

1804

1.35

4.86

1.1

6.24

3.41

u/ml

1.10

942

Sleep apnoea

769

4199

1.19

4.85

1.1

3.45

2.92

u/ml

0.38

342

2079

Cervicocranial syndrome

542

1.65

4.84

1.1

1.86

3.43

u/ml

1.29

262

Spondylosis

367

2345

1.28

4.84

1.1

1.66

3.19

u/ml

4.79

116

1129

Crohn disease (strict definition, require KELA, min 2 HDR)

400

1.77

4.83

1.0

1.92

2.12

u/ml

0.13

197

Suicide or other Intentional self-harm

121

1812

0.66

4.81

1.0

1.1

2.08

3.16

u/ml

1.04

951

Asthma-related infections

499

3981

1.23

4.80

1.1

2.78

3.12

u/ml

0.24

191

1898

Asthma, hospital admission 2, infections

499

3981

1.23

4.80

1.1

2.78

3.12

u/ml

0.24

191

1898

Benign neoplasm of other and ill-defined parts of digestive system

118

770

1.54

4.80

1.1

3.49

2.97

u/ml

0.10

319

Other specified/unspecified bacterial intestinal infections

285

1.91

4.79

1.1

2.47

2.35

u/ml

0.03

115

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

263

1.81

4.77

1.0

1.1

13.12

4.10

u/ml

0.62

140

Other disorders of fluid, electrolyte and acid-base balance

179

1209

1.41

4.73

1.1

4.01

3.73

u/ml

0.07

472

Disorders resulting from impaired renal tubular function

145

2.31

4.73

1.2

1.0

29.63

2.26

u/ml

—

Hypothyroidism, drug reimbursement

167

820

1.45

4.73

1.1

3.96

3.66

u/ml

0.09

508

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

440

1.72

4.72

1.0

1.73

2.13

u/ml

0.35

223

Covid-19 confirmed case

264

1995

1.33

4.72

1.1

4.93

3.27

u/ml

0.44

908

Benign neoplasm: Rectum

107

686

1.57

4.71

1.1

7.76

3.51

u/ml

0.43

262

Benign neoplasm: Caecum

344

1.81

4.70

1.0

1.1

2.71

2.76

u/ml

0.02

124

Asthma, unspecified (mode)

456

2770

1.24

4.67

1.1

2.15

2.95

u/ml

1.52

192

1397

Other disorders of bone

175

1243

1.42

4.65

1.1

1.84

3.34

u/ml

2.35

642

Vulvovaginal ulceration/inflammation in other diseases

450

1.71

4.65

1.1

1.44

2.98

u/ml

1.45

259

Accidents

808

3431

1.18

4.63

1.1

3.44

2.88

u/ml

0.45

366

1810

Endometriosis of intestine

116

2.47

4.61

1.1

1.43

2.92

u/ml

—

Radiculopathy

103

659

1.57

4.58

1.0

1.1

1.56

3.52

u/ml

2.91

300

Oesophagitis

186

2.12

4.58

1.1

1.0

3.54

1.95

u/ml

0.49

Crohn disease (strict definition, require KELA)

407

1.74

4.57

1.0

1.92

2.10

u/ml

0.12

202

Visual disturbances and blindness

399

3193

1.25

4.56

1.1

3.93

3.17

u/ml

0.31

143

1470

Intestinal adhesions without obstruction

276

1.90

4.54

1.0

1.1

1.55

3.11

u/ml

0.88

123

Reimbursement for rheumatic diseases

463

3753

1.23

4.54

1.1

3.77

3.03

u/ml

0.38

160

1815

Chronic periodontitis, including avohilmo

586

4712

0.83

4.53

1.1

4.17

2.83

u/ml

1.28

224

2352

Other and unspecified nonorganic psychotic disorders

1499

0.64

4.53

1.0

1.1

2.66

3.33

u/ml

0.29

825

Acne

132

894

1.49

4.52

1.1

2.81

2.65

u/ml

0.09

463

Metatarsalgia

491

1.66

4.52

1.1

2.46

3.07

u/ml

0.14

239

Periodontitis

589

4720

0.83

4.50

1.1

4.16

2.83

u/ml

1.27

225

2353

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

873

0.54

4.47

1.0

1.1

1.87

3.46

u/ml

0.98

328

Tramadol

676

3491

1.19

4.45

1.1

2.96

3.06

u/ml

0.06

245

1855

Somatoform disorder

151

1054

1.44

4.45

1.1

1.51

3.47

u/ml

2.84

556

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

182

1314

1.39

4.44

1.1

1.64

2.90

u/ml

2.43

697

Biomechanical lesions, not elsewhere classified

209

2.03

4.43

1.1

1.0

2.48

2.75

u/ml

0.06

Pemphigoid

2.85

4.40

1.0

1.48

1.70

u/ml

—

Asthma/COPD (KELA code 203)

885

5226

1.16

4.40

1.1

3.02

2.89

u/ml

0.11

422

2571

Insulin, fast-acting

284

2191

1.30

4.39

1.1

5.78

3.51

u/ml

0.87

1071

Benign neoplasm: Rectum, anus and anal canal

115

762

1.52

4.39

1.1

7.76

3.52

u/ml

0.42

294

Diseases of the ear and mastoid process

1126

4938

1.15

4.38

1.1

3.01

2.89

u/ml

0.12

507

2523

Insulin, fast-acting or short human

285

2202

1.30

4.36

1.1

5.78

3.38

u/ml

0.95

1066

Other anxiety disorders

510

3646

1.22

4.34

1.1

2.83

2.77

u/ml

0.04

186

2003

Other specified/unspecified arthritis

217

1616

1.35

4.34

1.1

4.33

3.14

u/ml

0.36

820

Ulcerative colitis, NAS

126

854

1.48

4.33

1.1

2.44

3.81

u/ml

1.30

438

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

268

1.89

4.30

1.1

5.21

2.27

u/ml

0.45

153

Injuries to the knee and lower leg

1101

5347

1.14

4.26

1.1

2.63

3.06

u/ml

0.67

485

2630

Injuries to the neck

203

1503

1.36

4.24

1.0

1.1

2.93

3.32

u/ml

0.19

785

SLE (Finngen)

159

2.17

4.24

1.2

1.0

3.81

2.15

u/ml

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

185

2510

0.73

4.23

1.1

2.06

2.88

u/ml

1.15

1346

Endometriosis of ovary

152

1046

1.43

4.23

1.1

1.67

3.24

u/ml

2.41

559

COPD/asthma/ILD related infections

973

4225

1.16

4.22

1.1

3.27

2.77

u/ml

0.43

421

2154

COPD/asthma related infections

973

4225

1.16

4.22

1.1

3.27

2.77

u/ml

0.43

421

2154

Lactose intolerance, other/unspecified

153

2.19

4.21

1.2

1.0

5.13

1.69

u/ml

1.18

Pain in thoracic spine

130

892

1.47

4.21

1.1

2.28

3.43

u/ml

0.94

459

Stomatitis and related lesions

162

1158

1.41

4.20

1.1

2.72

3.26

u/ml

0.18

554

Other metabolic disorders

123

836

1.48

4.19

1.1

3.22

3.51

u/ml

0.11

410

Presence of other devices

127

864

1.47

4.19

1.1

4.63

3.84

u/ml

0.14

330

Adjustment and management of implanted device

540

1.60

4.18

1.1

4.68

3.41

u/ml

0.19

196

Psychiatric diseases

905

3913

1.16

4.17

1.1

2.56

3.01

u/ml

0.61

414

2013

Symptoms and signs involving the urinary system

551

3498

1.20

4.15

1.1

2.40

3.43

u/ml

1.66

198

1637

Type 2 diabetes

663

4564

0.85

4.13

1.1

2.81

2.90

u/ml

0.07

263

2357

Care involving dialysis

322

1.78

4.13

1.1

11.25

3.69

u/ml

—

144

Infections with a predominantly sexual mode of transmission

341

2714

1.26

4.12

1.1

2.96

2.90

u/ml

0.03

160

1477

Visual disturbances

372

2993

1.25

4.12

1.1

3.82

3.25

u/ml

0.21

136

1398

Sciatica+with lumbago

417

3122

1.23

4.11

1.1

1.84

2.94

u/ml

2.83

167

1627

Rosacea

100

654

1.54

4.10

1.1

1.0

3.58

2.96

u/ml

0.27

312

Dysplasia of cervi uteri

240

1317

1.32

4.10

1.1

2.23

2.88

u/ml

0.56

131

724

Other shoulder lesions

529

1.60

4.07

1.1

1.88

3.27

u/ml

1.15

262

Vascular disorders of the intestines

155

2.14

4.05

1.2

1.1

6.33

2.13

u/ml

—

Other and unspecified effects of external causes

268

2079

1.29

4.05

1.1

4.15

3.00

u/ml

0.59

103

1076

Diabetic nephropathy, excluding more controls

452

1.59

4.03

1.1

17.08

3.36

u/ml

1.00

171

Cerebrovascular diseases

293

2617

0.78

4.01

1.1

2.71

3.76

u/ml

1.29

1123

Idiopathic urticaria

150

2.18

4.01

1.2

1.0

2.24

2.39

u/ml

0.06

Oedema, not elsewhere classified

208

1539

1.34

3.99

1.1

4.97

4.05

u/ml

0.30

736

Nontoxic goitre/thyroid nodule

197

1467

1.35

3.98

1.0

1.1

1.91

3.87

u/ml

2.51

615

Bulimia nervosa (incl. atypical)

291

1.82

3.94

1.1

1.0

2.59

3.35

u/ml

0.29

168

Diseases of salivary glands

255

1973

1.30

3.93

1.1

2.21

3.39

u/ml

1.78

104

974

Periapical abscess

233

3026

0.77

3.93

1.1

3.09

3.18

u/ml

0.05

102

1543

Unspecified haematuria

227

1428

1.32

3.92

1.1

3.37

4.05

u/ml

0.26

607

Other viral diseases, not elsewhere classified

268

2077

1.29

3.92

1.1

3.82

3.18

u/ml

0.31

136

1053

Other superficial mycoses

103

686

1.51

3.91

1.1

1.0

2.88

3.00

u/ml

0.03

366

Other sleep disorders

550

1.57

3.91

1.1

2.90

3.53

u/ml

0.20

273

Disorders of eyelid, lacrimal system and orbit

690

4479

1.17

3.89

1.1

2.53

3.18

u/ml

1.02

291

2145

Anogenital herpesviral [herpes simplex] infection

127

883

1.45

3.89

1.1

2.17

3.00

u/ml

0.59

484

Psychotic depression

306

1.78

3.89

1.1

1.97

2.99

u/ml

0.62

149

Other/unspecified enthesopathies, not elsewhere classified

373

1.70

3.89

1.1

1.70

2.84

u/ml

0.85

166

Anorexia (incl.atypical)

442

1.64

3.89

1.1

2.76

2.52

u/ml

0.10

224

Testicular hypofunction

145

2.17

3.89

1.1

2.17

2.19

u/ml

0.01

Other specified and unspecified disorders of eye and adnexa

172

2.06

3.87

1.0

2.91

1.79

u/ml

0.51

Haemangioma and lymphangioma, any site

482

1.61

3.85

1.0

1.1

1.74

3.40

u/ml

1.35

225

Disorders of parathyroid gland

120

816

1.46

3.84

1.1

9.64

3.20

u/ml

0.63

313

Deficiency of other B group vitamins

2.64

3.83

1.1

1.0

7.72

1.79

u/ml

—

Superficial injury of forearm

609

1.54

3.83

1.1

3.06

3.32

u/ml

0.11

310

Papulosquamous disorders

285

2247

1.27

3.80

1.1

2.31

3.46

u/ml

1.59

1087

Excessive vomiting in pregnancy

651

1.52

3.79

1.2

1.1

1.95

2.65

u/ml

0.61

365

Dermatophytosis

498

4160

1.20

3.79

1.1

2.04

3.03

u/ml

2.99

244

2016

Ocular pain

500

1.59

3.78

1.1

1.0

1.96

2.87

u/ml

0.69

249

Anogenital herpesviral [herpes simplex] infection

477

1.61

3.78

1.1

2.33

3.03

u/ml

0.25

272

Sub-endpoint used in defining T1D endpoints

241

1832

1.30

3.76

1.1

6.33

3.33

u/ml

1.14

914

Other inflammatory liver diseases

295

1.78

3.75

1.1

2.14

2.79

u/ml

0.27

135

Stroke, including SAH

216

2047

0.76

3.73

1.1

2.80

4.12

u/ml

1.25

805

Transplanted organ and tissue status

510

1.58

3.71

1.1

6.52

3.96

u/ml

0.28

231

Haemorrhage from respiratory passages

192

1296

1.34

3.71

1.1

3.04

4.10

u/ml

0.66

549

Polyarthrosis

119

764

1.45

3.70

1.0

1.1

4.10

3.14

u/ml

0.25

314

Other or unspecified ileus, impaction or obstruction

613

1.52

3.69

1.0

1.1

1.66

3.72

u/ml

2.17

274

Alzheimer’s disease (Atypical or mixed)

198

0.25

3.67

1.0

1.1

—

3.88

—

Achilles tendinitis

496

1.58

3.66

1.1

4.75

3.29

u/ml

0.25

254

Iron deficiency anaemia secondary to blood loss (chronic)

656

1.50

3.64

1.1

2.64

3.16

u/ml

0.22

278

Acute appendicitis, no complications

516

4329

1.19

3.62

1.1

3.55

2.85

u/ml

0.58

247

2287

Postprocedural endocrine and metabolic disorders, not elsewhere classified

112

772

1.46

3.61

1.1

3.49

3.53

u/ml

0.01

382

Small fibre neuropathy

104

2.34

3.61

1.1

1.0

2.25

2.32

u/ml

—

Autoimmune hyperthyroidism

367

1.68

3.59

1.1

1.0

2.67

2.07

u/ml

0.27

188

Carbimazole or st.post thyroidectomy, condition for graves disease

175

1304

1.35

3.58

1.1

2.93

3.35

u/ml

0.24

634

Nonsuppurative otitis media

250

1690

1.29

3.57

1.1

2.37

2.85

u/ml

0.51

110

839

Immunodeficiencies

256

1.82

3.56

1.0

1.1

2.52

2.44

u/ml

—

113

Viral Sepsis

132

940

1.41

3.56

1.1

2.36

3.48

u/ml

0.76

409

Implicit viral Sepsis

131

933

1.41

3.53

1.1

2.36

3.51

u/ml

0.79

405

Arthropathies in other diseases classified elsewhere

151

2.08

3.53

1.1

1.0

6.06

2.32

u/ml

—

Acute alcohol intoxication

1394

0.68

3.52

1.1

2.75

3.51

u/ml

0.49

691

Other specified/unspecified dorsopathies

158

2.05

3.52

1.1

1.0

1.10

2.73

u/ml

—

Hypoglycaemia, other or unspecified

354

1.68

3.51

1.2

1.1

4.54

2.38

u/ml

0.48

158

Monoamine oxidase A inhibitors

549

1.54

3.51

1.1

2.08

3.33

u/ml

0.84

254

Chondrocostal junction syndrome [Tietze]

193

1.94

3.50

1.3

1.0

3.54

2.28

u/ml

0.38

Candidiasis

111

770

1.45

3.48

1.1

2.22

3.33

u/ml

0.80

355

Syncope and collapse

295

2018

1.25

3.47

1.1

1.99

3.86

u/ml

3.43

942

Mucosal proctocolitis

113

787

1.44

3.47

1.1

2.46

3.67

u/ml

1.07

426

Other diseases of blood and blood-forming organs, wide

152

1114

1.37

3.46

1.1

5.63

3.61

u/ml

0.42

495

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

185

2419

0.76

3.46

1.1

2.06

2.96

u/ml

1.28

1400

Coagulation defects, purpura and other haemorrhagic conditions

148

1081

1.38

3.45

1.1

3.81

3.33

u/ml

0.09

507

Viral and other specified intestinal infections

296

2290

1.25

3.45

1.1

2.58

2.98

u/ml

0.25

149

1172

Disorders of sclera, cornea, iris and ciliary body

444

3712

1.20

3.44

1.1

3.78

2.95

u/ml

0.62

202

1830

Childhood asthma (age<16)

175

1030

1.35

3.44

1.1

2.06

2.89

u/ml

0.96

573

Injury of muscle and tendon at shoulder and upper arm level

205

1572

1.31

3.43

1.0

1.1

4.15

3.65

u/ml

0.14

711

Acute pharyngitis

156

1143

1.36

3.39

1.1

3.00

3.54

u/ml

0.21

617

Graves disease, strict definition

660

1.48

3.38

1.1

1.0

2.98

3.75

u/ml

0.30

332

Diabetic retinopathy, strict definition

573

1.49

3.37

1.1

5.63

3.12

u/ml

0.54

223

Other arthrosis

371

2106

1.22

3.37

1.1

3.45

3.01

u/ml

0.17

141

1058

Female genital prolapse

214

925

1.31

3.37

1.1

3.02

3.11

u/ml

0.03

454

Dislocation, sprain and strain of joints and ligaments at neck level

145

1061

1.37

3.36

1.0

1.1

1.79

3.45

u/ml

2.34

576

Childhood asthma (age<16), excluding more controls

175

1034

1.34

3.35

1.1

2.06

2.88

u/ml

0.95

575

Benign neoplasm: Stomach

374

1.64

3.35

1.1

1.0

6.67

3.57

u/ml

0.28

148

Fitting and adjustment of other devices

182

1241

1.33

3.35

1.1

2.58

3.93

u/ml

1.20

479

Other disorders of glucose regulation and pancreatic internal secretion

429

1.60

3.34

1.2

1.1

4.33

2.51

u/ml

0.43

189

Unspecified urinary incontinence

367

1.65

3.33

1.1

2.07

3.00

u/ml

0.33

146

Evidence of alcohol involvement determined by blood alcohol level

0.00

3.33

0.0

1.0

—

1.83

—

Inflammatory diseases of prostate (prostatitis)

398

1.62

3.32

1.1

5.34

4.58

u/ml

0.09

188

Ganglion

182

1381

1.32

3.32

1.1

4.57

3.17

u/ml

0.51

759

Other inflammation of eyelid

101

696

1.46

3.29

1.1

2.00

3.53

u/ml

1.08

311

Persons encountering health services in other circumstances

348

2842

1.22

3.28

1.1

5.40

2.68

u/ml

1.91

112

1486

Early syphilis

2.84

3.28

1.1

1.0

1.83

1.18

u/ml

—

Acute appendicitis

620

4999

1.16

3.28

1.1

3.47

2.77

u/ml

0.66

304

2562

Endometriosis ASRM stages 1,2

188

1437

1.32

3.27

1.1

1.71

3.06

u/ml

2.49

778

Postviral fatigue syndrome

2.66

3.27

1.0

3.43

1.98

u/ml

—

IgA nephropathy (IgA glomerulonephritis)

129

2.13

3.26

1.1

1.0

3.16

1.77

u/ml

—

Other Crohn's disease

424

1.59

3.26

1.1

2.62

2.15

u/ml

0.23

209

Colorectal cancer

110

754

1.43

3.26

1.0

1.1

4.95

3.97

u/ml

0.15

269

Ulcer of lower limb, not elsewhere classified

463

1.56

3.25

1.1

10.10

3.10

u/ml

0.66

173

Other and unspecified coagulation defects

317

1.69

3.24

1.1

1.0

0.83

2.08

u/ml

2.62

155

Other bacterial diseases

688

5017

0.87

3.23

1.1

3.01

2.97

u/ml

0.03

246

2517

Other disorders of patella

163

1223

1.34

3.23

1.0

1.1

5.68

2.95

u/ml

1.02

710

Allergic contact dermatitis

124

891

1.40

3.23

1.1

3.34

3.56

u/ml

0.06

471

Diseases of appendix

657

5136

1.15

3.22

1.1

3.60

2.79

u/ml

0.77

317

2612

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

150

2.03

3.22

1.1

1.0

2.70

1.78

u/ml

—

Childhood allergy (age < 16)

197

1248

1.31

3.22

1.1

2.26

3.06

u/ml

0.81

614

Trochanteric bursitis

650

1.47

3.22

1.1

2.38

3.19

u/ml

0.46

300

Reactive arthropathies, FINNGEN

402

1.60

3.22

1.0

1.1

1.68

2.49

u/ml

0.58

208

Acute alcohol intoxication, ICD10

1177

0.67

3.21

1.1

3.08

3.69

u/ml

0.32

617

Sequelae of external causes of morbidity and mortality

165

1241

1.33

3.20

1.1

2.79

3.70

u/ml

0.42

563

Appendicitis, broad definition

653

5123

1.15

3.20

1.1

3.60

2.79

u/ml

0.77

317

2608

Osteomyelitis

243

1.78

3.19

1.1

2.06

2.33

u/ml

—

Other coagulation defects

427

1.58

3.18

1.1

1.0

1.27

2.26

u/ml

1.15

202

Type1 diabetes, definitions combined, early onset

594

1.49

3.16

1.1

11.04

3.11

u/ml

1.00

315

Zoster [herpes zoster]

321

2583

1.23

3.16

1.1

3.33

3.50

u/ml

0.05

105

1158

Schizoaffective disorder

499

0.50

3.15

1.0

1.1

4.41

2.60

u/ml

—

266

Other protozoal intestinal diseases

131

2.09

3.15

1.2

1.0

1.36

2.71

u/ml

0.87

Other/unspecified synovitis and tenosynovitis

572

1.49

3.14

1.1

8.55

3.21

u/ml

0.79

275

Panic disorder

165

1247

1.33

3.13

1.1

2.48

2.89

u/ml

0.28

687

Acute and transient psychotic disorders

742

0.59

3.12

1.0

1.1

3.38

3.05

u/ml

0.07

384

Complications of surgical and medical care, not elsewhere classified

830

5009

1.14

3.12

1.1

2.73

3.03

u/ml

0.38

331

2498

Pain associated with micturition

573

1.49

3.12

1.0

1.1

1.28

3.45

u/ml

2.26

265

Haemangioma, any site

437

1.57

3.11

1.0

1.1

1.87

3.38

u/ml

1.04

205

Chondropathies

130

948

1.38

3.11

1.1

1.97

3.57

u/ml

1.78

477

Falls/tendency to fall

1057

4721

1.12

3.11

1.1

2.84

2.96

u/ml

0.10

464

2429

Melanocytic naevi

249

1986

1.26

3.10

1.1

2.81

3.13

u/ml

0.19

123

1007

Type 1 diabetes, strict definition

104

729

1.43

3.10

1.1

9.39

3.30

u/ml

0.98

403

Excessive attrition of teeth

515

4406

1.17

3.10

1.0

1.1

1.72

3.10

u/ml

6.70

220

2242

Duodenal ulcer

275

1.72

3.09

1.1

1.0

1.59

1.88

u/ml

0.18

103

Type 1 diabetes, strict definition, subgroup 1

101

705

1.44

3.09

1.1

9.78

3.33

u/ml

0.90

391

Other/unspecified reactive arthropathies

352

1.63

3.09

1.0

1.1

1.19

2.92

u/ml

2.24

168

Reactive arthropathies

462

1.55

3.08

1.0

2.38

2.50

u/ml

0.04

232

Sacrococcygeal disorders, not elsewhere classified

167

1.94

3.06

1.2

1.0

1.44

2.02

u/ml

0.53

Unspecified fall

370

3035

1.20

3.05

1.1

2.86

3.60

u/ml

0.44

124

1395

Diseases of middle ear and mastoid

573

4041

1.16

3.04

1.1

2.83

2.95

u/ml

0.11

259

2068

Dialysis, with operation codes

536

1.50

3.03

1.1

7.77

3.61

u/ml

0.47

240

Stroke, excluding SAH

200

1868

0.78

3.02

1.1

3.10

4.11

u/ml

0.73

706

Gastric ulcer

528

1.50

3.02

1.1

6.85

3.78

u/ml

0.30

215

Testicular dysfunction

161

1.95

3.01

1.1

2.17

2.66

u/ml

0.15

Vocal cord dysfunction

116

748

1.40

2.99

1.1

1.68

3.68

u/ml

3.26

458

Postprocedural disorders of digestive system, not elsewhere classified

120

2.10

2.99

1.2

1.0

2.59

1.68

u/ml

—

Psoriatic and enteropathic arthropathies

653

1.45

2.98

1.1

2.34

3.17

u/ml

0.58

341

Osteoporosis with pathological fracture (FG)

219

1.79

2.97

1.2

1.1

5.79

3.25

u/ml

—

Hyperkinetic disorders, excluding more controls

155

1120

1.33

2.97

1.1

3.14

2.87

u/ml

0.14

614

Other protozoal intestinal diseases

2.32

2.97

1.2

1.0

0.95

3.18

u/ml

—

Pityriasis rosea

2.91

2.96

1.1

0.93

2.00

u/ml

—

Mycoses

189

1468

1.29

2.94

1.1

2.25

3.58

u/ml

1.52

694

Flatulence and related conditions

2.89

2.94

1.0

1.1

0.66

2.86

u/ml

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

812

4892

1.13

2.94

1.1

2.40

3.08

u/ml

1.28

326

2434

Diabetes, insulin treatment (Kela reimbursement)

663

4582

0.87

2.94

1.1

3.54

2.98

u/ml

0.41

221

2298

Need for other prophylactic measures

280

1.69

2.93

1.0

1.1

1.42

2.58

u/ml

1.89

130

Selective deficiency of immunoglobulin A [IgA]y

3.88

2.93

1.2

—

1.01

—

Implicit viral Sepsis

182

1407

1.30

2.93

1.1

3.61

3.68

u/ml

0.01

612

Polymyalgia rheumatica

365

1.60

2.91

1.1

9.14

2.19

u/ml

—

113

Acute laryngitis and tracheitis

133

969

1.36

2.91

1.1

2.53

3.46

u/ml

0.64

510

Scleritis and episcleritis

358

1.61

2.91

1.1

2.25

2.14

u/ml

0.06

181

Left bundle-branch block

243

1.74

2.90

1.0

1.66

1.77

u/ml

0.08

Other noninflammatory disorders of vagina

422

1.55

2.87

1.2

1.1

1.67

3.53

u/ml

1.44

215

Diseases of external ear

239

1917

1.25

2.87

1.1

5.31

3.82

u/ml

0.53

901

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

129

2.03

2.86

1.0

2.14

2.40

u/ml

—

Atypical facial pain

267

1.70

2.86

1.1

1.0

2.52

3.20

u/ml

0.22

130

All chronic kidney diseases

349

2374

1.20

2.85

1.1

5.34

3.51

u/ml

0.52

1070

Codes for special purposes

433

3675

1.18

2.85

1.0

1.1

4.24

2.90

u/ml

0.67

181

1808

Polycystic ovarian syndrome, consortium definition

722

3758

1.14

2.84

1.1

3.21

2.60

u/ml

0.52

303

1903

Desensitization to allergens

448

1.53

2.84

1.1

1.0

4.97

2.23

u/ml

1.35

235

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1239

0.70

2.83

1.1

2.01

3.55

u/ml

1.11

669

Panniculitis affecting regions of neck and back

179

1.86

2.83

1.0

1.11

2.86

u/ml

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

430

2312

1.19

2.83

1.1

2.72

2.54

u/ml

0.11

194

1326

Enterocolitis due to Clostridium difficile

400

1.56

2.82

1.1

3.99

2.24

u/ml

0.39

152

Other sexually transmitted chlamydial diseases

121

889

1.37

2.81

1.0

1.1

1.81

2.83

u/ml

1.54

484

Cluster headache, wide

216

1.78

2.81

1.0

1.1

3.24

2.29

u/ml

0.30

107

Focal epilepsy, strict definition

1072

0.68

2.81

1.1

2.77

3.49

u/ml

0.38

485

Other maternal disorders predominantly related to pregnancy

592

3222

1.15

2.81

1.1

3.33

2.62

u/ml

0.55

303

1664

Provisional assignment of new diseases of uncertain etiology

432

3671

1.18

2.80

1.0

1.1

4.24

2.89

u/ml

0.67

181

1803

Other viral diseases

280

2285

1.23

2.80

1.1

4.33

3.16

u/ml

0.53

133

1156

6-mercaptopurine

224

1.76

2.79

1.1

1.91

2.47

u/ml

0.30

117

Insulin, intermediate and long-acting

366

2984

1.19

2.79

1.1

6.35

3.48

u/ml

1.11

1419

Adhesive capsulitis of shoulder

105

754

1.40

2.79

1.0

1.1

2.60

3.25

u/ml

0.35

357

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

387

3252

1.19

2.78

1.1

3.10

3.02

u/ml

0.03

156

1718

Obesity related asthma

260

2113

1.23

2.78

1.1

2.56

3.44

u/ml

1.01

1054

Other diseases of hard tissues of teeth

465

2047

1.18

2.76

1.1

2.59

3.46

u/ml

0.95

201

1069

Secondary hypertension

366

1.57

2.75

1.1

5.59

2.55

u/ml

0.54

175

Nasal polyp

117

858

1.37

2.74

1.1

3.20

3.77

u/ml

0.15

398

Disorder of lipoprotein metabolism, unspecified

419

1.53

2.73

1.1

13.18

2.69

u/ml

0.72

154

Other disorders involving the immune mechanism, not elsewhere classified

160

1.90

2.73

1.1

1.0

2.70

1.89

u/ml

—

Hypertrophy of tongue papillae

2.55

2.72

1.2

1.1

0.83

1.67

u/ml

—

Memory loss

286

1.65

2.72

1.2

1.0

1.96

2.21

u/ml

0.10

Systemic lupus erythematosus

189

1.82

2.72

1.2

1.1

3.81

2.26

u/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified

187

1469

1.28

2.72

1.1

3.21

2.99

u/ml

0.08

819

Deep endometriosis

608

1.44

2.72

1.1

1.13

3.16

u/ml

2.95

308

Infectious mononucleosis

700

1.41

2.71

1.1

2.71

2.67

u/ml

0.01

373

Endometriosis diagnosis and infertility diagnosis occurring together

119

878

1.36

2.71

1.1

2.79

3.34

u/ml

0.20

489

Dyspnoea

715

4663

1.13

2.71

1.1

3.54

3.09

u/ml

0.29

259

2297

Nerve, nerve root and plexus disorders

883

4827

1.12

2.71

1.1

2.77

2.99

u/ml

0.21

334

2470

Malignant neoplasm of bronchus and lung, including Hilmo

526

0.59

2.70

1.1

3.07

4.10

u/ml

0.31

166

Nontoxic multinodular goitre

116

852

1.37

2.70

1.1

1.71

3.41

u/ml

1.48

336

Disorders of vestibular function (Vertigo)

296

2405

1.21

2.69

1.1

2.52

3.65

u/ml

0.89

106

1074

Outcome of delivery

207

1011

1.27

2.69

1.1

2.56

2.90

u/ml

0.20

114

584

Sequelae with surgical and medical care as external cause

124

921

1.35

2.69

1.1

3.27

3.42

u/ml

0.04

405

Abnormal findings on diagnostic imaging of lung

246

1911

1.24

2.68

1.1

3.95

3.78

u/ml

0.04

754

Other predominantly sexually transmitted diseases, not elsewhere classified

226

1818

1.25

2.68

1.1

2.97

2.92

u/ml

0.02

999

Polycystic ovarian syndrome

503

1.49

2.68

1.1

3.42

2.80

u/ml

0.21

295

Hyperplasia of prostate

153

657

1.32

2.68

1.1

4.81

3.80

u/ml

0.25

293

Other and unspecified disorders of skin and subcutaneous tissue

280

1.65

2.68

1.0

1.1

7.81

2.41

u/ml

0.36

116

Colectomy operation

651

1.42

2.67

1.1

6.25

3.27

u/ml

0.41

261

Amenorrhoea

528

1.47

2.66

1.1

2.04

2.96

u/ml

0.68

299

Other and unspecified rosacea

471

1.50

2.65

1.1

3.86

3.34

u/ml

0.16

227

Colorectal adenocarcinoma

592

1.44

2.65

1.0

1.1

5.59

4.12

u/ml

0.17

201

Substance use, excluding alcohol

101

1385

0.73

2.64

1.1

4.57

3.45

u/ml

0.23

756

Hypo-osmolality and hyponatraemia

632

1.42

2.64

1.2

1.1

3.26

4.27

u/ml

0.34

238

Endometriosis of rectovaginal septum and vagina

383

1.55

2.64

1.2

1.1

1.29

3.92

u/ml

2.37

189

Premenstrual syndrome

2.30

2.64

1.0

1.1

1.63

3.66

u/ml

—

Other and unspecified injuries of head

328

1.60

2.63

1.0

1.1

2.90

2.17

u/ml

0.28

149

Hernia of abdominal wall

296

2453

1.21

2.63

1.1

3.74

3.48

u/ml

0.09

118

1170

Malignant neoplasm of bronchus and lung

433

0.55

2.62

1.1

3.36

4.39

u/ml

—

132

Other puerperal infections

705

1.40

2.62

1.2

1.1

1.76

2.75

u/ml

1.02

401

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

642

4396

0.88

2.62

1.1

3.55

2.96

u/ml

0.43

220

2222

L04AA Selective immunosuppressants

176

1379

1.28

2.61

1.1

2.51

3.56

u/ml

0.75

676

Mouth breathing

286

2361

1.21

2.61

1.1

3.13

3.74

u/ml

0.25

138

1143

Sulfasalazine

217

1743

1.25

2.61

1.1

2.07

3.46

u/ml

2.52

919

Conjunctivitis (acute, non atopic)

234

1889

1.24

2.60

1.1

5.37

3.16

u/ml

0.66

938

Poisoning by drugs, medicaments and biological substances

146

1894

0.77

2.60

1.1

1.84

3.07

u/ml

1.46

994

Lateral epicondylitis

106

773

1.38

2.60

1.1

5.65

3.49

u/ml

0.37

414

Disorders of calcium metabolism

267

1.66

2.60

1.1

0.96

2.24

u/ml

—

110

Other and unspecified visual disturbances

506

1.47

2.60

1.1

3.27

2.90

u/ml

0.11

243

Disorders of ocular muscles, binocular movement, accommodation and refraction

427

3627

1.17

2.59

1.1

2.73

3.08

u/ml

0.18

184

1786

Diabetes medication

760

5063

0.89

2.57

1.1

3.35

2.94

u/ml

0.35

283

2580

Other obstetric conditions, not elsewhere classified

433

2355

1.17

2.57

1.1

2.72

2.61

u/ml

0.06

197

1352

Raynaud syndrome

524

1.46

2.57

1.1

1.53

2.85

u/ml

1.73

255

Keratitis

275

2270

1.21

2.56

1.1

3.87

3.23

u/ml

0.34

131

1139

Other keratitis

674

1.40

2.56

1.1

3.87

2.55

u/ml

0.69

341

Use of pramipexole

124

929

1.34

2.56

1.1

6.50

3.31

u/ml

0.43

380

L04AD Calcineurin inhibitors

624

1.42

2.55

1.1

3.73

3.81

u/ml

0.01

300

Other and unspecified injuries of wrist and hand

223

1.72

2.55

1.0

5.01

2.73

u/ml

—

Additional codes for the location of defect, injury or illness

284

1.63

2.55

1.1

1.45

2.67

u/ml

1.36

121

Other arrhythmias

526

3450

1.15

2.54

1.1

3.16

2.99

u/ml

0.10

202

1764

Orchitis and epididymitis

323

1.59

2.54

1.0

6.04

2.88

u/ml

0.53

153

Disorders of mineral metabolism

363

1.55

2.53

1.1

1.60

2.65

u/ml

0.69

161

Other localized connective tissue disorders

2.19

2.53

1.0

1.62

1.86

u/ml

—

Agranulocytosis

567

1.44

2.52

1.0

1.1

1.91

3.43

u/ml

0.95

239

Disorders of lacrimal system and orbit in diseases classified elsewhere

122

1.99

2.52

1.0

2.23

2.00

u/ml

—

Alcohol abuse, main dg, excluding more controls

905

0.67

2.52

1.0

1.1

2.56

4.04

u/ml

0.87

500

Erosion of teeth , including avohilmo

233

1896

1.23

2.51

1.1

2.21

3.18

u/ml

1.17

106

988

Giant cell arteritis

115

2.02

2.51

1.1

13.68

2.62

u/ml

—

Spinal stenosis

264

1645

1.22

2.51

1.1

1.76

3.65

u/ml

3.83

705

Acute renal failure

103

752

1.37

2.51

1.1

10.18

3.10

u/ml

0.57

283

Localized scleroderma [morphea]

2.36

2.50

1.0

1.76

1.65

u/ml

—

Asthma-related pneumonia

228

1847

1.23

2.50

1.1

3.43

3.85

u/ml

0.13

818

Unspecified kidney failure

293

1.61

2.50

1.1

2.68

2.55

u/ml

—

103

Ovarian dysfunction

661

1.40

2.50

1.1

3.14

2.82

u/ml

0.12

385

External causes of morbidity and mortality

655

2888

1.14

2.50

1.1

3.37

2.94

u/ml

0.29

301

1557

Blepharochalasis

156

1212

1.29

2.49

1.1

2.83

3.90

u/ml

0.44

453

Hyperkinetic disorders

158

1205

1.29

2.49

1.1

3.14

3.10

u/ml

0.02

610

Other/unspecified soft tissue disorders related to use, overuse and pressure

151

1.88

2.48

1.3

1.0

1.37

2.56

u/ml

1.00

Polyarthritis, unspecified

151

1.87

2.48

1.0

3.41

2.18

u/ml

0.40

Other nutritional deficiencies

592

4905

1.14

2.47

1.1

3.31

2.84

u/ml

0.33

254

2476

False labour

376

1989

1.18

2.46

1.1

3.22

2.53

u/ml

0.32

181

1144

Malignant neoplasm of breast

250

1983

0.82

2.44

1.1

3.12

3.17

u/ml

0.02

110

951

Disorder of the sleep-wake schedule

103

2.07

2.44

1.0

2.56

2.99

u/ml

0.12

Asthma-related pneumonia or sepsis

228

1853

1.23

2.44

1.1

3.43

3.85

u/ml

0.13

821

Asthma, hospital admissions 3, pneumonia

228

1853

1.23

2.44

1.1

3.43

3.85

u/ml

0.13

821

Abnormal findings on examination of urine, without diagnosis

196

1.75

2.44

1.1

1.0

3.97

2.26

u/ml

0.54

Use of disulfiram, acamprosate or naltrexone

468

0.55

2.43

1.1

2.37

3.37

u/ml

—

249

Granulomatous disorders of skin and subcutaneous tissue

138

1.91

2.43

1.0

6.16

2.46

u/ml

—

Maternal care for other conditions predominantly related to pregnancy

252

2036

1.22

2.42

1.1

3.03

2.57

u/ml

0.20

124

1166

Seborrhoeic keratosis

116

869

1.34

2.41

1.1

2.32

3.66

u/ml

1.17

331

Endovascular or surgical operations to intracerebral aneurysms

267

0.41

2.41

1.1

1.0

1.16

3.12

u/ml

—

113

Injuries to the thorax

287

2393

1.20

2.41

1.1

2.78

3.47

u/ml

0.31

104

1139

L01XE Protein kinase inhibitors

191

0.36

2.40

1.0

—

2.23

—

Alcohol abuse, main dg

895

0.68

2.39

1.0

1.1

2.56

3.32

u/ml

0.38

466

Assault

977

0.69

2.39

1.1

3.89

3.24

u/ml

0.20

546

Cholangitis (primary sclerosing, PSC)

258

1.64

2.39

1.1

3.11

2.94

u/ml

0.05

110

Primary hyperparathyroidism

466

1.47

2.39

1.1

10.79

3.41

u/ml

0.41

179

Any dementia

748

0.70

2.38

1.1

1.35

4.49

u/ml

3.11

169

Antihypertensive medication - note that there are other indications

729

3438

1.13

2.38

1.1

2.91

3.03

u/ml

0.10

361

1829

Type 2 diabetes, wide definition

422

3133

0.86

2.37

1.1

3.35

3.28

u/ml

0.03

134

1526

Phlebitis and thrombophlebitis (not including DVT)

150

1168

1.29

2.37

1.0

1.1

2.66

3.32

u/ml

0.39

557

Psoriasis

201

1621

1.24

2.37

1.1

2.32

3.49

u/ml

1.32

797

Other bacterial diseases

595

4529

0.88

2.37

1.1

3.42

3.01

u/ml

0.39

207

2221

Algoneurodystrophy

198

1.74

2.37

1.1

1.18

1.95

u/ml

—

Abrasion of teeth

259

2145

1.21

2.36

1.1

2.20

3.27

u/ml

1.92

113

1084

Hyperparathyroidism

718

1.37

2.36

1.1

11.03

3.47

u/ml

0.65

274

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

408

3140

1.16

2.35

1.1

2.97

3.58

u/ml

0.33

137

1423

SLE, strict definition

191

1.75

2.35

1.2

1.0

4.34

2.23

u/ml

—

SLE, ICD10

191

1.75

2.35

1.2

1.0

4.34

2.23

u/ml

—

Redundant prepuce, phimosis and paraphimosis

134

1019

1.31

2.35

1.1

2.53

3.20

u/ml

0.31

548

Other follicular disorders

452

1.47

2.34

1.1

1.0

2.29

2.62

u/ml

0.18

235

Malignant neoplasm of breast, HER2-negative

246

1950

0.82

2.33

1.1

3.16

3.19

u/ml

0.01

107

935

Follow-up care involving plastic surgery

214

1.70

2.33

1.1

3.57

3.33

u/ml

0.05

103

Exclusions for E4_PCOS_BROAD

141

1092

1.30

2.33

1.1

3.71

3.86

u/ml

0.05

518

Bacterial infection, other or unspecified

314

2296

1.19

2.32

1.1

3.97

3.60

u/ml

0.11

992

Atrophic disorders of skin

107

798

1.35

2.32

1.0

1.1

2.05

3.47

u/ml

1.12

356

Adenocarcinoma and papilloma adenocarcinoma of rectum

268

1.61

2.31

1.0

1.1

3.22

2.32

u/ml

0.28

Malignant neoplasm of respiratory system and intrathoracic organs

520

0.62

2.30

1.1

2.64

4.09

u/ml

0.62

166

Alzheimer disease

574

0.66

2.30

1.0

1.1

1.45

4.23

u/ml

1.87

110

Disorders of muscles

520

1.43

2.29

1.1

7.82

2.67

u/ml

0.71

250

Gonarthrosis, primary, with knee surgery

205

2006

0.81

2.29

1.0

1.1

2.50

3.74

u/ml

1.24

786

Disorders of refraction and accommodation

245

2019

1.21

2.28

1.1

2.85

3.51

u/ml

0.21

104

1009

Cluster headache, strict

208

1.70

2.28

1.0

1.1

2.13

2.23

u/ml

—

104

Other disorders of eyelid

234

1833

1.22

2.27

1.0

1.1

2.71

3.93

u/ml

0.79

717

Other and unspecified nerve root and plexus disorders, also in other diseases

146

1141

1.28

2.27

1.1

2.20

3.71

u/ml

1.61

587

Gout

111

733

1.34

2.26

1.1

13.59

3.04

u/ml

0.91

290

Diabetes, varying definitions

762

4976

0.90

2.26

1.1

3.55

2.92

u/ml

0.60

288

2553

Erysipelas

385

3413

0.86

2.26

1.1

3.89

3.11

u/ml

0.61

127

1663

Short stature, not elsewhere classified

193

1.71

2.26

1.1

0.57

6.50

u/ml

—

Helminthiases

255

1.62

2.25

1.0

4.01

2.06

u/ml

0.37

117

Chronic periodontitis, complicated

250

2975

0.83

2.25

1.1

5.78

3.28

u/ml

0.94

1383

All influenza

174

1390

1.25

2.25

1.1

1.63

3.51

u/ml

3.42

656

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

278

1.59

2.25

1.0

1.1

3.22

2.26

u/ml

0.30

Mental retardation, wide definition

297

0.46

2.25

1.0

1.1

1.70

4.47

u/ml

—

117

HSIL lesion of the vulva

2.13

2.25

1.0

2.59

1.62

u/ml

—

Non-invasive ventilation

122

1416

0.77

2.24

1.1

4.91

3.20

u/ml

0.50

812

Other disorders of Eustachian tube

142

1.85

2.24

1.1

1.0

5.29

1.50

u/ml

0.44

Dental caries

190

1474

1.24

2.24

1.1

3.13

3.66

u/ml

0.21

791

Graves ophthalmopathy

128

1.90

2.23

1.0

2.23

1.91

u/ml

—

Other acute lower respiratory infections

402

3310

1.16

2.23

1.1

4.29

3.16

u/ml

0.62

145

1567

Ulcer of oesophagus

194

1.71

2.22

1.1

1.0

0.84

1.99

u/ml

—

Umbilical hernia

175

1402

1.25

2.21

1.1

2.95

3.59

u/ml

0.25

702

Anomalies of dental arch relationship, including avohilmo

190

1384

1.24

2.21

1.1

2.39

3.43

u/ml

1.01

101

658

Crushed, pushed or stepped on by crowd or human stampede

491

1.43

2.21

1.0

1.1

3.99

3.27

u/ml

0.18

251

Psoriatic arthropathies

516

1.42

2.20

1.1

1.0

2.41

3.04

u/ml

0.35

264

Antenatal screening

272

1272

1.20

2.19

1.0

1.1

2.45

2.86

u/ml

0.33

155

720

Acute bronchitis

284

2343

1.19

2.19

1.1

4.56

3.41

u/ml

0.49

104

1092

Benign lipomatous neoplasm

187

1512

1.24

2.18

1.1

3.57

3.81

u/ml

0.08

700

Assault by bodily force

552

0.61

2.18

1.1

3.76

2.73

u/ml

0.31

301

Open wound of ankle and foot

559

1.40

2.18

1.1

1.30

2.77

u/ml

2.34

280

Congenital malformations, deformations and chromosomal abnormalities

619

5080

1.12

2.17

1.1

2.44

2.92

u/ml

0.76

305

2588

Otitis externa

165

1317

1.26

2.17

1.1

6.05

3.52

u/ml

0.79

648

Benign paroxysmal vertigo

177

1424

1.25

2.17

1.1

2.62

3.57

u/ml

0.44

619

Early syphilis

2.20

2.17

1.1

1.0

2.20

1.81

u/ml

—

Disorders of vitreous body and globe

290

2351

1.19

2.16

1.1

4.30

3.41

u/ml

0.28

113

983

Diabetes mellitus

770

4995

0.90

2.16

1.1

3.52

2.92

u/ml

0.57

291

2563

Bacterial, viral and other infectious agents

502

1.42

2.15

1.1

1.49

2.65

u/ml

1.95

258

Thyroiditis

411

1.47

2.15

1.1

1.0

1.39

2.76

u/ml

1.60

195

Allergic colitis

189

1.71

2.15

1.2

1.1

7.89

5.16

u/ml

—

Abnormalities of gait and mobility

452

1.44

2.15

1.1

4.21

3.21

u/ml

0.15

163

Nontraumatic intracranial haemmorrhage

708

0.66

2.14

1.0

1.1

2.01

3.53

u/ml

0.68

265

Viral infections characterized by skin and mucous membrane lesions

321

2735

1.18

2.14

1.1

3.86

3.26

u/ml

0.25

118

1328

Non-selective monoamine reuptake inhibitors

238

1904

1.21

2.14

1.0

1.1

2.26

3.53

u/ml

1.83

896

Mental retardation

291

0.47

2.14

1.0

1.1

1.70

4.49

u/ml

—

114

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

209

1716

1.22

2.12

1.1

3.75

3.26

u/ml

0.18

106

871

Graves ophthalmopathy, strict

116

1.92

2.12

1.0

2.17

2.01

u/ml

—

Presence of cardiac and vascular implants and grafts

192

1156

1.24

2.12

1.1

4.56

3.82

u/ml

0.22

440

Cholangitis (primary sclerosing, PSC), with reimbursement 202

102

1.99

2.12

1.3

1.1

5.55

2.49

u/ml

—

Benign neoplasm: Descending colon

228

1.63

2.11

1.1

2.75

2.11

u/ml

0.17

Superficial injury of neck

138

1.84

2.11

1.0

2.91

2.36

u/ml

0.13

Exclusions for E4_PCOS_CONSORTIUM

715

4019

1.12

2.11

1.1

3.22

2.79

u/ml

0.38

323

2010

Car occupant injured in other and unspecified transport accidents

161

1287

1.26

2.10

1.0

1.1

1.97

3.43

u/ml

1.43

681

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

259

2174

1.19

2.10

1.1

2.08

3.00

u/ml

1.05

116

1133

Crowding of teeth, including avohilmo

110

691

1.32

2.10

1.0

1.1

2.46

3.49

u/ml

0.52

297

Cluster headache, wide,, including avohilmo

332

1.52

2.09

1.0

1.1

2.38

2.18

u/ml

0.09

170

Allergic urticaria

547

1.40

2.09

1.1

1.51

3.09

u/ml

1.44

273

Zoster [herpes zoster]

105

795

1.32

2.08

1.1

7.50

3.06

u/ml

0.51

322

Other disorders of the genitourinary system

539

1.40

2.08

1.0

1.1

1.42

3.79

u/ml

2.24

205

Fracture of shoulder and upper arm

234

1946

1.20

2.06

1.1

3.49

3.35

u/ml

0.04

862

Other disorders of nervous system

269

1.57

2.06

1.2

1.0

3.60

2.47

u/ml

—

116

Maternal care for known or suspected abnormality of pelvic organs

301

1739

1.18

2.06

1.1

3.12

2.43

u/ml

0.42

145

1017

Cellulitis

156

1246

1.26

2.06

1.1

3.54

3.55

u/ml

0.00

607

Bicipital tendinitis

199

1.67

2.06

1.1

2.28

2.27

u/ml

—

Inflammatory disease of uterus

140

1105

1.27

2.05

1.1

5.18

3.12

u/ml

0.55

599

Cardiovascular diseases

747

3614

1.11

2.05

1.1

3.71

2.85

u/ml

0.82

341

2025

Malignant neoplasm of rectum

277

1.56

2.05

1.0

1.1

3.46

2.22

u/ml

0.39

100

Myocarditis

230

1.62

2.05

1.1

1.84

3.19

u/ml

1.12

120

Alzheimer’s disease (Atypical or mixed), excluding more controls

117

0.34

2.04

1.0

1.1

—

2.91

—

Other diseases of gallbladder

169

1.73

2.04

1.0

2.03

1.86

u/ml

0.05

Abnormal results of function studies

449

1.43

2.04

1.0

1.1

1.35

2.86

u/ml

1.92

212

Supervision of normal pregnancy

259

1237

1.20

2.04

1.1

3.00

2.74

u/ml

0.11

138

705

Actinic keratosis

138

1005

1.27

2.04

1.1

2.99

4.84

u/ml

1.14

263

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

375

1.47

2.03

1.0

1.1

4.94

2.84

u/ml

0.25

171

ILD medications: azathioprine

121

939

1.29

2.03

1.1

6.01

3.96

u/ml

0.27

499

Bacterial infection, other or unspecified

353

2573

1.16

2.02

1.1

3.86

3.59

u/ml

0.09

109

1146

Venous thromboembolism

311

2568

1.17

2.02

1.1

3.87

3.61

u/ml

0.08

103

1130

Other symptoms and signs involving the urinary system

425

1.44

2.01

1.0

1.1

1.31

2.61

u/ml

2.17

177

Finngen Rheumatological endpoints

899

4652

1.10

2.01

1.1

3.22

2.88

u/ml

0.30

355

2442

Diabetic neuropathy

349

1.49

2.01

1.1

1.0

6.77

4.67

u/ml

—

122

Postprocedural disorders of nervous system

526

1.40

2.01

1.1

1.48

3.09

u/ml

2.11

285

Skin changes due to chronic exposure to nonionizing radiation

145

1060

1.26

2.01

1.1

2.81

4.59

u/ml

1.25

292

Fall on same level

1062

5314

1.09

2.01

1.1

3.23

2.91

u/ml

0.26

442

2690

Other and unspecified follicular disorders

216

1.63

2.01

1.1

1.0

2.51

2.48

u/ml

0.01

101

Placental disorders

2.19

2.01

1.1

1.27

2.75

u/ml

—

Enteropathic arthropathies

133

1.83

2.01

1.1

1.0

2.08

2.27

u/ml

—

Other diseases of lip and oral mucosa

288

2450

1.18

2.01

1.1

2.14

3.37

u/ml

1.98

102

1178

Other necrotizing vasculopathies

263

1.57

2.00

1.1

7.90

2.11

u/ml

0.40

Recurrent dislocation and subluxation of joint

451

1.43

2.00

1.2

1.1

3.45

2.61

u/ml

0.21

256

Ventral hernia

136

1074

1.27

1.98

1.1

4.40

3.32

u/ml

0.27

485

Congenital malformations and deformations of the musculoskeletal system

111

850

1.30

1.98

1.1

2.08

3.61

u/ml

1.44

404

Rheumatoid arthritis, including avohilmo

244

2049

1.19

1.98

1.1

2.68

3.42

u/ml

0.43

935

Convalescence

280

1.55

1.98

1.0

1.1

13.07

2.95

u/ml

—

133

Localized swelling, mass and lump of skin and subcutaneous tissue

217

1803

1.21

1.98

1.1

2.02

3.52

u/ml

2.14

885

Other and unspecified tonsillitis

357

2596

1.16

1.98

1.1

2.96

3.16

u/ml

0.14

174

1420

Pregnancy examination and test

196

996

1.23

1.97

1.1

2.42

2.60

u/ml

0.08

101

571

Parapsoriasis

1.96

1.1

0.93

2.06

u/ml

—

Disorders of vitreous body

279

2290

1.18

1.96

1.1

4.46

3.34

u/ml

0.36

108

962

Behçet disease

3.90

1.96

1.3

1.1

—

0.80

—

Superficial injury of shoulder and upper arm

605

1.36

1.96

1.1

1.57

3.19

u/ml

2.04

293

Caries of dentine

165

1298

1.24

1.96

1.1

3.29

3.82

u/ml

0.19

695

Disorders of tooth development and eruption

166

1085

1.24

1.96

1.1

4.00

3.43

u/ml

0.16

619

Cyst of kidney

233

1.60

1.96

1.0

1.85

2.25

u/ml

0.18

Rash and other nonspecific skin eruption

478

1.41

1.96

1.1

8.06

3.30

u/ml

0.70

228

Systemic lupus erythematosus, unspecified

164

1.73

1.96

1.1

1.0

4.96

2.45

u/ml

—

Seborrhoeic dermatitis

403

1.45

1.95

1.2

1.1

0.81

2.76

u/ml

4.16

188

Other and unspecified disorders of vitreous body

226

1862

1.20

1.94

1.1

4.18

3.65

u/ml

0.12

754

Syphilis

120

1.85

1.94

1.0

1.1

1.64

2.32

u/ml

—

Syphilis

120

1.85

1.94

1.0

1.1

1.64

2.33

u/ml

—

Other disorders of penis

379

1.46

1.93

1.0

1.1

2.46

3.17

u/ml

0.39

184

Injury, poisoning and certain other consequences of external causes

538

2390

1.13

1.93

1.1

3.01

2.87

u/ml

0.08

257

1298

Other disorders of adrenal gland

250

1.57

1.93

1.1

1.0

3.60

3.70

u/ml

—

107

Azathioprine

121

946

1.28

1.93

1.1

6.01

4.29

u/ml

0.22

497

Disorder of thyroid, unspecified

2.27

1.92

1.2

1.0

0.72

2.03

u/ml

—

Radial styloid tenosynovitis [de Quervain]

339

1.48

1.92

1.0

1.1

3.42

2.71

u/ml

0.26

172

Varicose veins

299

2633

0.86

1.92

1.1

3.32

3.48

u/ml

0.07

117

1213

Urethritis and urethral syndrome

106

1.91

1.92

1.0

1.1

2.15

2.18

u/ml

—

DVT of lower extremities

106

815

1.30

1.92

1.1

5.73

3.56

u/ml

0.29

354

Peroneal tendinitis

2.03

1.91

1.0

1.79

2.42

u/ml

—

Infections of the skin and subcutaneous tissue

483

4239

1.13

1.91

1.1

3.82

3.02

u/ml

0.67

184

2126

Episcleritis

315

1.50

1.91

1.2

1.1

2.28

2.11

u/ml

0.09

159

Other inflammation of vagina/vulva

267

1.55

1.91

1.1

1.0

4.63

2.88

u/ml

0.21

148

Complex cardiac defects

0.00

1.91

0.0

1.1

—

1.99

—

Chronic pancreatitis

472

1.40

1.91

1.0

1.1

6.16

3.06

u/ml

0.68

223

Endometriosis ASRM stages 3,4

200

1658

1.21

1.89

1.1

1.49

3.04

u/ml

4.06

856

Biological medication for rheuma

154

1244

1.24

1.88

1.1

1.94

3.46

u/ml

2.45

662

Acne vulgaris

714

1.32

1.88

1.1

2.59

2.76

u/ml

0.07

377

Exposure to other and unspecified inanimate mechanical forces

416

1.43

1.86

1.1

2.29

2.53

u/ml

0.11

204

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

221

1.60

1.86

1.1

1.0

2.48

2.27

u/ml

0.10

106

Disorders of orbit

213

1.61

1.86

1.1

1.0

1.88

2.68

u/ml

0.42

Olecranon bursitis

205

1.62

1.86

1.1

1.55

2.88

u/ml

1.56

Other infectious diseases

408

1.43

1.85

1.1

2.41

2.22

u/ml

0.07

174

Dystonia

277

1.53

1.85

1.0

1.1

2.97

3.04

u/ml

0.01

121

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

253

1.55

1.84

1.1

1.86

2.52

u/ml

0.54

132

Other ulcerative colitis

334

1.48

1.84

1.1

1.0

1.05

2.37

u/ml

2.85

166

Other symptoms and signs involving the circulatory and respiratory systems

293

1.51

1.84

1.0

1.1

1.79

2.92

u/ml

1.02

135

Spondylopathies

566

3021

1.12

1.84

1.1

1.64

3.06

u/ml

6.28

183

1553

Mental retardation, excluding more controls

268

0.50

1.83

1.0

1.1

1.70

4.75

u/ml

—

123

Malignant neoplasm of breast, including Hilmo

267

2027

0.85

1.83

1.1

2.97

3.12

u/ml

0.07

122

972

Focal epilepsy

1189

0.76

1.83

1.1

2.50

3.53

u/ml

0.76

542

Superficial injury of ankle and foot

109

848

1.29

1.83

1.1

1.56

3.45

u/ml

3.33

438

Malignant neoplasm of breast, HER2-negative, including Hilmo

267

2027

0.85

1.83

1.1

2.97

3.12

u/ml

0.07

122

972

Other disorders of breast

107

831

1.29

1.82

1.1

1.61

3.67

u/ml

2.57

401

Malignant neoplasm of colon

451

1.40

1.82

1.0

1.1

6.51

2.67

u/ml

0.39

154

Tinnitus

147

1186

1.24

1.82

1.1

1.93

3.68

u/ml

2.26

557

Other strabismus

192

1587

1.21

1.81

1.1

2.34

3.64

u/ml

1.09

783

Congenital malformations of the musculoskeletal system, not elsewhere classified

138

1.77

1.81

1.0

1.1

2.55

2.87

u/ml

0.08

Female infertility, tubal origin

319

1.48

1.81

1.0

1.1

1.36

3.68

u/ml

2.15

181

Other and unspecified injuries of lower leg

469

1.39

1.81

1.1

3.02

3.04

u/ml

0.00

237

Diseases of inner ear

337

2832

1.15

1.81

1.1

2.40

3.37

u/ml

0.89

123

1280

Other chondrocalcinosis

2.79

1.80

1.0

—

2.48

—

Kidney transplant status

279

1.52

1.80

1.1

15.48

3.71

u/ml

—

120

Diffuse large B-cell lymphoma, including Hilmo

138

1.75

1.79

1.0

1.44

2.02

u/ml

—

Diffuse large B-cell lymphoma, helper endpoint

138

1.75

1.79

1.0

1.44

2.02

u/ml

—

Diffuse large B-cell lymphoma

138

1.75

1.79

1.0

1.44

2.02

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

336

1.46

1.79

1.1

2.81

2.56

u/ml

0.06

134

Cluster headache, strict, including avohilmo

320

1.48

1.79

1.0

1.1

1.70

2.15

u/ml

0.40

165

Liquid cancers, helper endpoint

205

1492

1.20

1.79

1.1

1.94

3.71

u/ml

2.87

616

Any dementia, excluding more controls

662

0.74

1.78

1.0

1.1

1.35

4.65

u/ml

2.61

167

Poisoning by medicine

135

1675

0.80

1.78

1.1

1.91

3.15

u/ml

1.30

885

Bacterial, viral and other infectious agents

556

1.36

1.77

1.1

1.47

3.35

u/ml

2.15

292

Other congenital malformations of peripheral vascular system

1.93

1.77

1.1

6.74

1.63

u/ml

—

Erythema nodosum

154

1.70

1.77

1.0

3.28

1.92

u/ml

—

Scar conditions and fibrosis of skin

224

1.57

1.77

1.1

1.0

3.12

1.66

u/ml

0.58

100

Benign neoplasm of breast

660

1.32

1.76

1.2

1.1

1.92

3.57

u/ml

1.14

289

Benign mammary dysplasia

686

1.32

1.76

1.1

1.96

3.67

u/ml

1.07

287

Hypokalaemia

505

1.37

1.76

1.1

1.0

2.95

3.15

u/ml

0.07

216

Other respiratory diseases principally affecting the interstitium

582

1.34

1.76

1.0

1.1

13.20

3.47

u/ml

0.73

211

Congenital malformations of genital organs

761

1.30

1.76

1.0

1.1

1.37

3.45

u/ml

3.41

394

Interstitial lung disease

480

1.38

1.75

1.0

1.1

14.93

2.71

u/ml

0.77

160

Interstitial lung disease endpoints

480

1.38

1.75

1.0

1.1

14.93

2.71

u/ml

0.77

160

Suppurative and unspecified otitis media

371

2883

1.14

1.75

1.1

2.62

2.94

u/ml

0.30

151

1493

COPD (mode)

132

828

1.25

1.74

1.1

3.55

3.64

u/ml

0.04

306

Mandibular retrognathia

497

1.37

1.74

1.1

2.53

3.34

u/ml

0.38

235

Other interstitial pulmonary diseases

481

1.38

1.73

1.0

1.1

14.93

2.71

u/ml

0.77

160

Hydrocele

355

1.44

1.73

1.0

1.1

5.18

3.64

u/ml

0.21

153

Non-small cell lung cancer, including Hilmo

398

0.61

1.72

1.1

2.67

4.40

u/ml

—

119

Injuries to the shoulder and upper arm

634

4622

1.11

1.72

1.1

3.24

3.02

u/ml

0.16

274

2199

158

1184

1.22

1.72

1.1

2.92

4.46

u/ml

1.16

354

Laparoscopic right hemicolectomy

163

1.66

1.71

1.0

2.33

2.24

u/ml

0.03

Hyperkinetic disorders (excl. ADHD)

162

1.67

1.71

1.0

1.1

7.00

2.54

u/ml

—

Otalgia

483

1.37

1.71

1.0

1.1

3.18

4.23

u/ml

0.22

218

Ulcerative proctitis

357

1.44

1.70

1.0

1.06

2.61

u/ml

2.23

180

Gout, FINNGEN

111

872

1.27

1.70

1.1

13.59

3.31

u/ml

0.88

321

Femoral hernia

156

1.68

1.69

1.0

9.70

2.38

u/ml

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

484

1.37

1.68

1.1

2.59

3.31

u/ml

0.26

230

Melanocytic naevi of lower limb, including hip

243

1.53

1.68

1.1

1.0

2.26

2.09

u/ml

0.06

108

Primary_lymphoid and hematopoietic malignant neoplasms

117

929

1.26

1.68

1.1

1.80

3.38

u/ml

2.08

357

Other female pelvic inflammatory diseases

120

957

1.26

1.67

1.1

1.32

3.37

u/ml

3.62

472

Thoracic aortic aneurysm

459

1.38

1.67

1.1

9.02

2.68

u/ml

0.52

184

Other abnormal auditory perceptions

2.06

1.66

1.0

1.90

2.37

u/ml

—

Dental operations

473

2161

1.13

1.66

1.1

2.36

3.13

u/ml

0.91

208

1121

Oligomenorrhoea

220

1.56

1.66

1.1

2.91

3.85

u/ml

0.20

125

Organic, including symptomatic, mental disorders

146

1272

0.82

1.66

1.1

4.28

4.00

u/ml

0.07

401

Nephropathy related operations

520

1.35

1.65

1.1

8.93

3.75

u/ml

—

234

Lichen simplex chronicus

142

1.70

1.65

1.1

1.0

3.26

2.21

u/ml

—

Wide developmental disorders

290

0.55

1.65

1.0

1.1

1.42

2.25

u/ml

—

128

Malignant neoplasm of breast, ER-positive, including Hilmo

172

1595

0.83

1.65

1.0

1.1

1.97

3.17

u/ml

1.32

735

Diabetic maculopathy

425

1.38

1.64

1.1

4.89

2.97

u/ml

0.34

171

Sequelae of injuries of lower limb

504

1.36

1.63

1.2

1.1

4.12

2.78

u/ml

0.41

249

therapeutic use

105

1.82

1.63

1.2

1.0

4.36

2.25

u/ml

—

Other benign neoplasms of connective and other soft tissue

504

1.35

1.63

1.1

4.38

2.99

u/ml

0.46

234

Nontoxic single thyroid nodule

360

1.42

1.63

1.0

1.00

2.83

u/ml

1.96

156

Sequelae of injuries, of poisoning and of other consequences of external causes

167

1385

1.21

1.62

1.1

3.80

3.46

u/ml

0.13

706

Complications associated with artificial fertilization

128

1.74

1.62

1.0

1.1

6.20

4.79

u/ml

0.14

Autoimmune thyroiditis

113

1.79

1.62

1.2

1.0

1.63

1.82

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

837

4716

0.92

1.61

1.1

2.58

2.91

u/ml

0.33

323

2379

Superficial injury of lower leg

195

1642

1.19

1.61

1.1

2.37

3.22

u/ml

0.52

812

Other infestations

1.97

1.60

1.0

1.1

17.61

1.63

u/ml

—

Other reaction to severe stress, and adjustment disorders

361

3186

1.14

1.60

1.1

2.70

2.83

u/ml

0.10

125

1756

Hyperlipidaemia, other/unspecified

180

1384

1.20

1.60

1.1

3.31

3.70

u/ml

0.10

532

Enterobiasis

167

1.64

1.60

1.0

1.1

2.07

2.37

u/ml

0.11

112

892

1.26

1.60

1.1

3.58

2.96

u/ml

0.26

482

Autonomic disorders

106

1.81

1.59

1.1

1.0

1.63

1.57

u/ml

—

Disturbance of activity and attention

144

1156

1.23

1.59

1.1

3.09

3.02

u/ml

0.03

592

Diseases of oral cavity, salivary glands and jaws

449

2054

1.13

1.59

1.1

2.41

3.45

u/ml

1.21

191

1070

Other contact dermatitis

455

1.37

1.59

1.1

2.10

3.73

u/ml

0.83

238

ILD, hospital admissions

472

1.36

1.59

1.0

1.1

14.93

2.73

u/ml

0.77

158

Ischaemic Stroke, excluding all haemorrhages

191

1687

0.84

1.58

1.1

2.94

3.92

u/ml

0.70

611

Sequelae of cerebrovascular disease

100

1091

0.79

1.57

1.1

3.04

4.55

u/ml

0.77

393

Use of hypnotics and sedatives

887

4693

1.09

1.57

1.1

3.11

2.95

u/ml

0.10

360

2385

Effects of foreign body entering through natural orifice

177

1481

1.20

1.57

1.1

4.70

3.60

u/ml

0.27

737

Asthma mixed form (mode)

247

1.51

1.57

1.1

2.22

3.46

u/ml

0.34

117

Other and/or unspecified nontoxic goitre

363

1.41

1.57

1.0

1.98

2.79

u/ml

0.34

149

Other necrotizing vasculopathies (FG)

223

1.53

1.57

1.1

1.48

2.00

u/ml

—

Cerebrovascular diseases (FINNGEN)

182

1533

0.84

1.56

1.1

1.67

3.47

u/ml

3.98

852

Malignant neoplasm of skin

196

1590

0.84

1.56

1.1

2.92

3.71

u/ml

0.43

645

Hard cardiovascular diseases

504

3340

0.90

1.56

1.1

3.67

3.19

u/ml

0.27

203

1619

Other and unspecified diseases of blood and blood-forming organs

107

1.79

1.55

1.2

1.0

9.78

2.07

u/ml

—

Chronic apical periodontitis

857

5290

0.92

1.55

1.1

2.74

2.90

u/ml

0.19

337

2700

Deep bite

108

753

1.26

1.55

1.0

1.1

3.21

3.39

u/ml

0.05

302

Asthma mixed form (mode), excluding more controls

248

1.50

1.55

1.1

2.22

3.53

u/ml

0.37

117

Fall on same level involving ice and snow

421

3759

1.12

1.55

1.1

2.22

3.10

u/ml

2.01

170

1798

Gonarthrosis,primary

463

3180

0.90

1.54

1.1

3.31

u/ml

0.00

181

1458

Chronic hepatitis, not elsewhere classified

153

1.65

1.54

1.1

1.0

4.37

2.07

u/ml

—

Arthropathic psoriasis

588

1.31

1.53

1.1

2.37

3.12

u/ml

0.47

289

Mental and behavioural disorders due to sedatives or hypnotics

408

0.63

1.53

1.0

1.1

2.37

2.44

u/ml

—

216

ILD, hospital admissions 1, main diag only

424

1.37

1.53

1.0

1.1

15.71

2.47

u/ml

0.80

139

Other psoriatic arthropathies

545

1.33

1.53

1.1

2.41

3.15

u/ml

0.45

265

Other hereditary haemolytic anaemias

2.64

1.52

1.1

1.0

—

1.18

—

D07AA Corticosteroids, weak (group I)

136

1112

1.23

1.52

1.1

3.10

3.39

u/ml

0.12

540

Other disorders of skin and subcutaneous tissue, not elsewhere classified

659

1.29

1.51

1.0

1.1

5.61

3.18

u/ml

0.36

281

Ehlers-Danlos syndrome

101

1.81

1.51

1.1

1.0

3.02

2.05

u/ml

—

Degenerative diseases of the nervous system

694

0.76

1.50

1.0

1.1

3.41

3.90

u/ml

0.11

154

Uterine polyps

486

1.34

1.50

1.1

2.63

3.10

u/ml

0.18

241

Tooth eruption problems

158

1283

1.21

1.50

1.1

4.30

2.52

u/ml

0.59

625

Viral warts

178

1499

1.19

1.49

1.1

2.60

3.49

u/ml

0.66

752

Inguinal hernia

376

2228

1.13

1.49

1.1

2.60

3.46

u/ml

1.29

173

1117

Lung cancer and mesothelioma

471

0.69

1.49

1.1

2.97

3.84

u/ml

0.28

150

Monoarthritis, not elsewhere classified

210

1.53

1.49

1.0

2.86

1.91

u/ml

0.43

110

Focal epilepsy, mode (most common among epilepsy diagnosis)

1017

0.77

1.48

1.1

2.28

3.30

u/ml

0.71

462

Pediculosis, acariasis and other infestations

141

1163

1.22

1.48

1.1

4.85

3.08

u/ml

0.56

575

Stenosis and insufficiency of lacrimal passages

427

1.36

1.48

1.2

1.1

2.20

3.15

u/ml

0.50

172

Autism

216

0.50

1.48

1.0

1.1

1.42

2.24

u/ml

—

102

Anterior Iridocyclitis

137

1127

1.22

1.47

1.0

1.1

3.59

3.48

u/ml

0.02

545

Obstructed labour due to maternal pelvic abnormality

119

965

1.24

1.47

1.1

1.43

3.10

u/ml

2.66

501

Alopecia areata

163

1.61

1.47

1.1

4.48

2.39

u/ml

—

Kyphosis

2.25

1.47

1.0

1.1

1.06

1.77

u/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

260

2235

1.15

1.47

1.1

3.55

3.29

u/ml

0.08

1041

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

514

1.33

1.47

1.1

3.60

2.59

u/ml

0.29

289

Other and unspecified abdominal hernia

163

1.60

1.46

1.0

0.77

2.16

u/ml

—

Car occupant injured in noncollision transport accident

211

1.53

1.46

1.1

6.18

2.11

u/ml

0.79

Other surgical follow-up care

187

1.56

1.46

1.1

1.59

2.59

u/ml

—

Diseases of tongue

293

1.44

1.46

1.1

1.05

4.23

u/ml

2.80

138

Other disorders of thyroid

2.00

1.44

1.2

1.0

0.72

2.58

u/ml

—

Disorders of breast

425

3462

1.12

1.44

1.1

2.35

2.88

u/ml

0.78

209

1698

Bronchitis, not specified as acute or chronic

378

1.38

1.44

1.0

1.1

1.35

2.45

u/ml

2.26

186

Abnormalities of forces of labour

108

870

1.25

1.43

1.1

4.38

2.89

u/ml

0.36

511

Heterophoria

525

1.32

1.43

1.1

1.0

2.07

2.97

u/ml

0.73

250

Polyarthropathies

546

3237

1.10

1.43

1.1

4.44

2.87

u/ml

0.97

195

1677

Superficial injury of thorax

754

1.26

1.42

1.1

2.59

3.30

u/ml

0.27

360

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

290

2517

1.14

1.42

1.1

4.40

2.88

u/ml

0.69

132

1305

Retention of urine

146

994

1.21

1.41

1.1

2.67

3.68

u/ml

0.34

405

Mandibular retrognathia AND surgery (BSSO)

181

1.56

1.41

1.0

3.35

1.56

u/ml

0.62

Other skin changes

791

1.25

1.41

1.0

1.1

1.88

3.26

u/ml

1.32

337

Other specified/unspecified soft tissue disorders

197

1.53

1.40

1.1

1.0

1.42

2.34

u/ml

—

Alzheimer disease, including avohilmo

650

0.77

1.40

1.0

1.1

3.99

4.19

u/ml

0.04

124

Malignant neoplasm of breast, HER-positive

171

1575

0.84

1.40

1.0

1.1

1.96

3.17

u/ml

1.30

726

Neuromuscular dysfunction of bladder

389

1.37

1.39

1.1

1.78

2.52

u/ml

0.43

179

Persons encountering health services for specific procedures and health care

954

5320

1.08

1.39

1.1

4.08

2.80

u/ml

1.21

357

2702

Insulin, combination of fast acting with intermediate-acting or long-acting

397

3250

1.12

1.39

1.1

5.87

3.41

u/ml

1.02

103

1542

Sleep disorders, other/unspecified

214

1.51

1.39

1.1

1.0

1.75

2.54

u/ml

0.39

101

Perineal laceration during delivery

206

1478

1.17

1.38

1.1

2.37

2.64

u/ml

0.24

855

Psoriatic arthropathies, ICD10

563

1.30

1.38

1.1

2.41

3.10

u/ml

0.42

275

Benign neoplasm: Skin of trunk

198

1.52

1.38

1.1

1.0

3.39

2.09

u/ml

0.40

Vertical strabismus

166

1.58

1.38

1.1

1.0

1.00

2.08

u/ml

—

Other disorders of the musculoskeletal system and connective tissue

669

1.27

1.38

1.1

2.19

3.29

u/ml

0.55

293

Aortic aneurysm

647

1.28

1.37

1.1

7.87

3.98

u/ml

0.34

233

Postmenopausal osteoporosis with pathological fracture

174

1.56

1.37

1.3

1.1

6.60

2.36

u/ml

—

Disorders of purine and pyrimidine metabolism

2.99

1.36

1.0

—

1.33

—

Later onset COPD, excluding more controls

353

1.34

1.36

1.1

4.02

4.23

u/ml

—

Other and unspecified mononeuropathies of upper limb

143

1.62

1.36

1.0

1.83

2.05

u/ml

—

Unspecified privation

556

1.30

1.35

1.1

6.29

2.72

u/ml

0.40

261

Lichen ruber planus, wide definition including periferal and oral lichen planus

128

1057

1.21

1.35

1.1

2.54

3.22

u/ml

0.38

469

Pedestrian injured in collision with pedal cycle

151

1.60

1.35

1.0

1.78

2.50

u/ml

0.36

Other drug-induced secondary parkinsonism

0.00

1.35

0.0

1.0

—

2.22

—

Leukaemia of unspecified cell type

0.00

1.35

0.0

1.1

—

2.79

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

167

1.57

1.35

1.1

1.0

0.78

1.88

u/ml

—

Gonococcal infection

159

1.58

1.35

1.0

1.1

2.66

2.17

u/ml

—

Dislocation, sprain and strain of joints and ligaments of thorax

183

1.54

1.35

1.1

1.0

1.19

1.97

u/ml

—

Other bursopathies

530

1.31

1.35

1.1

1.94

3.06

u/ml

0.88

241

Congenital malformations, deformations and chromosomal abnormalities

555

4828

1.10

1.35

1.1

2.47

2.95

u/ml

0.65

266

2475

Malignant neoplasm of larynx, including Hilmo

0.00

1.34

0.0

1.0

—

3.16

—

Foreign body entering into or through eye or natural orifice

418

1.35

1.34

1.0

1.1

2.57

2.62

u/ml

0.02

195

AV-block

464

1.31

1.33

1.1

2.28

2.82

u/ml

0.30

160

Other and unspecified injuries of ankle and foot

274

1.43

1.33

1.0

2.62

2.73

u/ml

0.04

139

Other diseases of blood and blood-forming organs

299

1.41

1.33

1.2

1.1

11.64

2.16

u/ml

0.88

125

Abscess of anal and rectal regions

427

1.34

1.33

1.2

1.1

2.89

3.43

u/ml

0.17

231

Hydrocephalus

259

0.58

1.33

1.1

1.70

2.17

u/ml

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

419

1.34

1.33

1.0

1.1

1.63

3.89

u/ml

1.76

225

Non-Hodgkin lymphoma, all, including Hilmo

453

1.33

1.1

2.41

2.80

u/ml

0.19

169

Gonococcal infection

184

1.53

1.32

1.1

1.0

2.41

2.05

u/ml

—

Contraceptive management

376

2360

1.12

1.32

1.1

3.04

2.99

u/ml

0.02

175

1296

Placenta praevia

394

1.35

1.31

1.1

1.0

1.51

2.02

u/ml

0.64

237

Other condition

842

0.77

1.31

1.1

3.19

3.29

u/ml

0.03

418

Hypertrophic scar

334

1.39

1.31

1.1

1.0

2.70

2.26

u/ml

0.17

166

Disease of hard tissues of teeth, NOS

428

2015

1.11

1.31

1.1

2.54

3.24

u/ml

0.99

202

1063

Injury of muscle and tendon at forearm level

1.78

1.30

1.0

1.61

1.85

u/ml

—

Other noninfective disorders of lymphatic vessels and lymph nodes

161

1.56

1.29

1.0

3.53

1.87

u/ml

—

Bursitis of shoulder

114

1.68

1.29

1.2

1.0

1.53

1.79

u/ml

—

Malignant neoplasm of rectum, including Hilmo

395

1.34

1.28

1.0

1.1

3.18

3.24

u/ml

0.02

151

Malignant neoplasm of digestive organs

172

1156

1.18

1.27

1.0

1.1

5.60

3.79

u/ml

0.43

437

Pterygium

1.80

1.27

1.1

1.0

10.13

2.23

u/ml

—

Acute lymphadenitis

379

1.35

1.27

1.1

6.94

2.41

u/ml

0.80

189

Autism spe

204

0.53

1.27

1.0

1.42

2.27

u/ml

—

Cervicobrachial syndrome

157

1331

1.18

1.27

1.1

2.20

3.23

u/ml

0.82

694

Other disorders of conjunctiva

571

1.28

1.26

1.0

1.1

4.07

2.90

u/ml

0.29

236

Non-allergic asthma (mode), excluding more controls

121

992

1.21

1.26

1.0

1.1

1.77

3.72

u/ml

2.39

469

Other disorders of bladder

405

1.34

1.26

1.1

3.63

2.95

u/ml

0.10

164

Lichen sclerosus et atrophicus

484

1.31

1.25

1.0

1.1

1.31

3.41

u/ml

2.27

205

Inflammatory disease of cervix uteri

303

1.39

1.25

1.0

1.1

1.46

3.47

u/ml

1.26

140

Deforming dorsopathies

194

1675

1.16

1.25

1.1

2.09

3.27

u/ml

1.80

825

Benign neoplasm of other and unspecified endocrine glands

643

1.26

1.25

1.1

6.22

3.16

u/ml

0.55

280

Unspecified abortion

329

1.38

1.25

1.1

4.12

3.44

u/ml

0.10

177

Scoliosis

520

1.29

1.24

1.1

2.64

3.72

u/ml

0.54

259

Contusion of other and unspecified parts of foot

338

1.37

1.24

1.1

1.28

2.58

u/ml

1.93

169

Chondromalacia

147

1.58

1.23

1.0

1.52

2.05

u/ml

0.31

Special screening examination for neoplasms

179

1.51

1.23

1.1

1.21

4.00

u/ml

—

Medical abortion

590

2937

1.09

1.23

1.1

2.73

2.78

u/ml

0.03

272

1461

Other hammer toe(s) (acquired)

610

1.26

1.23

1.1

1.92

3.43

u/ml

0.92

234

Other or unspecified immunodeficiency

2.69

1.22

1.0

1.1

—

0.83

—

Renal tubulo-interstitial diseases

580

4692

0.92

1.22

1.1

4.34

2.92

u/ml

0.99

191

2259

Wide developmental disorders, excluding more controls

260

0.60

1.22

1.0

1.1

1.42

2.32

u/ml

—

126

Dermatopolymyositis, unspecified

2.67

1.22

1.0

1.1

—

3.31

—

Iridocyclitis

151

1281

1.18

1.22

1.0

1.1

3.67

3.28

u/ml

0.10

624

Hypermetropia

416

1.33

1.22

1.1

1.0

1.23

4.20

u/ml

2.25

174

Other abnormal immunological findings in serum

124

1.63

1.21

1.1

1.0

10.01

2.42

u/ml

—

Aneurysms, operations, SAH

719

0.76

1.21

1.1

1.69

3.33

u/ml

1.31

305

Spasmodic torticollis

156

1.55

1.20

1.1

4.32

1.87

u/ml

—

Other heart diseases

392

2830

0.90

1.20

1.1

3.12

3.07

u/ml

0.03

171

1567

Autism spe, excluding more controls

200

0.55

1.20

1.0

1.1

1.42

2.06

u/ml

—

103

Urethral stricture

156

1.54

1.20

1.0

1.1

3.33

2.47

u/ml

—

Scabies

123

1027

1.20

1.1

3.17

3.00

u/ml

0.06

512

Salpingitis and oophoritis

124

1036

1.20

1.0

1.1

2.07

3.78

u/ml

1.89

503

Thalassaemia

2.36

1.20

1.2

1.1

—

2.72

—

Use of anticholinesterases

674

0.78

1.20

1.1

2.45

4.37

u/ml

0.58

125

N06DA Anticholinesterases

674

0.78

1.20

1.1

2.45

4.37

u/ml

0.58

125

Other problems related to primary support group, including family circumstances

116

937

1.21

1.20

1.1

5.68

3.74

u/ml

0.61

470

Other diseases of arteries and capillaries

383

1.34

1.20

1.1

2.28

2.52

u/ml

0.09

164

114

946

1.21

1.19

1.1

4.30

2.79

u/ml

0.31

556

Any event in cancer register

699

4438

0.93

1.19

1.1

3.27

2.98

u/ml

0.25

333

2239

Acute and subacute iridocyclitis

128

1073

1.20

1.19

1.0

1.1

3.66

3.40

u/ml

0.06

521

Diseases of arteries, arterioles and capillaries (FINNGEN)

148

866

1.18

1.19

1.1

3.11

4.09

u/ml

0.32

448

Superficial injury of wrist and hand

173

1488

1.17

1.19

1.1

4.08

3.11

u/ml

0.18

755

Arthrosis

537

2698

1.09

1.19

1.1

3.92

2.84

u/ml

0.73

240

1410

Fibrosis and cirrhosis of liver

289

1.39

1.19

1.0

1.1

1.62

2.53

u/ml

—

113

Retinal detachments and breaks

171

1469

1.17

1.19

1.1

3.95

3.60

u/ml

0.07

593

Infliximab

117

1.64

1.19

1.1

1.0

1.24

2.24

u/ml

—

Myocardial infarction, strict

152

1271

0.85

1.19

1.1

9.84

3.73

u/ml

0.91

479

Diseases of arteries, arterioles and capillaries

339

2245

1.12

1.19

1.1

4.50

3.80

u/ml

0.17

944

L04AC Interleukin inhibitors

358

1.35

1.18

1.1

1.75

2.39

u/ml

0.50

183

Injuries to the wrist and hand

861

5572

1.07

1.18

1.1

2.94

2.99

u/ml

0.04

357

2770

Loose body in joint

1.71

1.18

1.2

1.0

9.11

1.68

u/ml

—

Acute nasopharyngitis (common cold)

680

1.25

1.17

1.1

2.18

3.16

u/ml

0.96

380

Carcinoma in situ of breast

0.00

1.17

0.0

1.0

—

2.14

—

Insulin, fast-acting (human)

116

966

1.20

1.17

1.1

7.07

3.28

u/ml

0.68

537

Tongue abnormality

265

1.40

1.16

1.1

1.15

2.38

u/ml

—

103

Labour and delivery complicated by umbilical cord complications

345

0.66

1.16

1.1

2.87

2.43

u/ml

0.15

191

Bilateral sagittal split ramus osteotomy operation

232

1.43

1.16

1.0

3.22

2.07

u/ml

0.42

119

Any reimbursement code in KELA

660

3059

1.08

1.15

1.1

3.24

2.86

u/ml

0.28

296

1756

Gout, idiopatic and unspecified

740

1.23

1.15

1.1

18.14

3.11

u/ml

0.96

272

Concussion

441

3280

1.10

1.15

1.1

2.93

3.14

u/ml

0.14

191

1704

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

126

1.60

1.15

1.1

5.31

1.79

u/ml

—

Hypopituitarism

412

1.32

1.15

1.1

6.53

3.14

u/ml

0.69

191

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

150

1.54

1.15

1.0

1.1

3.80

3.83

u/ml

—

Hypogonadotropic hypogonadism

142

1.56

1.15

1.0

1.1

8.62

2.07

u/ml

0.94

Lichen planus

562

1.27

1.14

1.1

2.63

3.62

u/ml

0.36

224

STROKE

313

2373

0.90

1.14

1.1

2.03

3.32

u/ml

2.69

111

1191

Abnormal findings on antenatal screening of mother

845

0.79

1.14

1.1

2.18

2.26

u/ml

0.04

499

Scleritis

1.77

1.14

1.1

1.0

1.88

1.49

u/ml

—

Unknown and unspecified causes of morbidity

326

1.35

1.14

1.0

1.1

2.14

2.45

u/ml

0.17

165

Disorders of speech understanding and production

278

1.38

1.14

1.1

3.31

4.17

u/ml

0.15

110

Other (seronegative) rheumatoid arthritis, wide

105

869

1.21

1.13

1.1

2.46

3.33

u/ml

0.48

369

Carcinoma in situ of skin of other and unspecified parts of face

183

1.48

1.13

1.0

1.1

1.48

2.59

u/ml

—

Congenital malformations of uterus and cervix

159

1.52

1.13

1.1

1.0

1.18

2.35

u/ml

1.07

Excessive earwax

328

2881

1.11

1.13

1.1

3.29

3.70

u/ml

0.24

149

1247

Intestinal stricture

153

1310

1.17

1.12

1.0

1.1

1.84

3.67

u/ml

2.86

539

Seronegative rheumatoid arthritis

528

1.27

1.12

1.1

2.75

2.65

u/ml

0.03

241

Tuberculosis, IBD comorbidity

200

1.45

1.12

1.1

4.18

2.14

u/ml

—

Other specified disorders of muscle

135

1.57

1.12

1.1

1.30

2.31

u/ml

—

Varicose veins of other sites

293

1.37

1.11

1.1

2.71

2.32

u/ml

0.21

131

Nystagmus and other irregular eye movements

1.80

1.11

1.2

1.1

5.03

2.47

u/ml

—

Other sexually transmitted chlamydial diseases

556

1.27

1.11

1.0

1.1

1.66

2.67

u/ml

1.18

326

Persistent mood disorders

137

1165

1.18

1.10

1.1

4.35

3.52

u/ml

0.33

596

Dermatitis due to substances taken internally

268

1.39

1.10

1.1

1.0

1.36

2.65

u/ml

1.53

125

Other abnormal products of conception

375

2250

1.11

1.09

1.1

3.06

2.72

u/ml

0.17

196

1287

Abnormal blood-pressure reading, without diagnosis

218

1.43

1.09

1.1

2.87

2.50

u/ml

0.09

101

Disorders of adult personality and behaviour

213

2415

0.88

1.09

1.1

1.93

2.79

u/ml

1.61

1305

Congenital ovarian cysts

338

1.34

1.08

1.0

1.73

2.87

u/ml

0.74

185

Chronic viral hepatitis

351

0.68

1.08

1.0

1.1

6.61

2.32

u/ml

—

191

Non-allergic asthma (mode)

121

1010

1.19

1.08

1.0

1.1

1.77

3.69

u/ml

2.34

470

Malignant neoplasm of stomach

128

1.57

1.08

1.0

3.99

3.05

u/ml

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

519

3786

1.09

1.08

1.1

2.70

2.74

u/ml

0.04

267

1924

Symptoms and signs involving the nervous and musculoskeletal systems

405

3694

1.10

1.08

1.1

1.76

3.30

u/ml

4.06

159

1719

Vitamin deficiency, wide

227

1.42

1.08

1.0

1.1

6.93

2.14

u/ml

—

105

Vitamin deficiency

227

1.42

1.08

1.0

1.1

6.93

2.14

u/ml

—

105

Acute pancreatitis

103

856

1.21

1.08

1.1

3.81

3.46

u/ml

0.14

397

Arthropathy in ulcerative colitis

1.78

1.07

1.2

1.0

3.07

1.66

u/ml

—

ILD, hospital admission 2, with pulmonary infections

295

1.36

1.07

1.0

1.1

23.83

2.54

u/ml

0.77

105

Congenital malformations of the urinary system

356

1.33

1.07

1.2

1.1

3.29

2.35

u/ml

0.19

155

Rheumatoid arthritis

203

1598

1.14

1.07

1.1

3.04

3.07

u/ml

0.01

804

Sequelae of other and unspecified infectious and parasitic diseases

338

0.68

1.07

1.1

1.0

1.85

2.19

u/ml

0.17

174

Sarcoidosis

676

1.23

1.06

1.1

3.37

3.29

u/ml

0.02

307

Psoriasis vulgaris

118

995

1.19

1.06

1.1

2.64

2.88

u/ml

0.13

489

Strabismus

208

1827

1.14

1.06

1.1

2.36

3.51

u/ml

1.01

883

Examination and encounter for administrative purposes

153

1.51

1.06

1.0

1.1

2.19

3.15

u/ml

—

Malignant neoplasm of stomach, including Hilmo

153

1.51

1.06

1.0

1.1

3.99

2.66

u/ml

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

228

1.41

1.06

1.1

1.0

6.42

2.15

u/ml

1.01

103

Other and unspecified iridocyclitis

228

1.41

1.06

1.0

2.18

2.11

u/ml

—

107

Glucosamine medication

205

1437

1.14

1.05

1.1

3.64

4.16

u/ml

0.22

477

Other and unspecified drugs and medicaments

436

1.29

1.05

1.1

1.53

2.81

u/ml

0.85

193

Other diseases of pancreas

305

1.35

1.05

1.0

1.1

9.44

3.55

u/ml

0.44

128

Fracture of rib(s), sternum and thoracic spine

152

1310

1.16

1.05

1.1

3.05

3.50

u/ml

0.10

573

Tuberculosis, wide

203

1.43

1.05

1.1

4.18

2.18

u/ml

—

Malignant neoplasm

603

3843

0.93

1.05

1.1

3.29

3.08

u/ml

0.15

281

1932

Septal defects

443

0.73

1.04

1.1

1.31

4.09

u/ml

2.10

178

Myocardial infarction, unclassifiable

507

0.76

1.04

1.1

2.72

3.64

u/ml

0.19

141

Scissor bite

252

1.39

1.04

1.1

4.92

3.14

u/ml

0.38

Spontaneous abortion

436

2692

1.09

1.04

1.0

1.1

2.27

2.82

u/ml

0.94

211

1403

Internal derangement of knee

268

2389

1.12

1.04

1.1

1.92

2.91

u/ml

2.28

133

1262

Hypertrophic disorders of skin

367

1.31

1.03

1.1

1.0

2.70

2.66

u/ml

0.01

187

Other specified disorders of kidney and ureter

146

1.52

1.03

1.1

1.0

1.12

1.82

u/ml

—

Benign neoplasm: Adrenal gland

306

1.34

1.03

1.1

11.25

1.92

u/ml

0.99

127

Viral agents as the cause of diseases classified to other chapters

122

1.57

1.03

1.1

2.94

2.00

u/ml

—

Spondyloarthritis

117

989

1.19

1.03

1.1

1.67

3.84

u/ml

2.94

520

Macular hole

179

1.46

1.03

1.0

1.1

0.83

2.00

u/ml

—

Non-follicular lymphoma

315

1.34

1.02

1.0

1.59

2.81

u/ml

1.31

108

Special screening examination for other diseases and disorders

535

1.25

1.02

1.1

2.08

3.41

u/ml

0.87

286

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

643

0.77

1.02

1.1

1.68

3.60

u/ml

2.02

365

Carpal tunnel syndrome

437

3537

1.09

1.01

1.1

3.13

3.07

u/ml

0.03

154

1777

Amputation

281

1.35

1.01

1.1

8.87

2.58

u/ml

—

102

Agoraphobia

239

1.39

1.01

1.2

1.0

3.73

2.31

u/ml

0.53

135

Other diseases caused by chlamydiae

115

1.58

1.00

1.2

1.0

3.09

1.87

u/ml

0.46

Myocardial infarction

172

1385

0.87

1.00

1.1

8.81

3.81

u/ml

0.81

537

Unspecified acute lower respiratory infection

827

1.20

1.00

1.1

4.56

3.26

u/ml

0.28

407

Unspecified jaundice

139

1.52

1.00

1.0

2.70

2.60

u/ml

—

Generalized epilepsy

291

1.35

1.00

1.1

2.59

2.27

u/ml

0.15

134

Purpura and other haemorrhagic conditions

691

1.22

1.00

1.0

1.1

6.16

3.60

u/ml

0.28

313

Tumor necrosis factor alpha inhibitors

132

1132

1.17

0.99

1.1

1.97

3.64

u/ml

2.50

606

Fracture of femur

106

808

1.19

0.99

1.1

2.60

3.67

u/ml

0.51

268

Major coronary heart disease event excluding revascularizations

235

1756

0.89

0.99

1.1

6.67

3.79

u/ml

0.65

709

Gangrene, not elsewhere classified

2.19

0.98

1.0

—

2.66

—

Exposure to other and unspecified animate mechanical forces

198

1.42

0.98

1.0

1.1

3.42

1.84

u/ml

—

Diplopia

620

1.23

0.98

1.1

2.87

3.23

u/ml

0.12

288

Maxillary retrognathism

132

1.53

0.98

1.0

1.1

2.77

2.39

u/ml

—

Trigeminal neuralgia

292

1.34

0.98

1.1

1.03

3.41

u/ml

—

143

Trigger finger

711

1.21

0.97

1.1

1.86

3.10

u/ml

1.38

350

Other viral hepatitis

412

0.73

0.97

1.1

5.07

2.14

u/ml

—

223

Other retinal disorders

345

2446

1.10

0.97

1.1

4.63

3.57

u/ml

0.41

103

1044

Other abnormal findings in urine

1.75

0.97

1.2

1.0

3.38

2.84

u/ml

—

Crohn's disease NAS

380

1.29

0.97

1.1

1.16

2.40

u/ml

2.59

184

Subarachnoid haemorrhage

377

0.71

0.96

1.0

1.1

2.25

3.15

u/ml

0.26

149

Herpesviral [herpes simplex] infections

676

1.22

0.96

1.0

1.1

2.88

3.41

u/ml

0.24

328

Brachial plexus disorders

622

1.23

0.96

1.1

1.0

1.12

3.60

u/ml

3.62

340

Other diseases of peritoneum

199

1.41

0.95

1.0

1.37

1.86

u/ml

—

Other benign neoplasms of skin

214

1904

1.13

0.95

1.1

3.25

3.47

u/ml

0.11

847

Early onset COPD, excluding more controls

822

1.19

0.95

1.1

3.48

3.99

u/ml

0.23

362

Malignant neoplasm of larynx

0.00

0.95

0.0

1.0

—

3.16

—

Lichen planus, including avohilmo

104

878

1.19

0.95

1.1

2.70

3.39

u/ml

0.31

378

Foreign body on external eye

814

1.19

0.95

1.1

2.99

2.80

u/ml

0.08

432

Asymptomatic human immunodeficiency virus [HIV] infection status

1.92

0.95

1.0

1.1

—

1.70

—

Viral pneumonia

632

1.22

0.94

1.1

3.18

2.82

u/ml

0.12

298

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

166

1.45

0.94

1.3

1.0

1.18

2.25

u/ml

1.38

Essential (haemorrhagic) thrombocythaemia

133

1.51

0.94

1.3

1.0

3.09

2.33

u/ml

—

Implicit bacterial Sepsis

211

1619

1.13

0.94

1.1

4.72

4.12

u/ml

0.10

652

Diseases caused by chlamydiae

109

1.58

0.94

1.2

1.0

2.30

1.94

u/ml

—

Sudden idiopathic hearing loss

408

1.28

0.94

1.1

1.0

3.45

2.50

u/ml

0.27

179

Left ventricular outflow tract obstruction, narrow definition

293

0.68

0.94

1.1

2.35

3.77

u/ml

—

130

Other and unspecified corneal deformities and disorders

158

1.46

0.94

1.0

0.79

2.15

u/ml

—

Myositis

109

1.57

0.94

1.3

1.0

21.69

2.29

u/ml

—

Carcinoma in situ of other and unspecified digestive organs

101

1.59

0.93

1.1

1.0

7.83

2.77

u/ml

0.55

Obsessive-compulsive disorder

552

1.24

0.93

1.0

1.1

2.36

2.82

u/ml

0.26

301

Ectopic pregnancy

147

1279

1.15

0.93

1.1

2.19

3.06

u/ml

0.68

676

Use of biperiden

245

0.65

0.93

1.0

3.05

2.23

u/ml

—

116

Lack of expected normal physiological development

153

1.44

0.92

1.0

1.1

2.14

8.95

u/ml

—

Dementia

103

837

0.85

0.92

1.1

3.60

4.01

u/ml

0.09

188

DVT of lower extremities and pulmonary embolism

207

1835

1.12

0.92

1.1

4.99

3.89

u/ml

0.26

762

All influenza (not pneumonia)

103

872

1.18

0.92

1.1

1.15

3.15

u/ml

4.96

444

Dipeptidyl peptidase 4 (DPP-4) inhibitors

276

1997

1.11

0.91

1.1

3.68

3.86

u/ml

0.05

831

Failed induction of labour

545

1.24

0.91

1.1

2.08

1.91

u/ml

0.11

329

Malignant neoplasm of endocrine gland

375

1.28

0.91

1.1

1.0

2.12

2.94

u/ml

0.41

171

Nonischemic cardiomyopathy

348

1.29

0.91

1.1

2.38

2.22

u/ml

0.08

140

Primary gonarthrosis, bilateral

206

1978

0.89

0.91

1.0

1.1

2.45

3.52

u/ml

0.96

788

Femoral hernia, unilateral

102

1.58

0.90

1.0

0.86

1.85

u/ml

—

Inguinal of femoral hernia, unilateral

102

1.58

0.90

1.0

0.86

1.85

u/ml

—

Inguinal hernia, unilateral

102

1.58

0.90

1.0

0.86

1.85

u/ml

—

170

0.58

0.90

1.1

1.0

17.00

2.02

u/ml

—

Short stature starting before birth

1.96

0.90

1.4

1.1

—

13.55

—

Malignant neoplasm of colon, including Hilmo

599

1.22

0.90

1.0

1.1

5.49

4.14

u/ml

0.14

212

Injuries to the elbow and forearm

565

4636

1.07

0.90

1.1

3.61

3.04

u/ml

0.34

217

2246

Combinations of oral blood glucose lowering drugs

135

1171

1.15

0.90

1.1

2.01

3.89

u/ml

2.70

498

Delirium, not induced by alcohol and other psychoactive substances

359

0.72

0.89

1.2

1.0

12.50

2.43

u/ml

—

112

Benign neoplasm: Liver/bile ducts

160

1.45

0.89

1.0

1.1

1.40

2.48

u/ml

0.78

Myasthenia gravis

1.70

0.89

1.2

1.0

1.42

1.76

u/ml

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.70

0.89

1.0

1.27

2.60

u/ml

—

Effects of other external causes

177

1.42

0.89

1.0

1.1

5.11

2.44

u/ml

0.45

Congenital malformations of cardiac septa

457

0.76

0.88

1.1

1.42

4.06

u/ml

2.02

184

Amblyopia ex anopsia

265

0.68

0.88

1.1

4.48

3.43

u/ml

—

112

Female infertility, associated with anovulation

684

1.20

0.88

1.1

2.48

3.04

u/ml

0.28

409

Other infective otitis externa

289

1.32

0.88

1.2

1.1

7.39

2.18

u/ml

1.09

136

Acute suppurative otitis media

273

2311

1.10

0.87

1.1

2.79

2.92

u/ml

0.08

114

1217

Abnormal findings on diagnostic imaging of other body structures

648

1.21

0.87

1.1

1.96

3.04

u/ml

0.65

279

Solid cancers, helper endpoint

596

3759

0.94

0.87

1.1

3.37

3.07

u/ml

0.23

276

1892

Benign neoplasm: salivary glands, exclude unknown (D119)

360

1.28

0.87

1.0

1.1

2.07

2.58

u/ml

0.37

156

Poor fetal growth

107

1247

0.86

0.87

1.1

4.44

2.90

u/ml

0.30

709

Valvular operations

476

1.24

0.86

1.1

1.45

3.48

u/ml

—

190

Supplementary factors related to causes of morbidity and mortality classified elsewhere

180

2025

0.89

0.86

1.1

2.47

3.45

u/ml

0.88

980

Other specified/unspecified inflammatory spondylopathies

299

1.31

0.86

1.1

1.36

3.51

u/ml

2.05

180

Tobacco use

287

0.69

0.86

1.1

1.0

3.59

2.37

u/ml

—

137

Fracture of lumbar spine and pelvis

101

859

1.18

0.85

1.1

3.04

3.12

u/ml

0.02

349

Superficial injury of hip and thigh

640

1.20

0.85

1.1

1.0

3.75

2.58

u/ml

0.45

278

Other deformities of toe(s)

145

1.46

0.85

1.0

3.70

1.57

u/ml

—

Presence of other functional implants

284

1790

1.10

0.85

1.1

3.91

3.66

u/ml

0.07

733

Other mycoses, not elsewhere classified/unspecified

1.60

0.85

1.0

3.94

2.18

u/ml

—

Torticollis

1.58

0.85

1.1

1.12

2.58

u/ml

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

460

1.24

0.84

1.1

2.64

3.22

u/ml

0.23

200

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

274

0.69

0.84

1.0

1.1

6.26

2.79

u/ml

—

132

Thrombocytopenia, unspecified

300

1.30

0.84

1.1

9.31

2.67

u/ml

0.40

116

Persons encountering health services for specific procedures, not carried out

506

1.23

0.83

1.1

1.73

2.38

u/ml

0.54

261

Otitis externa, unspecified

679

1.20

0.83

1.1

7.22

3.61

u/ml

0.59

331

Toxic effect of ethanol

238

0.67

0.83

1.0

2.57

2.14

u/ml

—

116

Viral pneumonia (unknown virus, not influenza)

336

1.28

0.83

1.0

1.37

2.22

u/ml

1.38

156

Malignant neoplasm of thyroid gland

345

1.28

0.83

1.1

1.0

2.10

3.04

u/ml

0.45

159

Colon adenocarcinoma

327

1.29

0.83

1.0

1.1

8.31

2.65

u/ml

0.35

102

All dysplastic lesions of the vulva

266

1.32

0.83

1.1

4.52

3.18

u/ml

0.22

132

Embolic stroke

114

0.52

0.83

1.0

—

1.62

—

Other disorders of veins

268

2425

1.10

0.82

1.1

2.13

3.04

u/ml

1.28

1168

Other diseases of pleura

155

1537

0.88

0.82

1.1

6.54

3.94

u/ml

0.61

580

Personality disorders

202

2248

0.90

0.82

1.1

2.23

2.87

u/ml

0.78

1220

Otitis media, unspecified

103

813

1.17

0.81

1.0

1.1

4.33

2.98

u/ml

0.32

363

Other endocrine disorders

374

1.26

0.81

1.1

0.72

3.95

u/ml

2.47

153

Problems related to lifestyle

643

0.81

1.0

1.1

3.21

3.40

u/ml

0.06

366

Other symptoms and signs involving cognitive functions and awareness

231

1901

1.11

0.81

1.1

1.63

4.20

u/ml

6.20

813

Other infectious diseases

320

1.28

0.80

1.1

1.65

2.52

u/ml

0.65

133

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

691

1.19

0.80

1.0

1.1

3.83

3.16

u/ml

0.23

314

Fracture of foot, except ankle

187

1674

1.12

0.80

1.1

2.38

3.23

u/ml

0.63

871

Condition for Implicit Sepsis (Organ dysfunction codes)

559

4204

0.94

0.80

1.1

2.54

3.04

u/ml

0.47

188

2045

Malignant neoplasm of thyroid gland, including Hilmo

392

1.25

0.79

1.1

1.0

2.01

2.85

u/ml

0.47

182

Malignant neoplasm of parotid gland, including Hilmo

1.83

0.79

1.2

1.1

—

4.24

—

Pre-eclampsia or eclampsia

195

1751

1.12

0.79

1.1

3.58

2.81

u/ml

0.23

935

Viral and other specified intestinal infections

194

1700

1.12

0.79

1.0

1.1

2.93

2.79

u/ml

0.05

847

Epileptic seizures related to alcohol

0.00

0.79

0.0

1.0

—

1.03

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

242

1.33

0.79

1.1

0.94

3.29

u/ml

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

0.79

0.0

1.1

—

2.25

—

Maxillary hypoplasia

0.00

0.78

0.0

1.1

—

2.70

—

Percutaneous Coronary Intervention

440

2897

0.93

0.78

1.1

4.06

3.34

u/ml

0.37

173

1351

Viral agents as the cause of diseases classified to other chapters

148

1.43

0.78

1.0

1.1

2.56

4.05

u/ml

—

Cerebral aneurysm, nonruptured

429

0.77

0.78

1.1

1.16

3.62

u/ml

2.66

190

Benign neoplasm: Skin of other and unspecified parts of face

438

1.24

0.78

1.2

1.0

5.96

2.42

u/ml

0.88

182

Asthma and opportunity respiratory infection

148

1.42

0.78

1.2

1.0

2.34

2.39

u/ml

—

Bullous keratopathy

0.00

0.78

0.0

1.0

—

2.71

—

Diabetic maculopathy, excluding more controls

538

1.21

0.78

1.1

4.65

2.49

u/ml

0.48

271

Thyrotoxicosis with toxic multinodular goitre

234

1.33

0.77

1.1

1.75

2.17

u/ml

0.21

Haemorrhage in early pregnancy

263

2338

1.10

0.77

1.1

4.01

2.66

u/ml

0.54

119

1264

Specific personality disorders

174

1943

0.89

0.77

1.1

2.06

2.96

u/ml

1.39

1058

severe traumatic brain injury, does not include concussion

835

0.84

0.77

1.1

2.92

2.82

u/ml

0.04

345

Major coronary heart disease event

470

3037

0.93

0.77

1.1

3.95

3.28

u/ml

0.36

184

1416

Acute pancreatitis (for exclusion)

103

889

1.16

0.77

1.1

3.81

3.06

u/ml

0.37

399

Burns and corrosions of external body surface, specified by site

649

1.19

0.76

1.1

9.70

2.43

u/ml

1.16

312

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

200

1.36

0.76

1.1

4.24

2.58

u/ml

—

Spondylopathies (FG)

101

871

1.16

0.76

1.1

1.66

3.52

u/ml

1.99

481

Complications predominantly related to the puerperium

245

2232

1.10

0.76

1.1

3.06

2.89

u/ml

0.06

116

1200

Ovarian hyperstimulation (induction)

149

1.42

0.76

1.0

6.20

2.21

u/ml

0.54

Long labour

214

2022

0.90

0.76

1.1

3.15

2.47

u/ml

0.35

129

1155

Congenital malformations of the urinary system

341

1.27

0.76

1.2

1.1

3.85

2.41

u/ml

0.24

148

Other orthopaedic follow-up care

270

1.30

0.76

1.1

1.0

13.87

2.67

u/ml

0.42

124

Other maltreatment syndromes

209

0.67

0.76

1.1

1.0

2.57

2.45

u/ml

—

103

Post-traumatic stress disorder

733

1.18

0.76

1.1

6.05

2.96

u/ml

0.61

405

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

737

4224

1.06

0.75

1.1

3.46

2.77

u/ml

0.57

284

2153

737

4224

1.06

0.75

1.1

3.46

2.77

u/ml

0.57

284

2153

Other malignant neoplasms of skin (=non-melanoma skin cancer)

172

1319

0.89

0.75

1.1

3.42

4.13

u/ml

0.28

485

Diagnoses used for exclusion with ILD

128

1124

1.14

0.75

1.1

3.10

3.61

u/ml

0.17

483

Inflammation of lacrimal passages (acute and unspecified)

1.58

0.75

1.0

3.27

1.73

u/ml

—

Other or ill-defined heart diseases

244

1.32

0.75

1.1

1.0

2.46

2.27

u/ml

0.07

120

Benign neoplasm of brain and other parts of central nervous system

297

1.28

0.75

1.1

6.84

2.53

u/ml

0.57

130

Burns and corrosions

854

1.16

0.75

1.1

9.34

3.27

u/ml

1.13

429

Melanocytic naevi of other and unspecified parts of face

315

1.27

0.75

1.1

1.0

2.03

2.21

u/ml

0.09

156

Postprocedural musculoskeletal disorders, not elsewhere classified

267

0.71

0.75

1.1

2.39

2.01

u/ml

—

103

Isolated proteinuria

141

1.43

0.75

1.1

1.0

4.41

2.23

u/ml

—

Anisometropia and aniseikonia

158

1.40

0.74

1.0

1.1

2.18

4.95

u/ml

—

Melanocytic naevi of trunk

679

1.18

0.74

1.1

1.0

2.49

3.31

u/ml

0.42

338

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

369

1.25

0.74

1.1

2.22

3.22

u/ml

0.32

156

Gout, unspecified

596

1.19

0.74

1.1

26.46

2.88

u/ml

—

211

Malignant neoplasm of cervix uteri, including Hilmo

133

1.44

0.74

1.0

1.1

1.81

3.09

u/ml

—

Coronary revascularization (ANGIO or CABG)

442

2898

0.93

0.74

1.1

4.05

3.34

u/ml

0.37

174

1352

Other CVD (FINNGEN)

306

1.24

0.73

1.1

3.29

2.75

u/ml

0.11

129

Herpesviral keratitis and keratoconjunctivitis

193

1.35

0.73

1.0

5.27

1.68

u/ml

0.76

All kidney diseases

742

5340

0.95

0.73

1.1

3.52

2.86

u/ml

0.52

262

2678

Toxic effect of contact with venomous animals

228

1.32

0.73

1.1

1.88

2.43

u/ml

—

105

Non-Hodgkin lymphoma, all

100

1.50

0.73

1.1

1.0

4.48

2.43

u/ml

—

Congenital malformations of aortic and mitral valves

242

0.70

0.73

1.0

1.1

1.39

3.87

u/ml

—

112

Dementia, including avohilmo

115

904

0.87

0.72

1.1

3.31

4.47

u/ml

0.35

213

Unspecified misadventure during surgical and medical care

242

0.70

0.72

1.1

1.0

6.70

2.67

u/ml

—

100

Localized skin eruption due to drugs and medicaments

1.68

0.72

1.3

1.1

1.02

1.05

u/ml

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

117

1.47

0.72

1.0

1.1

1.05

2.38

u/ml

—

Other disorders of male genital organs

159

1.39

0.72

1.3

1.0

2.52

2.73

u/ml

—

Hallux rigidus

543

1.20

0.72

1.1

2.15

2.97

u/ml

0.57

236

Dermatitis due to ingested food

287

1.28

0.71

1.1

1.53

3.87

u/ml

0.87

101

Suggestive for eosinophilic asthma

407

1.23

0.71

1.1

1.0

1.61

3.56

u/ml

1.82

178

151

1.40

0.71

1.1

2.04

3.31

u/ml

0.42

Other congenital malformations of the digestive system

285

0.73

0.71

1.1

1.0

4.70

4.19

u/ml

—

104

Hypertrophy of breast in women and men

158

1413

1.12

0.71

1.1

2.96

3.38

u/ml

0.25

735

Intermittent heterotropia

425

1.23

0.71

1.1

1.0

3.30

3.13

u/ml

0.03

195

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

182

0.65

0.71

1.0

1.40

2.09

u/ml

—

Injury of muscle and tendon at lower leg level

747

1.17

0.71

1.1

2.14

3.51

u/ml

1.20

377

Cysts of oral region, not elsewhere classified

282

1.28

0.71

1.0

1.30

2.28

u/ml

1.11

129

Ankylosing spondylitis

453

1.22

0.71

1.1

2.06

3.33

u/ml

0.63

242

Other neurotic disorders

203

1.33

0.70

1.2

1.0

3.19

2.52

u/ml

0.15

Campylobacter enteritis

143

1.41

0.70

1.1

1.0

1.76

2.03

u/ml

0.19

Other peripheral vertigo

381

1.24

0.70

1.0

1.1

3.22

2.85

u/ml

—

150

Ill-defined and unknown causes of mortality

240

0.71

0.70

1.0

1.1

4.01

2.59

u/ml

—

Varicella [chickenpox]

283

1.28

0.69

1.1

1.71

3.21

u/ml

0.75

136

Corneal scars and opacities

118

1.45

0.69

1.1

1.0

0.90

1.67

u/ml

—

Meralgia paraesthetica

152

1.39

0.69

1.0

1.1

1.26

3.15

u/ml

—

Postpartum haemorrhage

274

2123

1.09

0.69

1.1

2.68

2.53

u/ml

0.07

146

1215

Calculus of lower urinary tract

152

1.39

0.69

1.0

1.20

2.51

u/ml

—

Care involving use of rehabilitation procedures

468

4041

1.07

0.69

1.1

5.29

2.94

u/ml

1.21

166

2017

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

673

0.83

0.69

1.0

1.1

2.53

3.33

u/ml

0.30

260

Malignant neoplasm of parotid gland

1.87

0.68

1.2

1.1

—

4.24

—

Cirrhosis of liver, NAS

178

1.35

0.68

1.0

1.1

2.70

2.18

u/ml

—

Other and unspecified trigeminal disorders

1.61

0.68

1.2

1.0

1.20

2.24

u/ml

—

Vascular dementia

163

0.65

0.68

1.1

—

3.09

—

Emergency coronary revascularization (for ACS)

464

3005

0.94

0.68

1.1

4.08

3.29

u/ml

0.43

179

1377

Idiopathic thrombocytopenic purpura

144

1.40

0.68

1.1

1.0

2.06

1.94

u/ml

—

Molar incisor enamel hypoplasia, with caries

0.53

0.68

1.2

1.1

—

8.90

—

Other and unspecified psoriasis

293

1.27

0.68

1.2

1.0

1.17

2.43

u/ml

2.63

129

Other respiratory disorders and diseases

726

0.84

0.68

1.1

7.08

3.33

u/ml

0.51

270

Other diseases of the respiratory system

726

0.84

0.68

1.1

7.08

3.33

u/ml

0.51

270

Benign neoplasm: Parotid gland

329

1.25

0.67

1.0

1.1

2.18

2.33

u/ml

0.10

141

Cardiac arrhythmias

573

3517

1.06

0.67

1.1

3.48

2.77

u/ml

0.60

254

1931

Infections of genitourinary tract in pregnancy

705

1.17

0.67

1.1

1.70

2.73

u/ml

1.38

380

Speech and linguistic disorders, excluding more controls

628

1.17

0.67

1.1

2.30

3.34

u/ml

0.62

304

Artificial joint operation, meniscal resection

533

3667

0.94

0.67

1.1

3.14

3.25

u/ml

0.07

232

1729

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

153

1.38

0.67

1.1

1.0

0.63

1.76

u/ml

—

Primary biliary cholangitis (PBC)

1.50

0.67

1.0

0.54

1.44

u/ml

—

Open wound of forearm

493

1.20

0.67

1.0

1.1

2.08

2.39

u/ml

0.18

243

Diabetic retinopathy

147

817

1.12

0.67

1.1

7.05

3.29

u/ml

0.61

300

Complications of the puerperium, not elsewhere classified

348

1.24

0.66

1.0

1.38

3.03

u/ml

1.46

199

Juvenile osteochondrosis

223

1.31

0.66

1.0

1.1

1.24

2.62

u/ml

1.70

109

Myeloproliferative diseases (CML excluded)

276

1.27

0.66

1.2

1.0

2.97

2.12

u/ml

0.38

100

Crohn's disease of large intestine

303

1.26

0.66

1.1

1.0

2.19

2.38

u/ml

0.06

146

Dental pulpitis, including avohilmo

836

5179

1.05

0.66

1.1

3.58

2.72

u/ml

0.87

365

2688

Congenital malformations of breast

128

1.42

0.66

1.0

1.43

2.57

u/ml

—

Ulcer of vagina/vulva

145

1.39

0.66

1.2

1.1

2.36

2.50

u/ml

—

Single delivery by forceps and vacuum extractor

146

983

0.89

0.66

1.1

2.02

2.80

u/ml

1.00

555

Metabolic disorders

725

4207

1.05

0.66

1.1

3.55

2.94

u/ml

0.60

272

2126

Hypersomnia

1.55

0.66

1.2

1.1

1.13

2.25

u/ml

—

Conductive hearing loss, unspecified

417

0.79

0.65

1.0

1.1

3.83

3.22

u/ml

0.14

193

Other blood glucose lowering drugs, excl. Insulins

593

0.83

0.65

1.0

1.1

1.37

3.56

u/ml

2.57

224

Other fall from one level to another

153

1374

1.11

0.65

1.1

2.68

3.69

u/ml

0.82

661

Other viral diseases, not elsewhere classified

144

1286

1.12

0.65

1.1

5.45

3.77

u/ml

0.41

625

Impacted cerumen

394

1.22

0.65

1.0

1.1

3.81

2.27

u/ml

—

142

Carcinoma in situ of skin of upper limb, including shoulder

1.62

0.65

1.0

—

2.41

—

Coronary atherosclerosis

283

1937

0.92

0.65

1.1

4.48

3.57

u/ml

0.28

826

Seropositive rheumatoid arthritis

140

1247

1.12

0.65

1.1

2.92

3.82

u/ml

0.31

575

Procedures for purposes other than remedying health state

137

1.39

0.65

1.0

0.70

2.09

u/ml

—

Other superficial mycoses

120

1.43

0.65

1.2

1.0

0.79

1.94

u/ml

—

Inguinal hernia, bilateral

313

1.25

0.64

1.1

1.83

2.80

u/ml

0.90

133

Other congenital malformations of the digestive system

324

0.76

0.64

1.2

1.1

4.39

3.84

u/ml

0.08

118

Unspecified lump in breast

102

895

1.14

0.64

1.1

1.46

3.86

u/ml

2.89

415

Benign leiomyoma with endometriosis

792

1.15

0.64

1.1

4.57

3.60

u/ml

0.14

345

Malignant neoplasm of corpus uteri

270

0.74

0.64

1.1

4.14

2.75

u/ml

—

L02BG Aromatase inhibitors

135

1506

0.89

0.64

1.0

1.1

1.91

3.44

u/ml

1.52

614

Total colectomy operation

207

1.31

0.64

1.0

1.86

2.24

u/ml

—

Total colectomy

207

1.31

0.64

1.0

1.86

2.24

u/ml

—

Other misadventures during surgical and medical care

112

1.44

0.64

1.1

1.0

2.25

1.50

u/ml

—

Viral hepatitis

459

0.80

0.63

1.1

4.28

2.09

u/ml

0.39

246

Spinal instabilities

138

1.38

0.62

1.1

1.0

7.74

1.87

u/ml

—

Nontoxic diffuse goitre

138

1.38

0.62

1.1

1.0

2.70

1.88

u/ml

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

822

1.14

0.62

1.1

2.77

3.61

u/ml

0.41

309

Superficial injury of abdomen, lower back and pelvis

101

888

1.14

0.62

1.1

4.15

2.72

u/ml

0.26

453

Mitochondrial myopathy

1.69

0.62

1.0

1.1

—

4.42

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

860

1.14

0.62

1.1

2.99

3.79

u/ml

0.23

392

Burn and corrosion of trunk

147

1.37

0.62

1.0

3.57

2.11

u/ml

—

Abnormal involuntary movements

683

1.16

0.62

1.1

1.61

3.10

u/ml

1.90

308

Carcinoma in situ of skin of lower limb, including hip

1.61

0.61

1.0

1.1

—

2.13

—

malignant neoplasm of female genital organs

638

0.84

0.61

1.0

1.1

2.37

3.76

u/ml

0.73

236

Postpartum hemorraghe, parous women as controls

274

2162

1.08

0.61

1.1

2.68

2.79

u/ml

0.06

146

1187

Oral lichen planus, including avohilmo , including avohilmo

316

1.24

0.61

1.1

1.0

2.48

3.11

u/ml

0.19

133

Peripheral artery operations in Hilmo

370

1.22

0.61

1.2

1.1

7.62

2.91

u/ml

—

128

0.00

0.61

0.0

1.1

—

0.40

—

Open wounds involving multiple body regions

0.00

0.61

0.0

1.1

—

1.30

—

Abnormal pulmonary venous return

0.00

0.61

0.0

1.1

—

0.90

—

Degeneration of macula and posterior pole

174

1257

1.10

0.60

1.0

1.1

5.29

3.71

u/ml

0.30

364

Benign neoplasm of major salivary glands

407

1.21

0.60

1.1

1.0

1.94

2.94

u/ml

0.74

170

Malignant neoplasm of ureter, including Hilmo

0.00

0.60

0.0

1.1

—

3.06

—

Ischemic heart diseases

491

3120

0.94

0.60

1.1

3.92

3.21

u/ml

0.43

200

1486

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

0.00

0.60

0.0

1.1

—

2.35

—

Hydrocephalus in other diseases

0.00

0.60

0.0

1.0

—

3.26

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.51

0.60

1.1

1.15

2.66

u/ml

—

Implicit bacterial Sepsis

181

1461

1.10

0.60

1.1

5.37

3.99

u/ml

0.21

575

Abnormal findings in secretions and smears from cervix uteri vagina vulva

480

3427

1.06

0.60

1.1

2.54

2.70

u/ml

0.17

245

1803

Ischaemic heart disease, wide definition

386

2547

0.94

0.60

1.1

3.82

3.31

u/ml

0.23

143

1160

Malignant neoplasm, wide definition for exclusion

654

4025

0.95

0.60

1.1

3.25

3.04

u/ml

0.16

309

2025

Coxarthrosis, primary

269

2111

1.08

0.59

1.1

2.35

3.88

u/ml

2.25

810

Epilepsy

167

1830

0.91

0.59

1.1

2.57

3.73

u/ml

1.22

883

Inguinal or femoral hernia, bilateral

317

1.23

0.59

1.1

1.83

2.78

u/ml

0.89

134

Bilateral cryptorchidism (undescended testicles)

0.00

0.59

0.0

1.0

—

4.74

—

Abscess of Bartholin gland

197

0.71

0.59

1.1

1.0

2.38

2.11

u/ml

—

103

Myopia

106

940

1.13

0.59

1.0

1.1

3.85

3.45

u/ml

0.06

502

Other hypertrichosis

0.00

0.59

0.0

1.1

—

2.81

—

Cutaneous abscess, furuncle and carbuncle

185

1691

1.10

0.59

1.1

4.61

3.40

u/ml

0.40

880

Congenital malformations of ear causing impairment of hearing

0.00

0.59

0.0

1.1

—

3.32

—

Congenital malformations of breast

140

1.37

0.59

1.0

1.41

2.48

u/ml

—

Atrioventricular septal defect

0.00

0.59

0.0

1.1

—

3.52

—

Obesity due to excess calories

383

3602

1.06

0.58

1.1

3.82

2.89

u/ml

0.46

155

1854

Benign neoplasm: Conjunctiva

140

1.36

0.58

1.1

1.0

1.54

2.02

u/ml

—

Conduction disorders

136

991

1.11

0.58

1.1

1.93

3.20

u/ml

1.68

392

Malignant neoplasm of cervix uteri

1.47

0.58

1.0

2.28

2.58

u/ml

—

Sacroiliitis, not elsewhere classified

309

1.23

0.58

1.1

1.0

0.94

2.87

u/ml

2.14

182

Synovial cyst of popliteal space [Baker]

291

1.24

0.58

1.1

2.25

3.24

u/ml

0.44

123

Ménière disease

382

1.21

0.58

1.1

1.89

3.56

u/ml

0.80

154

Pneumonia due to other infectious organisms, not elsewhere classified

132

1.37

0.57

1.0

1.85

2.45

u/ml

—

Struck by thrown, projected or falling objec

274

1.24

0.56

1.1

5.86

2.70

u/ml

0.47

133

Traumatic subdural haemorrhage

360

0.80

0.56

1.0

1.1

4.61

3.97

u/ml

—

126

Disorders of continuity of bone

568

1.16

0.56

1.1

14.86

3.11

u/ml

0.64

276

Open wound of head

303

3122

0.93

0.56

1.1

4.75

3.48

u/ml

0.43

111

1472

Benign neoplasm: Other and unspecified parts of small intestine

1.46

0.56

1.3

1.0

—

1.99

—

Other juvenile arthritis

341

0.79

0.56

1.0

0.94

3.33

u/ml

—

171

Hypotension

503

1.17

0.56

1.1

3.10

2.59

u/ml

0.12

152

Multiple gestation

812

1.14

0.56

1.1

2.66

2.31

u/ml

0.19

488

Juvenile arthritis (FINNGEN)

374

0.80

0.56

1.0

0.94

3.14

u/ml

—

187

Other and unspecified acne

1.45

0.56

1.2

1.0

3.84

1.79

u/ml

—

Open wound of lower leg

784

1.14

0.55

1.0

1.1

2.40

2.78

u/ml

0.19

360

Foreign body in respiratory tract

275

1.24

0.55

1.0

1.1

10.93

2.72

u/ml

0.56

124

Chronic iridocyclitis

257

1.25

0.55

1.1

4.35

2.06

u/ml

0.70

117

Contact with sharp glass

251

0.75

0.55

1.1

1.0

2.10

2.09

u/ml

—

125

Convulsions, not elsewhere classified

130

1421

0.90

0.55

1.1

2.42

4.11

u/ml

1.67

713

Speech and linguistic disorders

708

1.14

0.55

1.1

2.32

3.10

u/ml

0.50

317

Acute tubulo-interstitial nephritis

387

3539

0.94

0.55

1.1

4.35

2.98

u/ml

0.78

135

1638

Sequelae of intentional self-harm, assault and events of undetermined intent

1.59

0.54

1.0

1.1

—

2.33

—

Other otitis externa (chronic)

330

1.22

0.54

1.1

1.91

2.82

u/ml

0.46

150

Other congenital malformations of face and neck

186

1.30

0.54

1.1

1.0

2.58

1.86

u/ml

—

Other and unspecified erythematous conditions

142

1.34

0.54

1.2

1.0

1.97

2.03

u/ml

—

Necrosis of pulp, including avohilmo

428

4508

0.95

0.54

1.1

4.34

2.81

u/ml

0.96

185

2359

Arthropod-borne viral fevers and viral haemorrhagic fevers

107

955

1.12

0.54

1.1

2.91

3.65

u/ml

0.22

437

Generalized skin eruption due to drugs and medicaments

195

1.29

0.54

1.0

1.54

2.22

u/ml

—

Other complications of surgical and medical care, not elsewhere classified

552

1.16

0.54

1.1

1.0

1.43

3.20

u/ml

2.14

263

Presbyopia

358

1.20

0.54

1.1

2.18

3.73

u/ml

0.92

185

Vasomotor rhinitis (mode)

358

1.20

0.54

1.0

1.1

4.74

2.37

u/ml

0.37

161

Diseases of peritoneum

450

1.18

0.54

1.0

1.1

2.41

3.56

u/ml

0.38

200

Dental caries, including avohilmo

575

2800

1.05

0.54

1.1

3.71

2.62

u/ml

0.82

243

1432

Optic neuritis

283

0.77

0.53

1.1

1.0

2.33

2.04

u/ml

—

146

Vestibular neuronitis

386

1.19

0.53

1.2

1.1

2.51

2.87

u/ml

0.13

166

Specific development disorders of speech and language

425

1.18

0.53

1.1

2.88

3.90

u/ml

0.25

189

Disorders of lens

338

2245

0.94

0.53

1.0

1.1

4.18

3.38

u/ml

0.25

113

1040

Injury of eye and orbit

102

910

1.12

0.53

1.0

1.1

1.60

3.41

u/ml

3.27

475

Other benign neoplasms of uterus

169

1.31

0.53

1.0

1.1

3.12

1.89

u/ml

—

Peripheral arterial reconstruction

432

1.18

0.53

1.1

6.90

2.83

u/ml

—

120

Open wound of abdomen, lower back and pelvis

178

1.30

0.53

1.0

2.53

2.14

u/ml

—

Retinal breaks without detachment

712

1.14

0.53

1.1

6.01

3.21

u/ml

0.38

303

Myeloproliferative diseases

304

1.22

0.53

1.2

1.1

2.97

2.09

u/ml

0.41

114

Pre-eclampsia

182

1674

1.09

0.53

1.1

3.58

2.83

u/ml

0.22

902

Perioral dermatitis

143

1.34

0.53

1.1

1.0

1.87

2.14

u/ml

—

Hypoplasia of dental enamel

0.60

0.53

1.2

1.1

—

10.46

—

Other epidermal thickening

187

1.29

0.53

1.2

1.0

32.38

1.98

u/ml

—

Prepatellar bursitis

187

1.29

0.52

1.0

1.1

2.57

2.73

u/ml

0.06

Mental and behavioural disorders associated with the puerperium

1.46

0.52

1.1

1.0

1.15

3.00

u/ml

—

Primary angle-closure glaucoma

117

1.37

0.52

1.3

1.0

13.00

2.92

u/ml

—

Generalized epilepsy, strict definition

161

1.31

0.52

1.1

3.47

1.73

u/ml

—

Abnormal spermatozoa

304

0.79

0.51

1.2

1.1

4.88

3.44

u/ml

0.33

105

Other and unspecified myopathies

326

0.80

0.51

1.0

1.1

1.34

2.83

u/ml

—

131

Other abnormal uterine and vaginal bleeding

142

924

1.10

0.51

1.1

2.04

2.97

u/ml

0.66

455

Diabetic retinopathy, excluding more controls

128

647

1.11

0.51

1.1

7.36

2.94

u/ml

0.67

253

Adalimumab

658

1.14

0.51

1.1

1.77

3.49

u/ml

2.07

351

Twin gestation

790

1.13

0.51

1.1

2.66

2.34

u/ml

0.17

475

Diseases of pulp and periapical tissues and dental caries

524

2554

1.05

0.51

1.1

3.46

2.71

u/ml

0.53

217

1301

Antepartum haemorrhage, not elsewhere classified

800

1.13

0.51

1.1

3.21

2.34

u/ml

0.36

486

Pregnancy hypertension

393

3332

1.06

0.50

1.1

3.30

2.64

u/ml

0.41

201

1761

Other peripheral vascular diseases

407

1.18

0.50

1.1

1.13

2.38

u/ml

—

183

Biological medicines for asthma

118

1.36

0.50

1.1

1.0

0.94

1.99

u/ml

—

Insulin medication

397

3161

1.06

0.50

1.1

5.87

3.30

u/ml

1.09

103

1530

Other medical care

211

2044

0.93

0.50

1.0

1.1

3.67

3.42

u/ml

0.12

900

Basal cell carcinoma

165

1244

0.92

0.50

1.1

3.30

4.27

u/ml

0.40

455

Seropositive rheumatoid arthritis, strict definition

745

0.87

0.50

1.1

1.82

3.12

u/ml

1.39

325

Sequelae of infectious and parasitic diseases

390

0.82

0.50

1.1

1.0

2.38

2.35

u/ml

0.01

188

Whooping cough

101

1.40

0.50

1.1

1.0

1.64

2.03

u/ml

—

Malignant neoplasm of ovary, including Hilmo

280

0.78

0.50

1.0

1.1

1.77

3.26

u/ml

—

114

Other/unspecified disorders of vestibular function

171

1.29

0.50

1.2

1.0

0.70

2.55

u/ml

—

Contusion of ankle

243

1.24

0.49

1.1

1.0

1.81

2.10

u/ml

0.15

117

All dysplastic lesions of the cervix uteri

238

2528

0.93

0.49

1.1

2.35

2.75

u/ml

0.35

138

1389

Donors of organs and tissues

1.44

0.49

1.0

1.82

2.12

u/ml

—

Separation of retinal layers (serosa)

189

1.27

0.49

1.1

1.0

4.21

2.41

u/ml

0.39

Family history of certain disabilities and chronic diseases leading to disablement

362

1.19

0.49

1.0

2.21

2.60

u/ml

0.12

193

Maltreatment syndromes

400

0.82

0.49

1.0

1.1

4.41

2.16

u/ml

0.67

214

Dislocation, sprain and strain of joints and ligaments of head

280

1.22

0.49

1.1

1.0

3.35

2.11

u/ml

0.60

140

Malignant neoplasm of corpus uteri, including Hilmo

334

0.81

0.48

1.1

3.62

3.48

u/ml

—

112

Carcinoma in situ of cervix uteri, endocervix

1.41

0.48

1.1

1.0

0.86

2.08

u/ml

—

Anorexia

1.41

0.48

1.0

1.62

1.74

u/ml

—

Personality disorders, excluding more controls

202

2174

0.93

0.48

1.1

2.23

3.04

u/ml

1.07

1259

Delivery

289

1625

0.94

0.48

1.1

2.49

3.04

u/ml

0.32

126

752

Contact with heat and hot substances

317

1.20

0.48

1.1

14.34

2.61

u/ml

0.91

136

Divergent concomitant strabismus

465

1.16

0.48

1.1

1.24

2.76

u/ml

2.36

235

Generalized epilepsy, mode (most common among epilepsy diagnosis)

208

1.26

0.48

1.1

2.74

1.77

u/ml

0.44

UC patients in KELA-register (code 208), prior to 1994

181

1.27

0.48

1.1

1.0

5.27

1.98

u/ml

—

Acute generalized exanthematous pustulosis

217

1.25

0.48

1.0

1.54

2.26

u/ml

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

255

0.78

0.48

1.1

1.35

2.60

u/ml

0.98

105

Conductive and sensorineural hearing loss

438

3107

0.95

0.48

1.1

3.90

3.28

u/ml

0.31

164

1440

Puerperal sepsis

784

0.88

0.48

1.1

6.24

3.75

u/ml

0.32

372

Palmar fascial fibromatosis [Dupuytren]

428

1.17

0.48

1.0

1.1

8.62

3.62

u/ml

0.62

159

Sequelae of injuries of upper limb

503

1.16

0.47

1.1

2.06

2.99

u/ml

0.70

252

Use of rivastigmine

332

0.81

0.47

1.1

4.70

3.12

u/ml

—

Single delivery by caesarean section

180

1118

0.92

0.47

1.1

2.14

2.77

u/ml

0.39

625

Postpartum hemorraghe, all women as controls

274

2534

1.07

0.47

1.1

2.68

2.64

u/ml

0.02

146

1427

Nonspecific lymphadenitis

355

1.19

0.47

1.0

1.1

2.24

3.60

u/ml

0.70

180

Mixed and other personality disorders

559

0.86

0.47

1.1

2.24

3.37

u/ml

0.66

304

Postpartum care and examination

157

913

1.09

0.47

1.1

2.32

2.60

u/ml

0.27

519

Missing teeth due to accident, extraction or parodontitis

293

2929

0.94

0.46

1.1

2.95

3.45

u/ml

0.26

100

1300

Other erythematous conditions

164

1.28

0.46

1.1

1.0

1.80

1.88

u/ml

—

Paralytic strabismus

277

0.79

0.46

1.0

2.04

2.44

u/ml

—

114

Pedal cyclist injured in collision with motor vehicle

173

1.28

0.46

1.1

1.0

1.27

1.84

u/ml

0.65

Bronchiectasis

227

1.24

0.46

1.1

2.54

2.56

u/ml

—

Malignant melanoma

548

0.86

0.46

1.1

2.01

3.27

u/ml

0.73

222

Chronic tubulo-interstitial nephritis

173

1.28

0.46

1.1

1.0

1.84

2.13

u/ml

—

Cardiodefibrillation

125

1136

1.10

0.46

1.1

5.88

3.81

u/ml

0.31

390

Maternal care for known or suspected malpresentation of fetus

216

1458

1.07

0.46

1.1

2.21

2.37

u/ml

0.15

110

861

conjunctival haemorrhage

291

1.21

0.46

1.0

1.1

1.15

2.02

u/ml

1.64

121

Carcinoma in situ of other and unspecified genital organs

1.39

0.46

1.0

1.51

2.07

u/ml

—

Certolizumab pegol

129

1.33

0.46

1.0

4.41

2.48

u/ml

—

Anankastic personality disorder

264

1.22

0.46

1.0

1.51

2.04

u/ml

0.57

135

Sulfonylureas

824

0.90

0.45

1.1

9.64

4.02

u/ml

0.41

248

Viral conjunctivitis

246

1.22

0.45

1.0

1.1

0.86

2.34

u/ml

—

118

Phobic anxiety disorders

125

1139

1.10

0.45

1.1

3.67

3.32

u/ml

0.12

620

Other congenital malformations

627

1.13

0.45

1.0

1.1

2.64

3.51

u/ml

0.25

293

Gestational diabetes (for exclusion)

420

2780

1.05

0.45

1.1

2.16

2.70

u/ml

0.86

209

1575

Social phobias

703

1.13

0.45

1.1

3.28

2.79

u/ml

0.17

384

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

526

0.86

0.45

1.0

1.1

2.56

3.55

u/ml

0.48

237

156

1.29

0.45

1.1

1.0

1.15

2.57

u/ml

—

Mental disorders, not otherwise specified

590

1.14

0.45

1.0

1.1

3.55

3.01

u/ml

0.15

332

Brain meningioma

198

0.76

0.45

1.1

1.0

1.63

2.02

u/ml

—

Transient global amnesia

301

1.20

0.45

1.2

1.0

2.08

2.57

u/ml

0.13

Symptoms and signs involving emotional state

183

1.26

0.45

1.0

2.88

2.03

u/ml

0.17

Bacterial meningitis

183

1.26

0.45

1.3

1.0

2.69

2.34

u/ml

—

Other, unspecified and serous retinal detachments

112

1.34

0.44

1.0

1.1

0.90

1.70

u/ml

—

Gout, strict definition

506

1.15

0.44

1.1

22.23

3.07

u/ml

0.90

171

Benign neoplasm of eye and adnexa

441

1.16

0.44

1.1

1.0

5.19

3.20

u/ml

0.24

187

Other obstructive and reflux uropathy

247

1.22

0.44

1.0

2.55

2.34

u/ml

—

111

Flat foot [pes planus] (acquired)

460

1.15

0.44

1.1

2.94

2.40

u/ml

0.20

229

Infections of breast associated with childbirth

284

1.20

0.44

1.0

2.25

2.72

u/ml

0.19

152

Ptosis of eyelid

423

1.16

0.43

1.0

1.1

1.92

3.55

u/ml

0.96

158

Fall on and from ladder

275

1.20

0.43

1.1

1.0

1.09

2.86

u/ml

2.98

112

Overexertion and strenuous or repetitive movements

564

1.14

0.43

1.1

2.18

2.74

u/ml

0.32

288

Alzheimer’s disease, strict definition

475

0.87

0.43

1.1

3.71

4.33

u/ml

—

Astigmatism

386

1.17

0.43

1.0

1.1

1.67

3.78

u/ml

0.95

168

Event of undetermined intent

393

0.84

0.43

1.1

3.29

2.28

u/ml

0.32

197

Paroxysmal tachycardia

162

1255

1.08

0.42

1.1

2.37

3.82

u/ml

1.28

652

Coxarthrosis, primary, with hip surgery

188

1639

1.07

0.42

1.1

2.32

4.43

u/ml

2.56

581

Glaucoma

260

2107

1.06

0.42

1.1

2.32

3.95

u/ml

0.92

102

807

Impetigo

327

0.82

0.42

1.0

1.1

3.83

2.08

u/ml

—

154

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.36

0.42

1.0

3.53

1.84

u/ml

—

Benzodiazepine use

807

5371

1.03

0.42

1.1

2.32

2.96

u/ml

0.94

320

2705

Ependymoma

0.00

0.42

0.0

1.2

—

1.03

—

Secondary and unspecified malignant neoplasm of lymph nodes

304

1.19

0.42

1.1

1.0

1.91

2.47

u/ml

0.35

120

Lesion of radial nerve

158

1.27

0.42

1.1

1.0

4.82

2.43

u/ml

—

Intracranial injury

414

3738

1.05

0.42

1.1

2.56

3.23

u/ml

0.55

163

1785

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

304

1.19

0.41

1.1

9.75

2.92

u/ml

—

105

Reduction defects of lower limb

0.00

0.41

0.0

1.0

—

4.90

—

Malignant neoplasm of ovary

195

0.77

0.41

1.0

2.17

1.92

u/ml

—

Other helminthiases

0.00

0.41

0.0

1.2

—

5.18

—

Internuclear ophthalmoplegia

0.00

0.41

0.0

1.1

—

0.77

—

Operations 1 for CAVS

0.00

0.41

0.0

1.2

—

1.57

—

LeFortI or BSSO operation

286

1.19

0.41

1.0

3.22

2.13

u/ml

0.40

150

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

0.41

0.0

1.2

—

4.00

—

Drug-induced dystonia

0.00

0.41

0.0

1.1

—

4.39

—

Neuroendocrine tumor and carcinoma of rectum

0.00

0.41

0.0

1.1

—

0.87

—

Family history of malignant neoplasm

756

1.11

0.41

1.1

1.45

3.35

u/ml

2.50

386

Benign neoplasm: Scrotum

0.00

0.41

0.0

1.0

—

1.45

—

Other ill-defined and unspecified causes of mortality

206

0.78

0.41

1.0

2.85

2.84

u/ml

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.41

0.0

1.0

—

1.00

—

Spina bifida

0.00

0.41

0.0

1.1

—

3.64

—

Artrosis, including avohilmo

655

3453

1.04

0.41

1.1

3.53

3.06

u/ml

0.31

304

1780

Pediculosis and phthiriasis

0.00

0.41

0.0

1.0

—

0.63

—

Restrictive cardiomyopathy

0.00

0.41

0.0

1.1

—

1.07

—

Nail disorders

454

1.15

0.41

1.2

1.1

4.76

2.75

u/ml

0.30

220

Erysipeloid

0.00

0.41

0.0

1.1

—

5.74

—

Carcinoma in situ of endometrium

0.00

0.41

0.0

1.1

—

2.65

—

Other/unspecified mastoiditis and related conditions

0.00

0.41

0.0

1.1

—

1.19

—

Meningitis

268

1.20

0.41

1.2

1.0

2.22

2.35

u/ml

—

126

Valgus deformity, not elsewhere classified

1.48

0.40

1.0

—

2.34

—

Hereditary corneal dystrophies

123

1.30

0.40

1.1

1.0

1.47

1.84

u/ml

—

Unstable angina pectoris

114

982

0.91

0.40

1.1

4.15

3.90

u/ml

0.08

338

Injury of muscle and tendon at hip and thigh level

511

1.14

0.40

1.1

2.66

3.36

u/ml

0.26

239

Benign neoplasm: Vertebral column

0.00

0.40

0.0

1.1

—

3.94

—

Alcoholic liver disease

358

0.84

0.40

1.1

2.32

2.66

u/ml

—

163

Epileptic seizures related to drugs

0.00

0.40

0.0

1.1

—

3.89

—

Reduction defects of lower limb

0.00

0.40

0.0

1.0

—

4.26

—

Idiopathic gout

250

1.20

0.40

1.1

1.0

4.28

2.74

u/ml

—

Diffuse brain injury

159

1.26

0.40

1.1

2.41

2.20

u/ml

—

Unspecific neurodegenerative disorder

744

0.91

0.40

1.1

3.75

5.33

u/ml

0.39

141

Other hearing loss

107

956

1.10

0.40

1.1

3.39

4.09

u/ml

0.27

353

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

578

1.13

0.40

1.1

2.48

3.71

u/ml

0.72

283

Other degenerative diseases of the nervous system

118

960

0.92

0.39

1.1

2.24

3.85

u/ml

1.16

430

Use of antiglaucoma preparations and miotics

232

1.21

0.39

1.0

0.81

2.32

u/ml

—

Maternal care for cervical incompetence

223

1.21

0.39

1.0

2.03

2.24

u/ml

0.09

110

Atrial fibrillation and flutter

186

1291

0.93

0.39

1.1

3.48

3.57

u/ml

0.03

704

Status post-ami

565

0.89

0.39

1.1

3.19

2.98

u/ml

0.06

176

Congenital malformations and deformations of the musculoskeletal system

688

1.12

0.39

1.1

1.43

3.31

u/ml

2.16

317

Vitamin D deficiency

104

0.67

0.39

1.0

1.1

—

1.68

—

Severe visual impairment, monocular

1.43

0.39

1.0

1.1

—

2.64

—

Toxic effect of other noxious substances eaten as food

0.00

0.39

0.0

1.1

—

0.64

—

Other infective (teno)synovitis

0.00

0.39

0.0

1.1

—

5.05

—

Carcinoma in situ of prostate

0.00

0.39

0.0

1.1

—

2.60

—

Disorders of acoustic nerve

106

1.33

0.39

1.1

1.0

2.73

2.70

u/ml

—

Other mental disorders due to brain damage and dysfunction and to physical disease

389

0.85

0.39

1.2

1.0

6.98

2.46

u/ml

0.54

134

Other congenital malformations of tongue, mouth and pharynx

136

0.73

0.39

1.0

1.1

8.38

6.19

u/ml

—

Disorders in reading

124

1.30

0.39

1.3

1.1

4.46

2.49

u/ml

—

Glaucoma suspect

167

1557

1.07

0.39

1.1

2.76

3.62

u/ml

0.28

589

Cerebral cysts

316

1.17

0.39

1.1

1.0

2.25

2.24

u/ml

0.01

154

Crossbite

544

1.12

0.38

1.1

5.53

3.92

u/ml

0.32

197

Malignant neoplasm of other connective and soft tissue, including Hilmo

151

1.26

0.38

1.1

1.0

2.89

2.01

u/ml

0.28

Mixed specific developmental disorders

198

0.79

0.38

1.0

1.1

6.44

6.27

u/ml

—

Tooth agenesis EXCLUDE clefts and syndromes

335

1.17

0.38

1.1

3.75

2.39

u/ml

0.29

134

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

1.40

0.38

1.0

1.1

—

4.14

—

Visual impairment including blindness (binocular or monocular)

270

1.19

0.38

1.0

1.1

5.97

2.50

u/ml

—

106

Congenital malformations of heart and great arteries

827

0.90

0.38

1.0

1.1

1.68

3.46

u/ml

2.17

373

Spondylopathies in diseases classified elsewhere

1.39

0.38

1.0

1.1

—

3.91

—

Pneumonia due to Streptococcus pneumoniae

170

0.76

0.38

1.1

1.0

1.16

1.96

u/ml

—

Calcific aortic valvular stenosis, including rheumatic fever

773

1.10

0.38

1.1

8.74

3.40

u/ml

0.35

220

Medicines for HER+ breast cancer

199

2007

0.94

0.38

1.0

1.1

1.91

3.37

u/ml

2.06

887

Sequelae of other external causes

261

1.19

0.38

1.1

1.0

1.30

2.46

u/ml

1.72

116

Urolithiasis

154

1433

1.08

0.38

1.0

1.1

1.77

4.07

u/ml

4.28

639

Hidradenitis suppurativa

252

1.19

0.38

1.1

1.0

1.86

2.12

u/ml

0.15

128

Malignant melanoma of skin

409

0.85

0.38

1.1

1.45

3.28

u/ml

1.32

165

Pneumonitis due to solids and liquids

247

0.81

0.38

1.1

2.57

2.10

u/ml

—

Injuries to the hip and thigh

249

2132

1.06

0.37

1.1

2.88

3.78

u/ml

0.74

924

Ulcerative enterocolitis

179

1.23

0.37

1.0

4.46

2.50

u/ml

—

Chronic suppurative otitis media

336

1.16

0.37

1.2

1.1

4.28

2.29

u/ml

—

156

Pregnancy with abortive outcome

593

2983

1.04

0.37

1.1

3.14

2.76

u/ml

0.26

278

1479

Hyperprolactinaemia

262

1.19

0.37

1.0

2.15

2.09

u/ml

0.02

141

Anomalies of pupillary function

125

1.29

0.37

1.1

1.0

2.22

2.16

u/ml

—

Seropositive rheumatoid arthritis, wide

140

1300

1.08

0.37

1.1

2.92

3.77

u/ml

0.29

565

Glaucoma secondary to other eye disorders

161

1.25

0.37

1.1

1.0

1.57

2.19

u/ml

—

Senile cataract

279

1801

0.95

0.37

1.0

1.1

4.53

3.49

u/ml

0.26

785

Lung diseases due to external agents

461

0.87

0.37

1.1

2.65

3.01

u/ml

0.16

171

Injury of unspecified body region

374

1.15

0.36

1.0

1.1

2.20

2.47

u/ml

0.11

165

Injury of intra-abdominal organs

135

0.74

0.36

1.2

1.0

3.70

1.74

u/ml

—

Contact with other hot fluids

189

1.22

0.36

1.0

1.1

12.06

2.18

u/ml

—

Chronic suppurative otitis media, including avohilmo

431

1.14

0.36

1.2

1.1

3.51

2.62

u/ml

0.35

184

Other/unspecified rheumatoid arthritis

497

1.13

0.36

1.1

1.0

1.62

3.53

u/ml

1.09

187

Benign neoplasm: Pituitary gland, craniopharyngeal duct

272

1.18

0.36

1.0

1.46

2.39

u/ml

0.72

126

Open bite that required surgery (Lefort1 or BSSO)

0.64

0.36

1.2

1.0

1.26

1.98

u/ml

—

Pedestrian injured in transport accident

347

1.15

0.35

1.1

1.0

2.05

2.41

u/ml

0.17

157

Venous complications and haemorrhoids in pregnancy

153

1.25

0.35

1.1

1.0

1.18

1.94

u/ml

—

Maternal care for known or suspected fetal abnormality and damage

174

1403

1.07

0.35

1.1

2.46

2.51

u/ml

0.04

834

Neovascular glaucoma

162

1.24

0.35

1.1

1.0

1.57

2.14

u/ml

—

Other assisted single delivery

135

1.27

0.35

1.1

1.03

2.99

u/ml

—

Hypertensive diseases

618

3608

0.97

0.35

1.1

2.89

2.96

u/ml

0.06

273

1899

Periodontal disease, other/unspecified

135

1.26

0.35

1.1

1.0

1.80

2.84

u/ml

—

Hypertensive Heart Disease

561

1.10

0.35

1.2

1.1

5.81

3.43

u/ml

0.52

193

Polycystic ovarian syndrome, broad definition

117

1083

1.08

0.34

1.1

2.25

2.60

u/ml

0.22

613

Bacterial pneumonia, not elsewhere classified

210

1746

1.06

0.34

1.1

3.34

3.53

u/ml

0.06

809

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

137

1276

1.07

0.34

1.1

1.77

3.78

u/ml

3.34

561

Calcific aortic valvular stenosis, diagnosis (helper)

770

1.10

0.34

1.1

8.74

3.40

u/ml

0.35

220

Operations 2 for CAVS

770

1.10

0.34

1.1

8.74

3.40

u/ml

0.35

220

Non-rheumatic valve diseases

208

1589

0.94

0.34

1.1

2.72

3.54

u/ml

0.61

672

Malignant neoplasm of breast, ER-negative, including Hilmo

120

1059

1.08

0.34

1.1

4.35

3.65

u/ml

0.16

434

Leisure time condition

113

1045

1.08

0.34

1.0

1.1

1.96

2.94

u/ml

0.89

494

Lesion of plantar nerve

274

1.17

0.34

1.1

1.0

3.30

3.93

u/ml

0.13

119

Emotionally unstable personality disorder

1033

0.92

0.34

1.1

2.12

3.25

u/ml

0.97

563

Gonarthrosis [arthrosis of knee](FG)

454

2742

0.96

0.34

1.1

3.43

3.12

u/ml

0.18

196

1402

Single spontaneous delivery

290

1612

0.95

0.34

1.1

3.07

3.05

u/ml

0.01

132

748

Use of glatiramer acetate

127

1.27

0.33

1.4

1.0

0.92

2.40

u/ml

—

Valvular heart disease excluding rheumatic fever

211

1611

0.94

0.33

1.1

2.72

3.73

u/ml

0.78

681

Normotensive glaucoma

237

1.18

0.33

1.0

1.56

2.33

u/ml

0.60

Rubella [German measles]

118

1.27

0.33

1.3

1.1

1.72

4.27

u/ml

—

Patent foramen ovale

155

0.77

0.33

1.1

1.34

3.02

u/ml

—

Hypertension

618

3602

0.97

0.33

1.1

2.89

2.96

u/ml

0.06

273

1896

Peritonsillar abscess

158

1482

1.07

0.33

1.1

2.44

3.20

u/ml

0.83

802

Maternal care for other known or suspected fetal problems

253

1685

0.95

0.33

1.1

2.98

2.40

u/ml

0.30

117

987

Spondylolisthesis/Spondylolysis

883

1.09

0.33

1.1

2.07

3.18

u/ml

1.01

429

Glomerulonephritis

463

1.12

0.33

1.1

2.81

2.55

u/ml

0.08

200

Other CVD

634

1.10

0.33

1.0

1.1

2.49

3.65

u/ml

0.38

219

Type of accident

173

1837

0.94

0.33

1.1

2.51

3.42

u/ml

0.75

885

Pregnancy, childbirth and the puerperium

224

1107

1.06

0.33

1.1

2.25

2.56

u/ml

0.26

490

Pre-eclampsia superimposed on chronic hypertension

1.28

0.32

1.0

—

1.20

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.36

0.32

1.2

1.0

2.28

2.42

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

793

5020

1.03

0.32

1.1

2.99

2.97

u/ml

0.02

305

2511

Benign neoplasm of other and unspecified female genital organs

201

1.20

0.32

1.0

1.1

3.41

2.11

u/ml

—

Atrial septal defect, secundum type

219

0.82

0.32

1.0

1.1

1.48

5.00

u/ml

—

Varicella [chickenpox]

341

1.15

0.32

1.1

1.71

3.25

u/ml

0.79

153

Torsion of ovary, ovarian pedicle and fallopian tube

137

1.25

0.32

1.1

2.90

4.63

u/ml

—

Mental and behavioural disorders of puerperium, not classified elsewhere

1.31

0.32

1.1

1.15

1.92

u/ml

—

Peripheral retinal degeneration

137

1.24

0.32

1.0

1.16

2.02

u/ml

—

Other and unspecified intracranial injuries

143

0.77

0.32

1.0

—

1.95

—

Cardiac murmurs and other cardiac sounds

600

1.11

0.32

1.1

4.46

4.11

u/ml

0.04

266

Elevated blood glucose level

379

1.14

0.32

1.1

5.05

2.59

u/ml

0.44

164

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

560

0.89

0.32

1.1

1.57

3.50

u/ml

1.71

268

Atrial septal defect

271

0.84

0.31

1.2

1.1

1.83

4.43

u/ml

—

107

Other congenital malformations of skin

496

0.89

0.31

1.0

3.46

3.07

u/ml

0.07

244

Pedal cyclist injured in other and unspecified transport accidents

643

0.90

0.31

1.1

4.21

2.84

u/ml

0.51

317

Alzheimer disease, excluding more controls

286

0.87

0.31

1.0

1.1

1.45

4.41

u/ml

1.35

Calcific aortic valvular stenosis

775

1.09

0.31

1.1

8.74

3.39

u/ml

0.35

221

Calcific aortic valvular stenosis, operated

775

1.09

0.31

1.1

8.74

3.39

u/ml

0.35

221

Ascites

239

1.17

0.31

1.1

0.86

3.52

u/ml

—

Cerebral palsy and other paralytic syndromes

589

1.10

0.31

1.0

1.1

2.19

2.86

u/ml

0.38

274

Other diseases of biliary tract

314

1.15

0.31

1.1

2.73

2.77

u/ml

0.01

118

Familial hypercholesterolemia, with ischemic heart disease

230

1.18

0.31

1.0

1.1

0.82

2.06

u/ml

—

Hallux valgus (acquired)

213

1453

1.05

0.31

1.1

2.47

3.09

u/ml

0.38

729

Gluteal tendinitis

193

1.19

0.31

1.3

1.1

0.81

4.09

u/ml

—

Other disorders of bone density and structure

147

1.23

0.31

1.2

1.0

3.67

2.18

u/ml

—

Dermatophytosis

561

1.11

0.30

1.1

2.48

2.89

u/ml

0.18

247

Chalazion

628

1.10

0.30

1.0

1.1

4.33

3.91

u/ml

0.08

297

Other symptoms and signs involving the nervous and musculoskeletal systems

287

2746

1.05

0.30

1.1

1.41

3.37

u/ml

8.87

124

1343

Other and unspecified vascular occlusions

283

0.85

0.30

1.0

1.1

1.45

1.90

u/ml

—

Bacterial Sepsis

216

1753

1.05

0.30

1.1

5.73

3.88

u/ml

0.39

730

Nummular dermatitis

324

1.14

0.30

1.1

11.19

2.65

u/ml

0.62

144

Retinal detachment with retinal break

485

1.11

0.30

1.1

5.94

2.90

u/ml

0.29

195

Other obstructed labour

533

1.11

0.30

1.1

2.82

3.20

u/ml

0.16

286

MS-disease / Multiple Sclerosis

514

1.11

0.30

1.2

1.0

1.00

2.87

u/ml

3.33

273

Benign neoplasm: Rectosigmoid junction

129

1.24

0.30

1.2

1.0

5.19

2.36

u/ml

—

Abscess of external ear

1.32

0.30

1.1

1.0

2.68

2.05

u/ml

—

Vitreous haemorrhage

419

1.12

0.30

1.1

6.45

2.85

u/ml

0.62

181

Disorders of globe

1.29

0.30

1.0

0.82

1.78

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

666

3940

0.97

0.30

1.1

3.22

2.94

u/ml

0.21

310

2172

Injuries to the head

890

5605

0.98

0.30

1.1

3.14

2.95

u/ml

0.14

359

2781

Postpartum haemorrhage due to anatomy

111

1034

1.08

0.30

1.1

3.75

3.13

u/ml

0.13

558

Parkinson's disease, strict definition

378

0.87

0.30

1.1

1.0

4.18

2.65

u/ml

—

Hypermobility syndrome

410

1.12

0.30

1.0

1.1

1.06

3.20

u/ml

2.40

233

Erysipelas

278

2568

0.96

0.29

1.1

4.65

3.52

u/ml

0.69

1186

Hypoplasia of dental enamel , including avohilmo

294

0.86

0.29

1.1

3.85

4.99

u/ml

0.21

102

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.25

0.29

1.1

1.0

—

2.52

—

Malignant neoplasm of brain, including Hilmo

217

0.83

0.29

1.1

3.42

2.21

u/ml

—

Other abnormal findings of blood chemistry

213

1.18

0.29

1.0

3.47

1.94

u/ml

0.40

Brain meningioma, including Hilmo

206

0.82

0.29

1.1

1.0

1.49

1.98

u/ml

—

Demyelinating diseases of the central nervous system

602

1.10

0.29

1.1

1.0

1.31

3.45

u/ml

2.75

312

Bruxism

130

1.24

0.29

1.1

1.0

1.29

2.00

u/ml

—

Bicuspidal aortic valve syndrome

195

0.82

0.29

1.0

1.1

1.31

2.65

u/ml

—

Inflammatory disorders of breast

459

1.11

0.28

1.1

3.24

3.29

u/ml

0.01

248

Atherosclerosis, excluding cerebral and coronary sclerosis

133

988

1.07

0.28

1.1

3.65

4.16

u/ml

0.08

309

Ankylosing spondylitis, strict definition

279

1.15

0.28

1.1

1.0

2.90

2.45

u/ml

—

145

Non-ischemic cardiomyopathy

118

888

1.07

0.28

1.1

6.77

3.56

u/ml

0.46

310

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

222

1884

1.05

0.28

1.1

2.97

2.86

u/ml

0.06

970

Other disorders of prostate

1.32

0.28

1.0

1.1

1.82

2.72

u/ml

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

418

3513

1.03

0.28

1.1

3.24

2.67

u/ml

0.35

215

1822

Non-allergic asthma

407

0.88

0.28

1.0

1.1

1.21

2.99

u/ml

1.21

168

Inflammatory diseases of the central nervous system

431

1.12

0.28

1.1

2.76

2.99

u/ml

0.07

202

Disturbances of smell and taste

186

1.19

0.28

1.0

1.60

1.92

u/ml

0.20

Other acquired deformities of musculoskeletal system and connective tissue

214

1.17

0.28

1.0

1.45

1.90

u/ml

—

Other obstetric trauma

451

1.11

0.27

1.1

1.41

2.41

u/ml

1.25

265

Other specified and unspecified personality disorders

595

0.91

0.27

1.1

2.38

3.59

u/ml

0.69

325

Bleeding

487

3571

0.97

0.27

1.1

3.30

3.31

u/ml

0.00

175

1651

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

762

5323

0.98

0.27

1.1

3.38

2.95

u/ml

0.33

290

2645

HSIL lesion of the cervix uteri

162

1709

0.95

0.27

1.0

1.1

2.44

2.86

u/ml

0.26

954

Decubitus ulcer and pressure area

172

0.81

0.27

1.0

—

2.04

—

Viral meningitis

224

1.16

0.27

1.2

1.0

2.12

2.36

u/ml

0.08

109

Problems related to social environment

150

0.80

0.27

1.1

1.0

5.50

2.02

u/ml

—

Methotrexate

720

1.08

0.27

1.1

2.08

3.45

u/ml

1.25

338

Other cataract

210

1515

1.05

0.27

1.0

1.1

4.79

3.63

u/ml

0.26

640

Secondary right heart disease

122

1.23

0.27

1.0

—

2.02

—

Other/unspecified seropositive rheumatoid arthritis

137

1292

1.06

0.27

1.1

1.77

3.77

u/ml

3.33

563

Impacted teeth

205

1740

1.05

0.26

1.1

3.62

2.52

u/ml

0.52

108

896

Bitten or struck by other mammals

799

1.08

0.26

1.0

1.1

2.69

3.22

u/ml

0.36

419

Peripheral artery disease

152

1145

1.06

0.26

1.1

4.24

4.10

u/ml

0.03

390

Pericarditis

141

1.21

0.26

1.2

1.0

3.81

2.33

u/ml

—

Contact with and exposure to communicable diseases

286

2958

0.96

0.26

1.1

3.12

2.88

u/ml

0.09

143

1580

Certain conditions originating in the perinatal period

701

0.92

0.26

1.1

9.49

2.70

u/ml

0.60

290

Early lumbar disc prolapse, operated

780

1.08

0.26

1.1

3.17

3.20

u/ml

0.01

475

Intrahepatic Cholestasis of Pregnancy (ICP)

597

1.09

0.26

1.1

1.76

3.40

u/ml

1.71

330

Familial hypercholesterolemia

472

1.10

0.26

1.1

1.22

3.28

u/ml

3.30

159

Burn and corrosion of hip and lower limb, except ankle and foot

132

1.22

0.26

1.2

1.0

1.20

2.11

u/ml

—

Transient ischemic attack

226

1750

1.05

0.26

1.1

2.25

3.94

u/ml

2.13

646

Lesion of lateral popliteal nerve

216

1.16

0.25

1.0

4.05

2.78

u/ml

—

Coronary artery bypass grafting

523

1.08

0.25

1.1

7.54

3.05

u/ml

0.82

157

Spermatocele

216

1.16

0.25

1.0

1.1

4.94

3.18

u/ml

0.31

Drug-induced cataract

114

1.23

0.25

1.1

1.0

7.62

2.15

u/ml

—

Thiazolidinediones

372

0.89

0.25

1.0

1.1

2.17

2.28

u/ml

—

148

Chronic ulcer of skin, not elsewhere classified

245

0.86

0.25

1.0

2.73

2.08

u/ml

—

Perforation of tympanic membrane

508

0.90

0.25

1.0

2.42

2.19

u/ml

0.10

233

Injury of other and unspecified intrathoracic organs

266

0.86

0.25

1.0

1.1

4.43

2.59

u/ml

—

117

Retinal vascular disorders

361

0.89

0.24

1.0

1.1

1.82

2.12

u/ml

0.15

113

COPD, hospital admissions 3, with asthma pneumonia sepsis

682

0.93

0.24

1.1

9.81

3.14

u/ml

0.59

213

Benign neoplasm of urinary organs

170

1.18

0.24

1.0

0.69

2.04

u/ml

—

COPD-related respiratory insufficiency

329

0.88

0.24

1.1

8.50

2.51

u/ml

—

103

Visual field defects

350

0.88

0.24

1.2

1.0

2.21

2.98

u/ml

0.24

155

Parkinson's disease

413

0.90

0.24

1.2

1.0

4.87

2.47

u/ml

—

107

Late syphilis

1.29

0.24

1.0

—

1.75

—

Chronic Coagulation defects

161

1.18

0.24

1.2

1.0

0.76

2.43

u/ml

—

Suppurative otitis media, unspecified

133

1.21

0.24

1.1

1.0

2.61

1.75

u/ml

—

Viral warts

609

1.09

0.24

1.1

4.72

3.09

u/ml

0.46

300

Other disorders of white blood cells

255

1.14

0.24

1.1

1.0

5.24

2.60

u/ml

—

111

Medial epicondylitis

212

0.85

0.24

1.1

2.79

2.61

u/ml

—

108

Pneumothorax

255

1.14

0.24

1.1

1.0

2.61

2.85

u/ml

0.07

103

Other intracranial haemorrhages

0.72

0.24

1.0

—

1.37

—

Ankylosing spondylitis, ICD10

494

1.09

0.24

1.1

2.06

2.57

u/ml

0.23

251

Cardiomyopathy, other and unspecified

286

0.87

0.23

1.2

1.1

3.01

2.22

u/ml

0.21

119

Benign neoplasm: Choroid

246

1.14

0.23

1.2

1.1

7.51

2.32

u/ml

—

Burn and corrosion of head and neck

115

1.22

0.23

1.0

1.1

26.87

2.58

u/ml

—

Overjet

226

1.15

0.23

1.2

1.1

3.97

4.36

u/ml

0.06

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

275

0.87

0.23

1.0

1.44

3.18

u/ml

—

130

Presbycusis

283

0.87

0.23

1.0

1.1

6.90

2.68

u/ml

—

COPD, hospital admissions 1, only main diagnosis

117

945

1.06

0.23

1.1

6.62

3.87

u/ml

0.43

318

Arthropod-borne viral fevers and viral haemorrhagic fevers

443

0.90

0.23

1.1

3.82

3.03

u/ml

0.12

206

Personal history of certain other diseases

143

1.19

0.23

1.1

1.0

5.77

2.37

u/ml

—

Hypertrophy of breast

137

1300

1.05

0.23

1.1

3.02

3.42

u/ml

0.20

686

Hereditary motor and sensory neuropathy

1.32

0.23

1.0

1.1

—

1.12

—

Corns and callosities

294

1.12

0.23

1.1

2.77

2.42

u/ml

—

121

Hirsutism in women

162

1.18

0.23

1.2

1.0

5.09

2.15

u/ml

—

Multiple delivery

629

0.92

0.22

1.1

3.85

3.00

u/ml

0.29

347

Focal brain injury

253

0.87

0.22

1.0

1.1

1.45

2.79

u/ml

1.18

123

Other neurological diseases

418

3191

1.03

0.22

1.1

2.53

3.45

u/ml

0.88

134

1455

Neuralgia and neuritis, unspecified

247

1.14

0.22

1.1

1.63

2.66

u/ml

0.81

118

Benign neoplasm: other/unspecified salivary gland

1.25

0.22

1.1

1.0

2.20

1.54

u/ml

—

L02BA Anti-estrogens

100

941

1.06

0.22

1.0

1.1

1.77

3.47

u/ml

1.60

433

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

177

1693

1.05

0.22

1.0

1.1

1.94

3.72

u/ml

3.32

859

Glucagon-like peptide-1 (GLP-1) analogues

177

1693

1.05

0.22

1.0

1.1

1.94

3.72

u/ml

3.32

859

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

602

1.08

0.22

1.1

1.0

1.76

3.95

u/ml

2.03

327

Epidural haemorrhage

1.25

0.22

1.0

1.1

—

1.52

—

Use of donepezil

413

0.90

0.22

1.1

1.02

3.63

u/ml

—

Acquired absence of organs, not elsewhere classified

1.25

0.22

1.0

1.1

—

2.06

—

Carcinoma in situ of cervix uteri

763

0.93

0.22

1.1

1.41

3.17

u/ml

2.89

425

Foreign body or object entering through skin

337

0.89

0.22

1.1

2.60

2.35

u/ml

0.13

170

Sexual dysfunction

1.27

0.22

1.1

1.0

0.76

1.80

u/ml

—

Fracture at wrist and hand level

229

2374

0.96

0.22

1.1

3.12

3.15

u/ml

0.01

1227

Golimumab

219

1.14

0.22

1.0

1.1

2.07

2.45

u/ml

—

115

Basal cell carcinoma, including avohilmo

185

1331

0.96

0.22

1.1

2.94

4.07

u/ml

0.63

495

Encephalocele

0.00

0.21

0.0

1.1

—

0.74

—

Pleural effusion

472

0.91

0.21

1.1

8.08

2.57

u/ml

0.51

155

Other disorders of amniotic fluid and membranes

143

1330

1.05

0.21

1.1

2.59

2.42

u/ml

0.11

783

Deficiency of other/unspecified vitamins

0.00

0.21

0.0

1.0

—

1.44

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.21

0.0

1.0

—

0.88

—

Intentional self-harm by jumping or lying before moving object

0.00

0.21

0.0

1.1

—

1.50

—

Dengue fever [classical dengue]

0.00

0.21

0.0

1.2

—

0.74

—

Dengue fever [classical dengue]

0.00

0.21

0.0

1.2

—

0.82

—

Complications following abortion and ectopic and molar pregnancy

163

1.17

0.21

1.0

0.80

4.05

u/ml

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.21

0.0

1.0

—

1.13

—

Other and unspecified heterotropia

0.00

0.21

0.0

1.0

—

1.46

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.2

—

4.62

—

Femoral hernia, bilateral

0.00

0.21

0.0

1.1

—

4.70

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

440

2512

1.03

0.21

1.1

4.22

2.58

u/ml

1.01

232

1369

Epidermolysis bullosa

0.00

0.21

0.0

1.3

—

5.72

—

Calcium deposit in bursa

0.00

0.21

0.0

1.1

—

1.00

—

Multiple congenital exostoses

0.00

0.21

0.0

1.1

—

1.14

—

Benign neoplasm: Pineal gland

0.00

0.21

0.0

1.2

—

1.29

—

Pityriasis rubra pilaris

0.00

0.21

0.0

1.1

—

0.82

—

Crushing injury of lower leg

0.00

0.21

0.0

1.1

—

1.06

—

Immunodeficiency associated with other major defects

0.00

0.21

0.0

1.1

—

6.34

—

Hereditary nephropathy, not elsewhere classified

0.00

0.21

0.0

1.1

—

1.72

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.21

0.0

1.0

—

1.33

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.21

0.0

1.0

—

1.14

—

Benign neoplasm: Epididymis

0.00

0.21

0.0

1.0

—

1.48

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

204

1440

0.96

0.21

1.1

3.00

3.79

u/ml

0.41

555

Fracture of forearm

391

3482

1.03

0.21

1.1

3.89

3.01

u/ml

0.38

151

1633

Noonan syndrome

0.00

0.21

0.0

1.1

—

0.56

—

Bacterial pneumoniae

220

1867

1.04

0.21

1.1

3.28

3.45

u/ml

0.05

875

Exposure to controlled fire, not in building or structure

0.00

0.21

0.0

1.1

—

0.97

—

Malignant neoplasm of vagina, including Hilmo

0.00

0.21

0.0

1.2

—

4.02

—

Lumbosacral plexus disorders

0.00

0.21

0.0

1.1

—

1.33

—

Lesion of medial popliteal nerve

0.00

0.21

0.0

1.2

—

2.98

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

0.21

0.0

1.0

—

1.21

—

Glaucoma-related operations

173

1.16

0.21

1.2

1.1

0.82

2.17

u/ml

—

Retinal vascular occlusion

356

0.90

0.21

1.0

1.1

1.82

2.14

u/ml

0.17

111

Other chronic obstructive pulmonary disease

162

1277

1.05

0.20

1.1

3.59

4.05

u/ml

0.23

453

Carcinoma in situ of breast, intraductal

408

0.91

0.20

1.1

5.56

3.50

u/ml

0.20

166

Cleft lip, lip and palate or palate

117

1.20

0.20

1.0

1.1

2.74

1.68

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

663

1.07

0.20

1.1

2.42

3.19

u/ml

0.49

273

Any mental disorder

917

4508

1.02

0.20

1.1

2.65

2.98

u/ml

0.51

367

2366

Extreme obesity with alveolar hypoventilation

166

0.84

0.20

1.1

1.0

11.18

2.35

u/ml

—

Malignant melanoma of skin, including Hilmo

553

0.92

0.20

1.1

1.51

3.34

u/ml

1.87

220

Assault by other and unspecified firearm discharge

0.00

0.20

0.0

1.1

—

1.00

—

Congenital mitral valve regurgitation

0.00

0.20

0.0

1.1

—

2.06

—

Delayed puberty

1.25

0.20

1.3

1.1

—

2.62

—

Myositis ossificans

0.00

0.20

0.0

1.1

—

0.88

—

Congenital ichthyosis

0.00

0.20

0.0

1.0

—

1.40

—

Injury of blood vessels at hip and thigh level

0.00

0.20

0.0

1.1

—

0.78

—

Injury of blood vessels at forearm level

0.00

0.20

0.0

1.0

—

1.00

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.20

0.0

1.1

—

1.13

—

Membranous nephropathy

0.00

0.20

0.0

1.1

—

1.35

—

Rheumatoid lung disease

0.00

0.20

0.0

1.1

—

1.08

—

Delayed milestone in childhood

168

0.85

0.20

1.0

1.1

1.70

8.66

u/ml

—

Right hemicolectomy

183

1.15

0.20

1.2

1.1

25.15

1.99

u/ml

—

Sensorineural hearing loss

400

2788

0.97

0.20

1.1

3.93

3.50

u/ml

0.17

141

1252

Benign neoplasm of thyroid gland

155

1.16

0.20

1.0

1.52

2.13

u/ml

—

Benign neoplasm: Skin of ear and external auricular canal

144

0.83

0.20

1.0

2.90

2.14

u/ml

—

Other embolism and thrombosis

558

1.08

0.19

1.1

2.08

3.39

u/ml

1.04

249

Postpartum haemorrhage due to retained placenta

123

1172

1.05

0.19

1.1

3.61

2.96

u/ml

0.17

652

Hypertensive heart and/or renal disease

626

1.06

0.19

1.2

1.1

5.11

3.51

u/ml

0.37

218

Acute myeloid leukaemia and myelodysplastic syndromes

1.18

0.19

1.0

—

2.41

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

539

1.08

0.19

1.1

2.14

3.06

u/ml

0.61

237

Other diseases caused by chlamydiae

1.23

0.19

1.2

1.0

4.37

2.07

u/ml

—

Obesity and other hyperalimentation

509

4794

1.02

0.19

1.1

3.35

2.87

u/ml

0.28

211

2441

Cholesteatoma of middle ear

186

0.86

0.19

1.2

1.0

6.00

2.62

u/ml

—

Complications of genitourinary prosthetic devices, implants and grafts

118

1.19

0.19

1.3

1.0

4.37

2.62

u/ml

—

Other disorders of cornea

462

1.08

0.19

1.0

1.1

2.89

2.17

u/ml

0.25

209

Benign neoplasm: Cranial nerves

118

1.19

0.19

1.1

1.0

2.73

2.55

u/ml

—

COPD, hospital admission 2, with asthma infections

895

0.95

0.19

1.1

7.41

3.76

u/ml

0.49

307

664

1.06

0.19

1.0

1.1

9.11

4.50

u/ml

0.47

130

Benign neoplasm: Lip

1.24

0.19

1.2

1.0

1.22

2.64

u/ml

—

Superficial injury of head

132

1380

0.96

0.19

1.1

2.42

3.56

u/ml

0.87

670

Hypertrichosis

175

1.15

0.18

1.2

1.0

6.72

2.30

u/ml

0.95

Meniscus derangement

352

2308

1.03

0.18

1.1

2.84

3.00

u/ml

0.10

160

1187

Other disorders of ear

627

4185

0.98

0.18

1.1

3.34

3.05

u/ml

0.18

241

2026

Cardiac arrest

174

1.13

0.18

1.1

1.51

2.21

u/ml

—

Bell's palsy

590

1.07

0.18

1.1

3.85

3.14

u/ml

0.21

286

Cytomegaloviral disease

119

1.18

0.17

1.1

1.0

19.60

2.58

u/ml

—

Bacterial pneumonia (organism specified)

235

2064

1.03

0.17

1.1

3.21

3.57

u/ml

0.12

933

Congenital deformities of hip

142

0.84

0.17

1.2

1.1

1.24

4.90

u/ml

—

Primary ovarian failure

138

1.16

0.17

1.0

1.1

1.92

2.53

u/ml

—

Viral conjunctivitis

138

1.16

0.17

1.1

1.0

0.87

2.51

u/ml

—

Malignant neoplasm of pancreas, including Hilmo

233

1.12

0.17

1.0

8.07

2.20

u/ml

—

Invasive ventilation

310

0.90

0.17

1.0

5.92

2.83

u/ml

—

120

Benign neoplasm: Small intestine

138

1.16

0.17

1.1

—

1.77

—

Late syphilis

1.13

0.17

1.0

—

1.94

—

Fracture of lower leg, including ankle

352

3571

0.98

0.17

1.1

2.57

3.10

u/ml

0.67

141

1717

Pacemaker

103

940

1.05

0.17

1.1

4.79

4.16

u/ml

0.09

295

Other local infections of skin and subcutaneous tissue

523

1.07

0.17

1.1

2.92

2.74

u/ml

0.07

240

Myocardial infarction, with ST-elevation

496

0.93

0.17

1.1

3.85

2.92

u/ml

0.34

166

Pneumonias (Asthma/COPD co-morbidities)

794

5416

0.98

0.17

1.1

3.38

2.92

u/ml

0.37

303

2706

All dysplastic lesions of the cervix uteri, vagina or vulva

272

2755

0.97

0.17

1.1

2.58

2.70

u/ml

0.08

154

1489

All pneumoniae

801

5438

0.98

0.17

1.1

3.35

2.91

u/ml

0.35

306

2718

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

278

0.90

0.17

1.0

2.33

2.08

u/ml

—

118

Personal history of other diseases and conditions

102

968

1.05

0.17

1.1

2.87

3.50

u/ml

0.38

476

Caught, crushed, jammed or pinched in or between objects

301

1.10

0.17

1.0

1.1

1.16

2.28

u/ml

2.27

141

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

0.71

0.16

1.0

—

1.89

—

Fracture of neck

215

1.12

0.16

1.0

4.96

2.27

u/ml

—

Spontaneous rupture of synovium and tendon

340

1.09

0.16

1.2

1.1

3.72

3.27

u/ml

0.11

139

Contact with sharp object, undetermined intent

141

0.85

0.16

1.1

1.0

0.88

1.91

u/ml

—

Von Willebrand disease

1.20

0.16

1.1

0.96

2.02

u/ml

—

Serous carcinoma of ovary, including Hilmo

130

0.84

0.16

1.0

2.22

2.24

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

370

0.92

0.16

1.1

3.93

2.49

u/ml

0.22

168

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

652

1.06

0.16

1.1

1.67

3.38

u/ml

1.97

343

Benign neoplasm of other and unspecified sites

151

0.86

0.15

1.4

1.0

2.28

2.14

u/ml

—

L01XX Other antineoplastic agents

168

1.13

0.15

1.3

1.0

3.18

2.15

u/ml

—

Benign neoplasm: Kidney

130

1.16

0.15

1.0

1.1

0.77

2.18

u/ml

—

Abnormal findings on diagnostic imaging of central nervous system

264

1.10

0.15

1.0

2.25

2.31

u/ml

0.03

126

HSIL lesion of the vagina

1.21

0.15

1.0

3.52

2.15

u/ml

—

Malignant neoplasm of tongue, including Hilmo

0.75

0.15

1.3

1.0

—

3.08

—

Heart failure and antihypertensive medication

114

778

0.96

0.15

1.1

5.65

4.67

u/ml

0.15

363

Etanercept

419

1.08

0.15

1.0

1.1

1.68

2.80

u/ml

1.02

214

Benign neoplasm: Skin, unspecified

178

1.13

0.15

1.2

1.0

4.28

2.41

u/ml

—

Toxic effects of substances chiefly nonmedicinal as to source

663

1.06

0.15

1.0

1.1

1.65

3.04

u/ml

1.74

345

Preterm labour and delivery

203

1970

1.03

0.15

1.1

2.47

2.74

u/ml

0.20

1067

Parkinson's disease, including avohilmo

430

0.93

0.14

1.2

1.1

4.18

2.94

u/ml

—

113

Benign neoplasm of meninges

430

1.07

0.14

1.0

1.1

3.41

3.06

u/ml

0.07

171

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

389

2507

0.98

0.14

1.1

3.31

2.94

u/ml

0.20

180

1437

COPD

170

1346

1.03

0.14

1.1

3.54

4.03

u/ml

0.25

481

Other demyelinating diseases of the central nervous system

256

1.10

0.14

1.1

1.0

1.61

2.18

u/ml

0.36

132

Malignant neoplasm of pancreas

179

1.12

0.14

1.0

1.1

11.70

2.51

u/ml

—

Pulmonary embolism

126

1214

1.04

0.14

1.1

6.07

3.63

u/ml

0.45

487

Malignant melanoma, including Hilmo

665

0.95

0.14

1.1

1.95

3.47

u/ml

1.15

262

Angina pectoris

251

1630

1.03

0.14

1.1

3.48

u/ml

0.00

650

Diabetes mellitus in pregnancy

371

2326

1.02

0.14

1.1

2.80

2.52

u/ml

0.25

195

1342

Disorders of psychological development

100

966

0.96

0.14

1.1

2.05

3.16

u/ml

0.97

452

Papillary adenocarcinoma of thyroid gland

266

1.09

0.14

1.1

1.0

2.39

2.22

u/ml

0.06

123

Complications of labour and delivery

539

2946

1.02

0.14

1.1

3.81

2.60

u/ml

0.87

263

1484

Use of levodopa decarboxylase inhibitor

367

0.93

0.13

1.2

1.0

5.49

2.38

u/ml

—

Embedded and impacted teeth

275

2216

1.02

0.13

1.1

3.70

2.54

u/ml

0.69

146

1162

Other diseases of pericardium

170

0.88

0.13

1.0

2.16

2.08

u/ml

—

Pilonidal cyst

607

1.06

0.13

1.0

4.11

3.04

u/ml

0.23

354

Routine general health check-up of defined subpopulation

128

0.86

0.13

1.0

1.1

1.88

4.56

u/ml

—

Other salmonella infections

218

1.10

0.13

1.0

3.48

2.34

u/ml

0.26

101

Statin medication

593

3387

0.98

0.13

1.1

2.88

2.98

u/ml

0.07

291

1803

Pneumonia derived septicemia

149

0.87

0.13

1.1

10.54

1.79

u/ml

—

Labour and delivery complicated by fetal stress [distress]

265

1777

0.98

0.13

1.1

3.92

2.55

u/ml

0.97

150

1034

Hyperfunction of pituitary gland

344

1.08

0.13

1.1

1.0

2.01

2.07

u/ml

0.03

183

Burn and corrosion confined to eye and adnexa

151

1.13

0.13

1.0

1.90

2.44

u/ml

—

Pulmonary heart disease

126

1216

1.04

0.13

1.1

6.07

3.63

u/ml

0.45

487

Congenital malformations of the circulatory system

930

0.96

0.13

1.1

2.65

3.81

u/ml

0.48

420

Emotional disorders and disorders of social functioning with onset specific to childhood

501

0.94

0.13

1.0

1.1

3.94

3.27

u/ml

0.13

220

Haemorrhagic and haematological disorders of fetus and newborn

181

1.11

0.13

1.3

1.1

25.45

6.04

u/ml

—

Other secondary gonarthrosis

211

0.90

0.13

1.1

1.0

1.90

2.04

u/ml

—

Calculus of kidney and ureter

140

1355

1.03

0.13

1.0

1.1

1.84

4.14

u/ml

3.90

607

Other congenital malformations of skin

238

1.09

0.13

1.0

1.1

6.06

3.29

u/ml

—

109

Cardiomyopathy (excluding other)

448

0.94

0.13

1.1

2.38

2.71

u/ml

0.15

190

Heart failure and coronary heart disease

145

994

1.03

0.13

1.2

1.1

10.35

3.42

u/ml

1.09

327

Other complications of labour and delivery, not elsewhere classified

127

1126

1.04

0.13

1.1

1.69

2.32

u/ml

1.03

661

Other and unspecified local infections of skin and subcutaneous tissue

491

1.06

0.13

1.1

3.04

2.71

u/ml

0.13

225

Lymphoid leukaemia

190

0.89

0.13

1.1

1.28

2.71

u/ml

—

Subacute thyroiditis

190

1.11

0.12

1.1

1.0

1.16

2.24

u/ml

—

Major anomalies of jaw size

169

0.89

0.12

1.1

0.77

1.79

u/ml

—

Otosclerosis

316

1.08

0.12

1.2

1.1

1.37

3.43

u/ml

1.79

134

Congenital iodine-deficiency syndrome/hypothyroidism

123

1.14

0.12

1.4

1.0

3.03

2.36

u/ml

—

Burns and corrosions confined to eye and internal organs

171

1.11

0.12

1.0

2.60

2.76

u/ml

—

Diseases caused by chlamydiae

1.18

0.12

1.2

1.0

3.04

2.10

u/ml

—

Malignant neoplasm of prostate

481

1.04

0.12

1.0

1.1

3.34

4.10

u/ml

0.19

182

Injuries to unspecified part of trunk, limb or body region

531

1.06

0.12

1.1

1.92

2.45

u/ml

0.31

240

Malignant neoplasm of breast, HER-negative

916

1.04

0.12

1.2

1.1

5.42

3.99

u/ml

0.26

354

Implicit Sepsis

540

4005

0.98

0.12

1.1

2.69

3.15

u/ml

0.40

182

1920

Premature rupture of membranes

218

1598

0.98

0.12

1.0

1.1

2.53

2.40

u/ml

0.06

112

929

Heart failure, not strict

405

2702

1.02

0.12

1.1

4.86

3.49

u/ml

0.49

102

1240

LSIL lesion of the cervix uteri

101

974

1.04

0.12

1.1

1.98

3.39

u/ml

1.48

541

Drug-induced neutropenia

323

0.93

0.12

1.1

1.0

2.80

2.48

u/ml

—

136

Pathological resorption of teeth

191

1.10

0.11

1.1

1.0

4.03

1.99

u/ml

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

209

0.91

0.11

1.1

1.0

1.71

1.80

u/ml

—

Pneumococcal septicemia

147

0.88

0.11

1.1

10.54

2.13

u/ml

—

Hypertrophic cardiomyopathy

147

0.88

0.11

1.1

4.17

2.73

u/ml

—

Open bite

425

0.94

0.11

1.2

1.1

2.39

2.85

u/ml

0.14

192

Macular pucker

464

1.06

0.11

1.1

3.23

3.64

u/ml

0.09

130

Ingrowing nail

308

1.07

0.11

1.2

1.1

6.71

2.78

u/ml

0.36

146

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

106

1062

0.97

0.11

1.1

1.94

3.70

u/ml

1.35

482

Other heart diseases, wide

775

4793

0.99

0.11

1.1

3.31

2.91

u/ml

0.36

330

2473

Other specified/unspecified hearing loss

322

0.93

0.11

1.1

1.0

1.32

2.08

u/ml

—

120

Use of teriflunomide

1.17

0.11

1.5

1.0

1.14

1.47

u/ml

—

Osteonecrosis

250

1.08

0.11

1.1

1.0

0.64

2.88

u/ml

—

104

ILD, hospital admissions 3, with pneumonia sepsis

250

1.08

0.11

1.0

1.1

3.66

2.47

u/ml

—

Obesity

503

4785

1.01

0.11

1.1

3.37

2.87

u/ml

0.30

209

2435

Atrial fibrillation and flutter with reimbursement

133

821

1.03

0.11

1.1

3.92

3.99

u/ml

0.01

416

Congenital deformities of feet

260

1.08

0.10

1.0

2.79

3.21

u/ml

0.11

120

Other chronic obstructive pulmonary disease, including avohilmo

211

1782

0.98

0.10

1.1

5.10

3.73

u/ml

0.38

684

Disorders of optic nerve and visual pathways

566

0.95

0.10

1.1

1.93

3.62

u/ml

1.14

280

Congenital malformations of eye, ear, face and neck

456

1.05

0.10

1.2

1.1

2.58

2.39

u/ml

0.08

213

Parkinson's disease, excluding more controls

328

1.06

0.10

1.2

1.1

4.87

4.76

u/ml

—

104

Lesion of ulnar nerve

698

0.96

0.10

1.1

2.50

3.12

u/ml

0.23

359

Cardiomyopathies, Primary/intrinsic

423

0.95

0.10

1.1

2.38

2.95

u/ml

0.27

183

Delivery, wide proxy

247

1338

0.98

0.10

1.1

2.04

2.72

u/ml

0.80

103

624

Leiomyoma of uterus

483

2699

1.01

0.10

1.1

3.10

2.74

u/ml

0.22

215

1340

Pyogenic arthritis

251

1.08

0.10

1.0

2.47

2.57

u/ml

0.03

116

Personal history of malignant neoplasm

388

1.06

0.10

1.0

1.1

4.40

3.66

u/ml

0.14

173

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

663

1.04

0.10

1.1

1.67

3.89

u/ml

2.24

341

Artificial opening status

228

0.92

0.10

1.1

1.92

2.21

u/ml

—

Viral infections of the central nervous system

398

1.06

0.10

1.2

1.1

2.60

2.36

u/ml

0.09

191

Asymmetry of jaw

106

1.13

0.10

1.3

1.0

3.93

1.96

u/ml

—

Hepatomegaly and splenomegaly, not elsewhere classified

1.11

0.10

1.0

1.1

—

2.88

—

Other specific arthropathies, wide

106

1.13

0.10

1.1

1.0

1.06

2.44

u/ml

—

Retained placenta and membranes, without haemorrhage

831

1.04

0.09

1.0

1.1

4.61

3.05

u/ml

0.24

437

Hypertensive diseases (excluding secondary)

476

2802

0.99

0.09

1.1

3.14

2.96

u/ml

0.12

217

1591

Follicular cysts of skin and subcutaneous tissue

101

979

1.03

0.09

1.1

6.90

3.24

u/ml

0.52

491

Cyst of Bartholin Gland

242

1.08

0.09

1.0

1.1

2.50

2.08

u/ml

0.17

125

Gonarthrosis

403

2262

1.01

0.09

1.1

3.63

2.97

u/ml

0.41

177

1157

Convergence insufficiency and excess

1.15

0.09

1.0

1.26

2.02

u/ml

—

Other forms of systemic lupus erythematosus

1.06

0.09

1.4

1.1

—

1.67

—

Early onset COPD

950

1.03

0.09

1.1

3.48

3.38

u/ml

0.04

419

Septicaemia

191

1824

0.98

0.09

1.1

3.92

3.95

u/ml

0.01

753

Implicit Sepsis

472

3513

1.01

0.09

1.1

2.97

3.30

u/ml

0.20

138

1638

Persons with potential health hazards related to communicable diseases

359

3506

1.02

0.09

1.1

2.88

2.89

u/ml

0.00

165

1856

Viral infections of the central nervous system

438

1.05

0.09

1.2

1.1

2.50

2.53

u/ml

0.01

212

Residual foreign body in soft tissue

252

1.07

0.09

1.0

1.1

1.68

2.55

u/ml

0.73

126

Male infertility

299

0.94

0.09

1.1

1.0

3.42

2.58

u/ml

0.26

175

Morphin

1.04

0.09

1.0

—

2.29

—

Diseases of the myoneural junction and muscle

497

1.05

0.09

1.1

6.46

2.86

u/ml

0.31

202

Foreign body in alimentary tract

262

1.07

0.09

1.2

1.0

3.02

2.29

u/ml

—

119

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

677

4379

0.99

0.09

1.1

3.06

2.99

u/ml

0.05

268

2196

Wet age-related macular degeneration

387

1.05

0.09

1.0

1.1

12.77

3.48

u/ml

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

586

1.04

0.09

1.1

1.59

3.30

u/ml

1.98

239

Complications of other internal prosthetic devices, implants and grafts

155

1.10

0.09

1.1

1.0

3.40

2.08

u/ml

—

Other disorders starting during childhood or adolescence

457

0.95

0.09

1.0

1.1

2.83

3.62

u/ml

—

195

Contact with venomous snakes and lizards

1.11

0.09

1.0

1.1

—

2.99

—

Primary open-angle glaucoma, strict

815

0.97

0.09

1.1

1.42

4.01

u/ml

3.12

234

Other acute skin changes due to ultraviolet radiation

134

0.89

0.08

1.0

2.52

2.06

u/ml

—

Corneal ulcer

115

1120

1.03

0.08

1.1

4.56

3.42

u/ml

0.29

568

Primary open-angle glaucoma

975

0.97

0.08

1.1

1.37

4.07

u/ml

4.21

275

Fall on and from stairs and steps

146

1427

1.02

0.08

1.1

4.42

3.40

u/ml

0.14

677

Dilated cardiomyopathy

400

0.95

0.08

1.1

2.44

2.56

u/ml

—

165

Bipolar affective disorders

142

1453

0.98

0.08

1.1

2.42

3.09

u/ml

0.45

815

Oxycodone

165

1524

0.98

0.08

1.1

3.86

3.96

u/ml

0.03

704

Distal bite

339

1.06

0.08

1.1

5.39

4.41

u/ml

0.09

116

Calcific tendinitis of shoulder

302

1.06

0.08

1.1

1.25

2.84

u/ml

1.41

150

Other disorders of central nervous system

0.82

0.08

1.2

1.1

—

1.08

—

Hodgkin lymphoma, hilmo

146

1.10

0.08

1.0

1.1

1.68

2.65

u/ml

—

Motorcycle rider injured in other and unspecified transport accidents

371

1.05

0.08

1.0

1.1

2.73

2.30

u/ml

0.17

186

Amputation of thigh

0.79

0.08

1.0

1.1

—

3.19

—

Covid-19 suspected case

170

1666

1.02

0.08

1.0

1.1

4.24

3.08

u/ml

0.39

868

Other disorders of pigmentation

185

1.08

0.08

1.3

1.0

1.17

2.26

u/ml

—

Other disorders of optic [2nd] nerve and visual pathways

328

0.94

0.08

1.0

1.1

1.68

3.53

u/ml

1.00

146

Supervision of high-risk pregnancy

201

1187

1.02

0.08

1.1

1.86

2.77

u/ml

1.54

102

683

Other appendicitis

460

1.04

0.08

1.0

1.1

4.95

3.21

u/ml

0.20

223

HSIL lesion of the cervix uteri, vagina or vulva

180

1834

0.98

0.08

1.0

1.1

2.41

2.90

u/ml

0.35

104

1017

Family history of other specific disorders

1.13

0.07

1.0

1.1

4.73

2.09

u/ml

—

Sequelae of injuries of head

264

1.06

0.07

1.0

6.77

2.20

u/ml

0.64

126

Cardiomyopathy

662

0.97

0.07

1.1

2.67

3.18

u/ml

0.24

289

Other renal tubulo-interstitial diseases

137

1.10

0.07

1.3

1.1

6.02

2.39

u/ml

—

Contact with machinery

451

1.04

0.07

1.1

2.81

2.56

u/ml

0.06

233

Viral hepatitis, IBD co-morbidity

333

1.05

0.07

1.1

5.00

3.63

u/ml

—

215

Primary coxarthrosis, bilateral

975

0.97

0.07

1.1

2.19

4.15

u/ml

1.63

335

Other and unspecified mood [affective] disorders

550

1.04

0.07

1.1

1.36

2.87

u/ml

2.00

309

Diseases of spleen

1.03

0.07

1.0

1.1

—

1.19

—

Cholecystitis

540

1.04

0.07

1.0

1.1

3.46

2.95

u/ml

0.19

226

Benign neoplasm: Liver

147

1.09

0.07

1.0

1.1

1.65

2.51

u/ml

—

Disorders of choroid and retina

468

3291

1.01

0.07

1.1

4.65

3.26

u/ml

0.68

173

1515

Traumatic amputation of wrist and hand

163

0.92

0.07

1.0

1.1

1.54

3.15

u/ml

—

Benign neoplasm: Duodenum

1.02

0.07

1.0

—

1.67

—

Pulmonary heart disease, diseases of pulmonary circulation

133

1303

1.02

0.07

1.1

6.07

3.54

u/ml

0.48

511

Nephrotic syndrome

167

1.08

0.07

1.1

5.08

2.54

u/ml

—

Malignant neoplasm of bladder, including Hilmo

273

1.06

0.07

1.1

0.94

4.64

u/ml

—

Other facial nerve disorders

128

1.09

0.06

1.1

1.61

2.25

u/ml

—

Ulcerative rectosigmoiditis

482

1.04

0.06

1.0

1.1

1.87

2.80

u/ml

0.86

250

Polypectomy (DHB20)

285

1.05

0.06

1.1

1.0

1.33

2.45

u/ml

1.40

121

Entropion and trichiasis of eyelid

226

1.06

0.06

1.0

1.1

3.22

2.28

u/ml

—

Malignant neoplasm of urinary organs

285

1.05

0.06

1.1

13.60

3.03

u/ml

—

100

Impacted maxillary molar

502

1.04

0.06

1.2

1.0

8.87

2.37

u/ml

1.00

263

Later onset COPD

510

1.03

0.06

1.1

14.02

4.51

u/ml

—

Dissociative [conversion] disorders

254

0.94

0.06

1.1

1.0

1.36

2.22

u/ml

—

138

Congenital malformations of the respiratory system

111

0.90

0.06

1.0

1.1

2.48

5.98

u/ml

—

Other noninflammatory disorders of uterus, except cervix

101

665

1.02

0.06

1.1

1.79

3.63

u/ml

1.62

294

Other and unspecified nail disorders

109

1.10

0.06

1.1

1.0

0.96

1.97

u/ml

—

Acute appendicitis, with complications

104

1018

1.02

0.06

1.1

3.14

3.31

u/ml

0.04

499

Use of interferon beta-1a

168

1.07

0.06

1.3

1.1

0.65

2.45

u/ml

—

Use of memantine

512

0.97

0.06

1.1

3.86

4.32

u/ml

0.07

Use of other anti-dementia drugs

512

0.97

0.06

1.1

3.86

4.32

u/ml

0.07

Melanocytic naevi, other sites/unspecified

454

1.04

0.05

1.2

1.0

4.01

2.43

u/ml

0.36

225

Convergent concomitant strabismus

405

0.96

0.05

1.2

1.0

5.34

3.37

u/ml

0.29

213

Gingival hyperplasia

192

0.94

0.05

1.0

1.1

4.18

2.14

u/ml

—

Misadventures to patients during surgical and medical care

712

1.03

0.05

1.0

1.1

3.18

3.12

u/ml

0.01

318

Obstructed labour due to malposition and malpresentation of fetus

223

2054

1.01

0.05

1.1

2.06

2.50

u/ml

0.69

122

1199

Speech disturbances, not elsewhere classified

344

0.96

0.05

1.1

3.92

2.32

u/ml

0.55

138

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

435

0.97

0.05

1.0

1.1

2.05

2.71

u/ml

0.40

215

Disorders of lipoprotein metabolism and other lipidaemias

497

3101

0.99

0.05

1.1

3.32

3.18

u/ml

0.08

179

1528

All-cause Heart Failure

209

1494

0.99

0.05

1.1

8.07

3.66

u/ml

0.84

520

Explicit bacterial Sepsis

445

1.03

0.05

1.0

1.1

5.64

2.41

u/ml

0.56

189

Condition for Implicit Sepsis (Organ dysfunction codes)

666

4619

0.99

0.05

1.1

2.93

2.99

u/ml

0.04

256

2274

Mixed conductive and sensorineural hearing loss

465

0.97

0.05

1.1

2.81

2.93

u/ml

0.03

182

Chromosomal abnormalities, not elsewhere classified

188

1.06

0.05

1.1

4.85

3.85

u/ml

0.13

Acute bronchiolitis

446

0.97

0.05

1.0

1.1

4.55

3.17

u/ml

0.22

156

Contusion of toe(s) without damage to nail

159

1.07

0.05

1.1

2.32

2.34

u/ml

—

Hydronephrosis

475

1.03

0.05

1.0

1.1

1.64

2.67

u/ml

0.76

194

Benign neoplasm: Cerebral meninges

386

1.04

0.05

1.1

1.0

3.70

3.28

u/ml

0.08

154

Other pleural conditions

313

0.96

0.05

1.0

1.1

3.90

2.31

u/ml

—

104

Other disorders starting during childhood or adolecense, excluding more controls

406

0.97

0.05

1.0

1.1

2.83

3.96

u/ml

—

188

Molar incisor enamel hypoplasia

311

0.96

0.05

1.1

3.62

4.98

u/ml

0.28

108

Myocardial infarction, without ST-elevation

126

1166

0.98

0.04

1.1

11.72

4.17

u/ml

0.88

392

Early lumbar disc prolapse operation

843

1.02

0.04

1.1

3.14

3.45

u/ml

0.09

489

Secondary uncertain malignant neoplasm

466

1.03

0.04

1.0

1.1

1.81

3.12

u/ml

1.01

186

Aortic valve malfunction, age under 60 years

486

1.03

0.04

1.0

1.1

1.44

3.01

u/ml

2.54

251

Other disorders of binocular movement

140

0.93

0.04

1.0

1.1

2.02

2.05

u/ml

—

Injury of muscle and tendon at ankle and foot level

140

0.93

0.04

1.1

1.0

2.76

1.96

u/ml

—

Coxarthrosis

255

1667

1.01

0.04

1.1

2.07

3.07

u/ml

1.64

786

Infective dermatitis

536

1.03

0.04

1.1

9.56

3.45

u/ml

0.54

255

Malignant neoplasm of prostate, including Hilmo

515

0.98

0.04

1.0

1.1

3.14

4.01

u/ml

0.24

205

Benign neoplasm of ovary

884

1.02

0.04

1.0

1.1

1.72

3.61

u/ml

1.97

387

Acute peritonitis

249

1.04

0.04

1.0

1.1

4.15

2.50

u/ml

—

102

Atopic conjunctivitis

269

1.04

0.04

1.2

1.0

1.59

2.08

u/ml

0.41

125

Benign neoplasm: Long bones of lower limb

200

0.95

0.03

1.0

1.73

2.31

u/ml

—

Other and unspecified glaucoma

200

1.05

0.03

1.0

1.42

2.01

u/ml

—

Benign neoplasm of middle ear and respiratory system

309

1.04

0.03

1.2

1.0

1.42

2.73

u/ml

1.68

126

Benign neoplasm: Skin of lower limb, including hip

129

0.93

0.03

1.1

1.0

1.40

1.48

u/ml

—

Intracranial trauma

477

3372

0.99

0.03

1.1

2.90

3.09

u/ml

0.14

202

1759

Carrier of infectious disease

131

1.07

0.03

1.0

1.57

1.75

u/ml

—

Influenza and pneumonia

873

5527

1.00

0.03

1.1

3.13

2.91

u/ml

0.17

338

2775

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

369

1.03

0.03

1.0

1.1

1.16

2.96

u/ml

1.89

161

Superficial injuries involving multiple body regions

151

1.06

0.03

1.0

2.28

1.93

u/ml

—

Occupational exposure to risk-factors

151

1.06

0.03

1.1

1.0

0.97

2.24

u/ml

—

Alcohol-induced chronic pancreatitis

260

0.96

0.03

1.0

1.1

4.93

2.76

u/ml

—

118

Exposure to other specified electric current

159

0.94

0.03

1.0

1.00

2.32

u/ml

—

All dysplastic lesions of the vagina

161

1.06

0.03

1.1

1.0

2.96

2.67

u/ml

—

LSIL lesion of the vulva

179

0.95

0.03

1.1

1.0

6.46

2.26

u/ml

—

Gingivitis and periodontal diseases

830

4266

1.00

0.03

1.1

3.36

3.03

u/ml

0.28

394

2122

LSIL lesion of the cervix uteri, vagina or vulva

119

1176

1.01

0.03

1.1

2.60

3.06

u/ml

0.23

659

Pedal cyclist injured in noncollision transport accidents

692

0.98

0.03

1.1

1.81

3.13

u/ml

1.50

344

Assault by sharp object

102

1.08

0.03

1.1

1.0

8.72

1.88

u/ml

—

Heart failure,strict

201

1406

1.01

0.03

1.1

7.32

3.77

u/ml

0.67

522

Pedestrian injured in collision with car, pick-up truck or van

118

0.93

0.02

1.0

2.92

1.91

u/ml

—

Coxarthrosis [arthrosis of hip](FG)

274

1915

1.01

0.02

1.1

2.15

3.32

u/ml

1.91

886

Ulcerative ileocolitis

239

0.96

0.02

1.1

1.07

2.55

u/ml

—

118

Pre-eclampsia or poor fetal growth

282

2827

0.99

0.02

1.1

4.06

2.66

u/ml

0.55

125

1541

Melanocytic naevi of upper limb, including shoulder

128

0.94

0.02

1.2

1.0

0.69

1.91

u/ml

—

Heart failure and bmi 25plus

115

785

0.99

0.02

1.1

10.37

4.25

u/ml

0.72

294

COPD related to multimorbidity

127

1083

0.99

0.02

1.1

7.72

4.21

u/ml

0.49

361

Hordeolum and other deep inflammation of eyelid

341

1.03

0.02

1.1

1.59

2.59

u/ml

0.63

154

COPD, hospital admissions

162

1358

1.01

0.02

1.1

5.63

3.74

u/ml

0.41

493

Pedal cyclist injured in transport accident

144

1428

1.01

0.02

1.1

2.69

3.29

u/ml

0.46

720

Parkinson's disease, strict definition, excluding more controls

306

1.03

0.02

1.1

4.18

4.12

u/ml

—

Scabies

268

0.97

0.02

1.0

1.1

4.77

2.10

u/ml

—

135

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS